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Antibiotic and mercury resistance in the oral cavity
Abstract
The commensal microbiota o f the oral cavity may act as a reservoir o f antibiotic- 
resistant microorganisms, and factors which may promote this antibiotic 
resistance need to be determined. The aims o f this PhD were to determine the 
prevalence and proportion o f antibiotic-resistant bacteria in the cultivable oral 
microbiota isolated from the dental plaque o f healthy children and to investigate 
factors which may promote antibiotic resistance. Such factors may include, 
previous antibiotic use, ethnicity and cross resistance with heavy metal 
resistance genes. To investigate tetracycline-resistant oral bacteria more fu lly, 
the effect this antibiotic has on the antibiotic resistance profile and microbial 
community o f microcosm dental plaques was investigated using an in vitro 
system. The ability o f a tetracycline resistance determinant to transfer w ith in an 
oral b io film  was also determined.
Dental plaque from children aged 4-5 years old was screened for the presence o f 
antibiotic- and mercury-resistant bacteria. The majority o f the children 
harboured a diverse collection o f ampicillin-, penicillin-, erythromycin-, and 
tetracycline-resistant bacteria. None o f the children harboured metronidazole- 
resistant anaerobic bacteria or Gram-positive vancomycin-resistant bacteria. 
Am oxic illin  use in the previous three months increased the number, proportions, 
MICs and cross-resistance profile o f the ampicillin-resistant isolates. The 
percentage o f tetracycline-resistant bacteria was greater in South Asian and 
Japanese children than in white children, suggesting possible ethnic differences 
in the levels o f tetracycline-resistant oral bacteria. 71% o f the children harboured 
mercury-resistant oral bacteria and the median percentage o f the total oral
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microbiota resistant to mercuric chloride was 0.007% (range 0-5.3%). 60% o f 
the mercury-resistant isolates were also resistant to at least one o f the four 
antibiotics tested. Using a model system it was shown that the addition o f 
tetracycline to microcosm dental plaques altered the composition and enriched 
for antibiotic-resistant bacteria to tetracycline and other unrelated agents. 
Tetracycline resistance was shown to transfer in a model oral system.
It is hoped that this work w ill help in evaluating factors which promote antibiotic 
resistance in the oral cavity o f children.
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1.1 The British Government's view
In his Explanatory Memorandum o f 19 July 2001, the Parliamentary Under­
secretary o f State at the Department o f Health (Lord Hunt) stated that antimicrobial 
resistance is a “ major public health issue which the Government takes very 
seriously” . He added that the Government had published a three year strategy and 
action plan to minimise morbidity and mortality due to infections by antimicrobial- 
resistant microorganisms and to maintain the effectiveness o f antimicrobial agents 
in the treatment and prevention o f infections in man.
1.2 Bacteria of the oral cavity
It has been estimated that between 400 and 1000 taxa may be present in the oral 
cavity and bacteria isolated from the oral cavity include obligate aerobic, facultative 
and obligate anaerobic bacteria, many o f which are specific to this region o f the 
human body (Haffajee et al., 1999). The main areas that bacteria may be isolated 
from include dental plaque present on the exterior tooth surface above 
(supragingival plaque) and below (subgingival plaque) the gingival margin, mucosal 
epithelial cells and saliva. The oral microbiota w ill change in its composition over 
time and in response to external factors. Such factors include: whether the subject 
has teeth or synthetic materials in the oral cavity, the age, race and health o f the 
subject, the level o f circulating hormones, the subject’s diet and the use o f 
medication. In addition to these factors, each day a variety o f microbes are ingested 
with food and drinks or inhaled from the air, thus the exact composition o f the
26
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microbiota at any given point w ill vary within individuals over time and the region 
o f the oral cavity examined (Roberts, 1998). In addition, bacteria from the oral 
cavity are able to reach other areas o f the human body by being swallowed, inhaled 
or even entering the circulatory system after dental procedures such as tooth 
extraction or by chewing or flossing between teeth (Seymour et al., 2000). These 
mechanisms allow the oral microbiota to leave the oral cavity and spread throughout 
the body providing new opportunities to interact with bacteria from different 
ecosystems and potentially cause infections at other body sites.
1.2.1 Dental plaque
Dental plaque is an example o f an oral biofilm, it is a diverse microbial community 
found on the tooth surface embedded in a matrix o f polymers o f bacterial and 
salivary origin (Figure 1.1). Plaque grows as a dense, structurally complex, biofilm, 
containing a large number o f different bacteria (Marsh, 1995; Listgarten, 1976). 
After tooth cleaning, a conditioning film  o f proteins and glycoproteins adsorbs 
rapidly to the tooth surface. The subsequent formation o f plaque involves the 
interaction between early bacterial colonisers and the conditioning film  (the 
acquired enamel pellicle). During microbial colonisation o f the tooth surface, some 
receptors on salivary molecules are only exposed to bacteria once the molecule is 
adsorbed to a surface (Marsh and Bradshaw, 1995). The primary colonisers include 
Neisseria and streptococci, predominantly Streptococcus sanguis and Streptococcus 
oralis (McBride and Gislow, 1977; Shibata et al., 1980). These pioneer populations 
multiply, forming micro-colonies and secrete the extracellular matrix. Salivary
27
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polymers w ill continue to be adsorbed on to bacteria already on the tooth surface 
and so contribute to the extracellular matrix. Eventually, growth o f individual 
colonies results in the formation o f a confluent film. As the plaque develops, the 
metabolism o f the pioneer species creates an environment suitable for further 
colonisation by bacteria with more demanding atmospheric and nutritional 
requirements. Oxygen is consumed by the aerobic and facultatively anaerobic 
species and replaced with carbon dioxide. This allows the colonisation o f anaerobic 
rods and filaments, which i f  the plaque is allowed to accumulate, can dominate the 
climax community. Metabolic end-products o f primary colonisers can serve as 
nutrients for other organisms e.g. some strains o f Streptococcus mutans require p- 
aminobenzoic acid for growth, and this could be supplied by S. sanguis (Marsh and 
Bradshaw, 1995). This process o f plaque formation leads to an increase in the 




Figure 1.1 Disclosing solution showing dental plaque (a) and a Transmission 
electron micrograph o f in vivo dental plaque (b). Bar represents 10 pm 
(Vvahopoulos, 1989).
1.3  Defining an antib io tic
Antibiotics are chemotherapeutic agents used for the treatment o f bacterial 
infections. These agents must display selective toxicity to be clinically useful, with 
the ability to k ill (bactericidal agents) or inhibit (bacteriostatic agents) the growth o f 
a bacterium without damaging the mammalian host cells. There are two main groups 
o f chemotherapeutic agents classified on the basis o f their origin; the naturally- 
produced antibiotics and the synthetic drugs. The medical dictionary definition o f an 
antibiotic is any antibacterial agent that is derived from a microorganism (Black’s 
Medical Dictionary, 1990); such products include penicillin, streptomycin, 
vancomycin, chloramphenicol and chlortetracycline. Although in practice the term
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antibiotic is often used to describe any antibacterial agent whether it was derived 
from a microorganism or was synthetically produced.
1.4 Antibiotic use
1.4.1 Worldwide use of antibiotics
The introduction into clinical practice o f the sulphonamides in 1935 and penicillin 
in 1943 heralded not only the beginning o f effective life-saving treatment o f 
bacterial infections but also an era in which antibiotics were and still are heavily 
used throughout the world. When comparing antibiotic use, the unit approved by the 
World Heath Organisation is the defined daily dose (DDD) per 1000 population per 
day and is based on the assumed average daily dose o f a drug when used by adults 
for its main indication (Nordic Council on Medicines, 1993). I f  one examines the 
DDD for 4 European countries (Figure 1.2), it can be seen that large quantities o f 





France Italy UK Germany
Figure 1.2 The DDD o f oral antibiotics in four European countries (McManus, 
1997; Cars et al., 2001; ESAC, 2004)
1.4.2 Antibiotic exposure
Antibiotics are prescribed in medicine and in dentistry to treat and prevent a variety 
o f infectious diseases and as patients we are frequently exposed to these agents. 
However, in addition to the controlled use o f antibiotics, exposure may result from 
self-administered antibiotics or via environmental exposure either from a 
contaminated environment or from food containing antibiotic residuals (Figure 1.3).
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Exposure to antibiotics
Figure 1.3 Human exposures to antibiotics
1.4.3 Medical and dental prescribed antibiotic use
Several studies have investigated antibiotic prescription, one such study reported 
that antibacterials were given to 63% of children by 1 year of birth, this increased 
with age with 75% of children having received an antibacterial agent within 2 years 
of their birth (Steinke et a l, 2002). In the USA, longitudinal data were collected 
from a cohort of 789 children recruited at birth from 8 hospitals. Antibiotic use was 
shown to be common in the cohort and again increased with age. At 50, 100, 150, 
and 200 days of life, 8.7%, 26.7%, 37.3%, and 70.5%, respectively, of the infants 
had used at least 1 antibiotic. Infants were most frequently treated with amoxicillin 
and otitis media (inflammation of the inner ear) was the infection that most 
commonly prompted antibiotic use (Bergus et a l, 1996). These findings concur with 
the results of a UK study of 7 -  8 year old children in which amoxicillin was also
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the most frequently used antibiotic. Additionally, only 6.7% o f the children had 
never taken an antibiotic and the majority o f children had received multiple 
prescriptions during their lives (M iller et al., 2001). Other studies have 
demonstrated that disproportionate quantities o f antibiotics are given to children, the 
elderly and those admitted to hospital (Roberts, 1998; van Houten et al., 1998). 
However, not all prescriptions are appropriate and the inappropriate use o f 
antibiotics is a concern not only in the medical, dental and scientific community but 
also for the British Government (House o f Lords, 1998; Department o f Health, 
1998). Bauchner and Philipp (1999) surveyed the level o f inappropriate antibiotic 
prescription in 1000 paediatricians. The physicians were chosen randomly by the 
American Academy o f Paediatrics and o f those surveyed, 40% indicated that 10 or 
more times in the past month a parent had requested an antibiotic when the 
physician did not feel it was indicated. In follow-up questions, approximately one- 
third o f these physicians reported they occasionally, or more frequently, complied 
with these requests. Palmer et al. (2000) reported that over 40% o f general dental 
practitioners would prescribe prophylactic antibiotics for minor oral surgery to 
prevent postoperative infection in the absence o f any relevant medical history.
1.4.4 Self-administered antibiotic use
In addition to the controlled administration o f antibiotics, it is possible in many 
countries to acquire antibiotics without a medical or dental practitioner’s 
prescription (Hart and Kariuki, 1998; Borg and Scicluna, 2002). This ‘over-the- 
counter’ use o f antibiotics (self-medication) has been reported to be prevalent in
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developing countries and also documented in Western Europe (Hart and Kariuki, 
1998; DOH, 1998; Borg and Scicluna, 2002). A study carried out in Malta, a 
country in which dispensing antibiotics without a prescription is illegal, found 19% 
o f subjects questioned reported taking antibiotics without a prescription. 
Interestingly, this proportion increased with an increase in the education levels, with 
31% o f university graduates taking antibiotics without prescription (Borg and 
Scicluna, 2002). Antibiotics were obtained from a pharmacy in 86% o f the cases; 
pharmacists reported that the illegal sale o f antibiotics was due to financial 
competition with other pharmacies. Although at the present time in the UK it is 
illegal to sell antibiotics without a prescription, some antivirals and antifungals can 
currently be purchased over the counter and it has been suggested that a limited 
number o f antibiotics could also be sold without a prescription for the treatment o f 
specific infections (Reeves et al., 1999). However, the theoretical impact on 
antibiotic resistance as highlight by Sir Alexander Fleming in 1946, o f such 
legislation may well prevent this change in license status.
“the greatest possibility o f evil in self-medication is the use o f too small doses so 
that instead o f clearing up infection, the microbes are educated to resist penicillin 
and a host o f penicillin-fast organisms is bred out which can be passed to other 
individuals and from them to others until they reach someone who gets septicaemia 
or a pneumonia which penicillin cannot save. ”




People can come into contact with antibiotics via the ingestion o f food and by 
association with contaminated environments. This may occur on a farm or a fishery 
where antibiotics are used in veterinary medicine, prior to 1999, they were also 
frequently used as growth promoters, resulting in contamination o f the local 
environment (Levy, 1992). However, the EU banned the use o f five antibiotics for 
growth promotion in 1999, on the basis o f the “ Precautionary Principle” . These 
antibiotics were avoparcin (a glycopeptide), bacitracin, spiramycin and tylosin 
(macrolides), and virginiamycin (a streptogramin combination). Unfortunately, there 
has been a substantial increase in the use o f therapeutic antibiotics in Europe 
(Muirhead, 2002; Veterinary Medicines Directorate, 2002). In Denmark an overall 
increase from 48 tonnes in 1968 to 94 tonnes in 2001 has been reported (Bager and 
Emborg, 2001). The main antibiotics involved in this increase have been 
tetracycline, mostly used in pigs, whose usage increased from 12.9 to 27.9 tonnes (a 
106% increase), macrolides and lincosamides (7.6 to 14.3 tonnes, 88%), and 
aminoglycosides (7.1 to 11.9 tonnes, 68%) (Bager and Emborg, 2001; Bager et al., 
2002).
An additional antibiotic burden may be present in food sources either in animals 
given therapeutic antibiotics in the UK or imported foods where the use o f 
antibiotics as growth promoters is still practiced. In the seafood industry 
(aquaculture), antibiotics are used to reduce disease in intensive seafood farming 
systems. The Public Health Laboratory Service surveyed 98 cooked prawns from 
Malaysia, Thailand and Indonesia and detected trimethoprim in 15 samples and low
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levels o f gentamicin in 3 samples (W illis et al., 1999). It has been reported that more 
than half o f the antimicrobial agents produced worldwide are used in animal 
husbandry, inappropriate use o f antibiotics in agriculture and aquaculture may 
therefore constitute an additional antibiotic burden on man (Wilcox, 1998).
1.5 Antibiotic resistance
1.5.1 Defining antibiotic resistance
The word resistance originates from the latin word “ re-sisto ” meaning to withstand. 
Antibiotic resistance is therefore defined as the natural or acquired ability o f an 
organism to resist the killing or inhibitory effects o f an antibiotic (Black’s Medical 
Dictionary, 1990). Antibiotic resistance can be classified as either intrinsic or 
acquired resistance. Intrinsic resistance is a result o f inherent features o f the 
bacterium that prevent antibiotic action. An example o f intrinsic resistance can be 
demonstrated in Pseudomonas aeruginosa, which is intrinsically resistant to 
tetracycline as the antibiotic may only penetrate the outer membrane poorly. 
Acquired resistance however, refers to the emergence o f resistant strains from a 
previously susceptible population and has been observed after antibiotic exposure 
(Ingham et al., 1978). This form o f resistance may result from spontaneous point 
mutations o f chromosomal genes. Point mutations generally result in a microbe that 
is more resistant to the antibiotic than its parent, providing a moderate increase in 
the level o f antibiotic resistance. High-level resistance to an antibiotic as a result o f 
such mutations usually requires multiple changes (Roberts, 1989). Alternatively, 
resistance may be acquired from other bacteria via mobile genetic elements, which
36
introduction
may confer resistance to a single agent or several antibacterial agents (Gentry, 1991, 
Roberts et al., 1999).
1.5.2 Emergence and spread of antibiotic resistance
The emergence o f drug resistance as a practical clinical problem was soon realised 
after the introduction o f antibiotics (Table 1.1). Within a few years, sulphonamide- 
resistant strains o f bacteria were common (Mitsuhashi, 1993). By 1946, the 
proportion o f penicillin-resistant bacteria had significantly increased and by 1960, 
penicillin-resistant Staphylococcus aureus had not only emerged in the hospital 
setting but was responsible for the majority o f all nosocomial (hospital acquired) 
infections (Fekety, 1964). The Pharmaceutical Industry has endeavoured to match 
this rate o f microbial resistance by innovation and the discovery o f novel products. 
Since the introduction o f benzyl penicillin (penicillin G) in 1943, the major classes 
o f antibiotics have been developed. Between 1944 and 1948 the aminoglycosides, 
steroids, fusidic acid, chloramphenicol and tetracyclines were discovered. The 
1950’s lead to the discovery o f the glycopeptides, macrolides, novobiocin and 
rifamycins. However, despite the introduction o f these different products, not a 




Table 1.1 The date that antibiotics were first introduced into clinical practice and 





Time for resistance 
to emerge (years)
Penicillin 1943 1946 3
Ampicillin 1961 1973 12
Erythromycin 1952 1988 36
Tetracycline 1948 1959 11
Vancomycin 1956 1988 32
Metronidazole 1962 1978 16
(Ingham et al., 1978; Samuelson, 1999; Palumbi, 2001).
1.6 Antimicrobial agents investigated in this study
1.6.1 Penicillin /  Ampicillin
Penicillin and ampicillin are members o f the B-lactam group o f antibiotics and are 
considered to be bactericidal antibiotics. Penicillin (penicillin G) was the first 
member o f this group to be used commercially and was introduced into clinical 
practice in 1941 (Slocombe, 1994). The synthesis and structural modification o f the 
B-lactam nucleus o f penicillin lead to the development o f ampicillin as a clinically- 
effective therapeutic agent (Kidwai et al., 1999). The B-lactam group produces few
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side effects and has a good level o f bacterial toxicity, making them the most 
commonly-used group o f antibiotics worldwide accounting for over 65% o f the 
world antibiotic market (Elander, 2003).
1.6.1.1 Antibiotic structure
The B-lactam group o f antibiotics derives its name from the possession o f a four- 
membered cyclic amide ring, often referred to as the B-lactam ring (Fig. 1.4). The 
different groups within the family are distinguished by the structure o f the ring 
attached to the B-lactam ring; for penicillin and ampicillin this is a five membered 





Figure 1.4 Structure o f penicillin and ampicillin
1.6 .1 .2  Spectrum o f activity and clinical use
Penicillin and ampicillin have an important role in the treatment o f many oral and 
respiratory infections. They have antibacterial activity against both Gram-positive 
and Gram-negative bacteria including aerobic and anaerobic organisms. Ampicillin
b (CH,)2






is used in susceptibility testing for the determination o f resistance to the more 
frequently prescribed antibiotic amoxicillin (NCCLS, 2003; Andrews, 2001).
1.6 .1 .3  Clinical use in oral infections
Penicillin and ampicillin are used widely in the treatment o f oral infections. 
Orofacial infections caused by pathogens from the oral cavity (odontogenic 
infections) frequently are mixed infections in which aerobic and anaerobic bacteria 
and fungi can be involved (Piesold et al., 1999). Penicillins, often in conjunction 
with surgical therapy, are often used for the management o f these infections (Piesold 
et al., 1999; Swift and Gulden, 2002). A study by Akimoto et al., (1994) 
demonstrated that the peak levels o f amoxicillin in pus from odontogenic infection 
exceeded the MIC for 90% o f alpha-haemolytic streptococci that had previously 
been isolated from odontogenic infection. The recommended treatment for an acute 
dental abscess is 2 high doses o f amoxicillin (BNF, 2004) and penicillin has also be 
used successfully (Lewis et al., 1993). Oral bacteria may also cause infection in sites 
other than the oral cavity. In community acquired pneumonia and lung abscesses, 
infection may be caused by anaerobic bacteria, for which it has been suggested that 
the oral cavity may be a major source (Scannapieco and Mylotte, 1996). A case o f 
infection with Actinobacillus actinomycetemcomitans leading to the development o f 
pleural abscess was reported by Chen et al., (1995), oral amoxicillin was given for a 
period o f 3 months, leading to the patient’s recovery without any sequelae. 
Periodontitis is an inflammatory disease o f the tissues supporting the teeth and is a 
result o f immune responses to periodontopathic pathogens (predominantly Gram-
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negative anaerobic bacteria; Haffajee et al., 1999). The adjunctive use o f antibiotics 
has become a recognised approach in the clinical treatment o f such patients 
(Tenenbaum et al., 1997). Tetracycline is still the recommended antibiotic for 
treatment (BNF, 2003), however due to resistance to this agent, the use o f 
amoxicillin has become more popular in the treatment o f periodontal diseases 
frequently in conjunction with metronidazole (Abu-Fanas et al., 1991; Klienfelder et 
al., 1999; Walker and Karpinia, 2002).
1.6.1 .4 Clinical use fo r endocarditis
High doses o f oral or intravenous amoxicillin generally administered 1 hour before 
specific dental procedures are carried out, are prescribed to prevent infective 
endocarditis (IE) caused by members o f the oral microbiota in “ at risk”  patients 
(BNF, 2003). IE is an infection o f the endocardial (inner) surfaces o f the heart, 
which normally affects abnormal or prosthetic heart valves and, i f  untreated, has a 
mortality rate approaching 100% (Seymour et al., 2000). Bacteria that are present in 
the oral cavity, in particular the oral streptococci, have been shown to be important 
causative agents o f this infection and can enter the circulatory system after dental 
procedures are carried out leading to a bacteraemia and a possible reservoir o f 
infection. The prophylactic use o f antibiotics to prevent IE caused by post-procedure 
bacteraemia is a controversial issue, the incidence o f IE has not reduced after the 
implementation o f prophylaxis and many patients have developed IE after receiving 
prophylaxis (Lockhart, 2000; Seymour et al., 2000). However, the use o f antibiotics
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for these procedures accounts for approximately 25% o f all the antibiotics 
prescribed in dentistry (Epstein et al., 2000).
1 .6 .1 .5  Penicillin /  am picillin mode o f action
Penicillin and ampicillin are inhibitors o f bacterial cell wall synthesis and exert their 
activity through a complex process involving the binding o f the antibiotic to 
proteins that are located on the bacterial cytoplasmic membrane. As a consequence, 
in Gram-negative organisms penicillin and ampicillin must cross the outer 
membrane to exert their inhibitory effects. The majority o f B-lactam antibiotics 
cross the outer membrane by passive diffusion through porin channels. The influx 
rate is dependent on several factors including: hydrophobicity, size and net charge 
o f the antibiotic. As a general rule, the greater the hydrophobicity, size or net charge 
o f the antibiotic the lower the rate o f permeation through the porin channels 
(Gentry, 1991). Once they have reached their target site they interrupt the 
transpeptidation process that links the peptidoglycan components o f the bacterial 
cell wall to one another (Roberts, 1998). Peptidoglycan is a vital component o f the 
cell wall that is unique to bacteria and consequently provides an excellent target for 
selective toxicity (Ghuysen, 1994). It comprises approximately 50% o f the weight o f 
a Gram-positive bacterial wall and is composed o f sugar (glycan) chains, which are 
cross-linked by short peptide bridges. In the final cross-linking stage o f 
peptidoglycan synthesis, linear glycan strands are cross-linked via their peptide 
chains to the mature peptidoglycan cell wall. It is the transpeptidase enzymes that 
catalyse this cross-linking (Ghuysen, 1994). Penicillin and ampicillin inhibit
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transpeptidation by acting as an alternative substrate for the transpeptidase. They 
mimic the D-alanyl-D-alanine residues o f the natural substrate. The B-lactam bond 
is broken within the antibiotic and the transpeptidase binds to the ring. Whilst the 
transpeptidase is bound to the ring, it cannot participate in further rounds o f 
peptidoglycan cross-linking by reaction with its true substrate. The transpeptidase 
enzymes are consequently referred to as penicillin binding proteins (PBPs). The 
PBPs demonstrate varying affinities for the different B-lactam agents resulting in 
variability in susceptibility to a range o f B-lactam antibiotics (Roberts, 1998).
It was thought for many years that these agents worked solely by the inhibition o f 
the cross-linking reaction between peptide side chains in the peptidoglycan, 
resulting in an osmotically-fragile organism. It is now understood that B-lactam 
antibiotics bind several PBPs in the bacterial cell membranes. Inhibition o f one or 
more o f these essential enzymes results in the accumulation o f precursor cell wall 
units activating the cell’s autolytic system resulting in cell lysis (Roberts, 1998).
1.6.1.6 Mechanisms of penicillin and ampicillin resistance
1.6.1.6.1 (3-lactamases
The production o f a bacterial enzyme known as a B-lactamase is the most frequent 
resistance mechanism demonstrated by Gram-negative bacteria to the B-lactam 
antibiotics, although Gram-positive bacteria can also produce these enzymes 
(Murray, 1992; Bush et al., 1995). B-lactamases can catalyse the hydrolysis o f 
penicillin G and ampicillin to penicillinoic acid and ampicillinoic acid, respectively 
which destroys the antibiotic’s activity (Gentry, 1991; Kishore et al., 1994; Roberts,
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1998). The genes for these enzymes are ubiquitous and can be found on plasmids, 
transposons, integrons, or the chromosomes o f different bacterial species (Bush et 
al., 1995). The first 6-lactamase described in an oral bacterium was the TEM-1 6- 
lactamase in Haemophilus influenzae, this enzyme was thought to have originated in 
Escherichia coli (Elwell et al., 1975) and is still the most common 6-lactamase 
found in Gram-negative organisms (Roberts, 1998). More recently, 6-lactamases 
from Tannerella forsythensis (formerly Bacteriodes forsythus), Capnocytophaga 
spp., Prevotella melaninogenica and Veillonella spp. have been described (Roscoe 
et al., 1992; Bush et al., 1995).
1.6.1.6.2 Non-enzymatic resistance
Resistance to 6-lactam antibiotics may also be achieved without the production o f 6- 
lactamases although such mechanisms are generally less common (Roberts, 1989). 
These mechanisms have been demonstrated in both Gram-positive and Gram- 
negative organisms (Rice, 1999; Roberts, 1998). In bacteria that are naturally 
transformable (H. influenzae, Neisseria spp. and streptococci) resistance may be 
achieved by replacement o f parts o f the PBP-encoding genes with corresponding 
regions from more resistant species (Roberts, 1998). In Strep, pneumoniae, 
resistance to 6-lactam antibiotics has been shown to be due to reduced affinity for 
the antibiotic o f the high molecular mass PBPs and this has arisen by horizontal 
gene transfer (Hakenbeck et al., 1986; Dowson et al., 1989; Dowson et al., 1993; 
Barcus et al., 1995). In penicillin-resistant Neisseria meningitidis, the PBP 2 gene 
(penA) has arisen by the introduction o f regions from the penA genes o f two oral
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commensal species, N. flavescens and N. cineria (Bowler et al., 1994; Dowson et 
al., 1989). Chromosomal DNA from N. flavescens and N. cineria were shown to 
transform a penicillin-susceptible N. meningitidis to increased levels o f penicillin 
resistance (Bowler et al., 1994). In bacteria that have not been demonstrated to be 
naturally transformable such as staphylococci, the mecA resistance gene encoding a 
PBP 2 has been isolated (Ubukata et al., 1990). The mecA has been identified on a 
Staph, aureus transposon Tn4291, which may account for its dispersal among the 
staphylococci (Trees and Iandolo, 1988).
1 .6 .1 .7  Prevalence o f penicillin- and am piciiiin-resistant bacteria
Resistance to penicillin and ampicillin in important oral isolates is o f clinical 
significance in dentistry due to the wide use o f these antibiotics in patient treatment. 
In one study, the percentage o f viable microorganisms isolated from the total saliva 
microbiota that were resistant to ampicillin (16 pg/ml) was very low with a median 
value o f zero (Edlund et al., 1996). Walker et al. (1983) found that the penicillins, 
with the exception o f cloxacillin, were the most effective group o f antibiotics at 
inhibiting bacteria isolated from the subgingival microbiota o f periodontally- 
diseased patients. Benzylpenicillin was shown to consistently inhibit the growth o f 
90% o f the total viable microbiota, while ampicillin was shown to frequently inhibit 
99% or more o f the total viable bacteria isolated (Walker et al., 1983). However, in 
clinical practice ampiciiiin-resistant organisms are a concern in the treatment o f oral 
infections. The increasingly high prevalence o f B-lactamase production in isolates o f 
Prevotella intermedia may be diminishing the usefulness o f amoxicillin for the
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treatment o f active forms o f periodontal diseases (Handal et al., 2004). Penicillin- 
resistant microbes isolated from patients with adult periodontitis include species o f 
Bacteroides, Veillonella, Haemophilus, Eikenella, and Capnocytophaga (Kinder et 
al., 1986). The incidence o f antibiotic-resistant microbiota may be increased further 
by the use o f antibiotics as demonstrated when proportions o f penicillin-resistant 
pigmented Bacteriodes and Veillonella species were shown to be greater in subjects 
with recent penicillin exposure (Kinder et al., 1986).
1.6.2 Erythromycin
The macrolide group o f antibiotics has been in use since the early 1950s and 
erythromycin is the most widely used member o f this group (Klein, 1997; Neu 
1991). Erythromycin is classified as a bacteriostatic agent (inhibits bacterial growth) 
(Berry et al., 1998), however it may demonstrate bactericidal activity at higher 
concentrations against a range o f microorganisms, including Streptococcus 
pneumoniae and the periodontal pathogen Actinobacillus actinomycetemcomitans 
(Ednie et al., 1996; Piccolomini et al., 1998). It is considered a safe antibiotic with a 
low risk o f serious side effects, although gastric distress occurs in a significant 
proportion o f patients (Klein, 1997).
1.6.2.1 Erythromycin structure
The macrolide group o f antibiotics derives their name from the possession o f a large 
cyclic molecule, the macrocyclic lactone nucleus (Neu, 1991). The chemical 
structure o f erythromycin consists o f a macrocyclic lactone ring attached to two
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sugar moieties, desoamine and cladinose (Fig. 1.5) (Gharbi-Bebarous, 1991). 













Figure 1.5 Structure o f erythromycin
1.6.2.2 Spectrum o f activity and clinical use
Erythromycin is predominantly active against Gram-positive bacteria, however it is 
effective against some Gram-negative and cell wall-free species. The spectrum o f 
activity o f this antibiotic covers many respiratory pathogens including; H. 
influenzae, Bordetella pertussis, Legionella pneumophila, Mycoplasma pneumoniae, 
Mycobacterium avium complex, non-tuberculous mycobacteria, Chlamydia
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pneumoniae and Chlamydia trachomatis (Amsden 1996; Klein, 1997; Alvarez- 
Elcoro and Enzler, 1999). The mode o f administration is either oral or intravenous. 
Erythromycin is clinically effective for the treatment o f common respiratory and 
skin/skin-structure infections, particularly in children (Amsden, 1996; Neu, 1991). 
Bacterial pneumonia is often the result o f aspiration o f the oropharyngeal microbiota 
into the lower respiratory tract. The host defence mechanisms fail to eliminate the 
contaminating bacteria, allowing them to multiply in the lung resulting in infection 
(Scannapieco and Mylotte, 1996). Erythromycin use is indicated for the treatment o f 
bacterial pneumonia (Klein, 1997; BNF, 2003) and is the drug o f choice for infants 
and children with a variety o f respiratory infections including: Legionnaire’s 
disease, pertussis, diphtheria, pneumonia, lower respiratory tract infections (Klein, 
1997). It may also be used to treat pharyngitis / tonsillitis in penicillin-allergic 
patients (Tarlow, 1997) and may be used in the treatment o f periodontal diseases 
(Piccolomini et al., 1998). Interest in this group o f antibiotics has increased due to 
the development o f derivatives that have a broader spectrum o f activity than 
erythromycin, such as clarithromycin and azithromycin (Kirst, 1991; Amaya-Tapia 
et al., 1993; Alvarez-Elcoro and Enzler, 1999).
1.6 .2 .3  Erythromycin mode o f action
Erythromycin exhibits its antibacterial action by the inhibition o f RNA-dependent 
protein synthesis (Brisson-Noel et al., 1988). In common with mammalian cells, the 
ability o f bacteria to synthesise proteins is essential for growth and survival. The 
basic mechanism o f protein synthesis is considered to be universal, however,
48
Introduction
bacteria differ from mammalian cells in having ribosomes with a different structure. 
Bacterial ribosomes being smaller (10-20 nm) than eukaryotic ribosomes, with a 
sedimentation coefficient o f 70S comprising a 30S and 50S subunit, compared to the 
80S eukaryotic ribosomes (40S and 60S subunits) (Greenwood et al., 2002). It is by 
preferentially binding to the bacterial ribosome that erythromycin inhibits protein 
synthesis and demonstrates selective toxicity. This is achieved by reversibly binding 
to the donor site on the 50S subunit o f the bacterial ribosome o f susceptible 
organisms and inhibiting elongation o f the peptide chains (Taubman et al., 1963; 
Weisblum, 1995). Peptide translocation is inhibited, a stage in protein synthesis 
when the incoming amino acid would bond to the growing peptide chain, thus 
preventing the transfer o f the peptide chain from the acceptor site and protein 
synthesis (Brisson-Noel et al., 1988).
1.6 .2 .4  Mechanisms o f erythromycin resistance
Gram-negative bacteria are generally considered to be intrinsically-resistant to 
erythromycin as this hydrophobic compound is unlikely to be able to penetrate the 
outer membrane (Russell and Chopra, 1990).
1.6.2.4.1 Erythromycin ribosome methylation {erm)
The most common mechanism o f resistance to erythromycin is by modification o f 
the ribosomal target site (Pechere, 2001). Post-transcriptional modification o f the 
23S rRNA occurs by an adenine-specific A-methyltransferase (methylase) specified 
by a class o f genes bearing the name erm (erythromycin ribosome methylation)
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(Weisblum, 1995). The resultant conformational changes o f the rRNA prevent 
binding o f erythromycin and thereby confer resistance to this antibiotic (Pechere, 
2001). The last decade has witnessed the isolation and characterisation o f 
approximately 30 erm genes. These erm genes may be subdivided into family 
groups (ermA, ermB etc.) dependent on high DNA and amino acid homology, and 
are found in a variety o f oral / respiratory bacteria (Weisblum, 1995; Roberts, 1998). 
Erythromycin resistance by erm genes frequently provides cross-resistance to other 
macrolide antibiotics and the chemically-distinct but functionally-overlapping, 
lincosamide, and streptogramin B antibiotics referred to as MLS resistance 
(Weisblum, 1995).
1.6.2.4.2 Macrolide efflux resistance mechanisms
Two other resistance phenotypes the MS-type (Macrolides and streptogramin B 
resistance) and M-type (Macrolides resistance) have been reported in staphylococci 
and streptococci due to reduced accumulation (Nakajima, 1999). The efflux o f 
erythromycin from the bacterial cell against the concentration gradient requires an 
energy-dependent pump. In Strep, pyogenes and Strep, pneumoniae erythromycin 
resistance has become relatively common due to the presence o f the mefA and mefE 
genes, respectively (Sutcliffe et al., 1996). The efflux mechanisms for erythromycin 
resistance have been reported in Staph, aureus as a result o f the presence o f msrA 




There are several additional mechanisms o f resistance to erythromycin including 
drug inactivation due to hydrolysis o f the lactone ring by plasmid-mediated 
esterases (Barthelemy et al., 1984). Lactobacilli, E. coli and staphylococci (including 
Staph, aureus) have been shown to produce inactivating enzymes. These enzymes 
are relatively rare and usually only confer resistance to a single group o f antibiotics 
in the MLS group (Roberts, 1998; Nakajima, 1999).
1 .6 .2 .5  Prevalence o f erythrom ycin-resistant bacteria
The excessive use o f erythromycin in the 1960’s may have led to the emergence o f 
erythromycin-resistant Staph, aureus. More recently, erythromycin-resistant Strep, 
pyogenes and Strep, pneumoniae have been isolated in the UK, Finland, Australia 
and the USA (Sutcliffe, 1996). A study by Edlund et al., (1996) examining the 
frequency o f antimicrobial resistance in the oral microbiota reported that the median 
percentage o f microorganisms isolated from the total saliva microbiota that were 
resistant to erythromycin (4pg/ml) was 1.4% ranging from 0 -  52%. Important oral 
bacteria containing erythromycin resistance genes include: A.
actinomycetemcomitans, Fusobacterium nucleatum, Streptococcus sanguis and 
Porphyromonas spp. (Roberts, 1998)
1.6.3 Tetracycline
The tetracyclines have been used clinically for over 50 years and are considered a 
relatively safe group o f bacteriostatic antibiotics (Smilack, 1999). With remarkably
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few side effects, a low cost and broad spectrum o f activity, they are a popular group 
o f antibiotics for clinical practice. Tetracycline achieves its selective toxicity by 
actively concentrating in susceptible bacterial cells but not in mammalian cells 
(Chopra et al., 1992). The tetracyclines are the second most widely used group o f 
antibiotics worldwide in total tons used per annum (Col and O’Connor, 1987). In 
1994 in the UK over 20% o f the oral antibiotics sold were tetracyclines (McManus 
et al., 1997). However, their therapeutic use is reported to have declined, as bacterial 
resistance has become more widespread (Roberts, 1998).
1.6.3.1 Tetracycline structure
Their structure consists o f a nucleus containing four fused rings (Fig. 1.6). The 






Figure 1.6 Structure o f tetracycline
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1.6 .3 .2  Spectrum o f activity and clinical use
As the first major broad-spectrum group o f antibiotics, the tetracyclines have been 
used extensively in the treatment o f human infectious diseases and in animal 
medicine (Roberts 1996; 1998). The route o f administration is almost always oral. 
The spectrum o f activity o f this antibiotic is broad, encompassing Gram-positive 
and Gram-negative species, aerobic and anaerobic species, mycoplasmas, 
chylamydiae, mycobacteria and rickettsia. In addition, tetracycline is also active 
against protozoa such as the enteric pathogens Entamoeba histolytica, Giardia 
lamblia and the malarial parasite Plasmodium falciparum (Chopra et al., 1992; 
Roberts, 1996; Smilack, 1999). It is a useful antibiotic for the treatment o f oral and 
respiratory diseases and may be administered for the treatment o f acute exacerbation 
o f chronic bronchitis, atypical pneumonia syndromes, Q fever, psittacosis, skin and 
soft tissue infections, Lyme and rickettsial diseases (Chopra et al., 1992; Roberts, 
1996). The recognition that destructive periodontal diseases may be caused by 
specific bacterial pathogens led to an increased interest in the use o f tetracycline as 
an adjunct to conventional periodontal therapy (Gordon et al., 1981; BNF, 2003). 
However, in clinical practice the results o f these adjunct therapies have been 
variable. The use o f doxycycline, a tetracycline derivative, has been reported to have 
positive clinical effects (Crout et al., 1996; Schroeder et al., 1992), and no 
significant effects (Chaves et al., 1995; Ng and Bissada, 1998). It has been 
suggested more recently that poor absorption o f orally administered tetracyclines in 
many individuals may account for the variability in clinical response to antibiotics 
that has been observed in practice (Sakellari et al., 2000; BNF, 2003). Regardless o f
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these discrepancies, systemically-administered tetracyclines have been and are still 
widely used for the treatment o f periodontal diseases (Sakellari et al., 2000) 
including localised aggressive periodontitis (Genco, 1981; Slots and Rosling, 1983; 
Gordon and Walker, 1993). Tetracycline has been shown to be a successful 
antibiotic for the treatment o f periodontal abscesses and, in combination with 
drainage, can promote healing and re-attachment (Hafstrom et al., 1994). The use o f 
this antibiotic however, should be avoided in pregnancy, during breast-feeding and 
should not be given to children under 12 years o f age as it may be deposited in the 
developing teeth resulting in permanent yellow staining and it has been suggested 
that it may also interfere with bone development (Smilack, 1999; BNF, 2004).
1.6 .3 .3  Tetracycline mode o f action
Like erythromycin, tetracycline has a target site that is located within the bacterial 
cell. In order to reach this target site the antibiotic must cross either one or two 
membranes depending on whether the bacterium is Gram-positive or Gram- 
negative. In terms o f transport barriers, Gram-negative organisms have both an outer 
and cytoplasmic membrane, whereas the Gram-positive bacteria do not have an 
outer membrane. Tetracycline gains access to the bacterial ribosome by passive 
diffusion through hydrophilic pores in the outer membrane, this is followed by an 
energy-dependent active transport mechanism through the inner membrane (Chopra 
et al., 1992). The antibacterial activity o f tetracycline results from the inhibition o f 
protein synthesis (Gentry, 1991). Tetracycline binds to the 30S ribosomal subunit 
and reversibly prevents attachment o f the aminoacyl-transfer RNA to the ribosomal
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receptor (Roberts, 1996). There have been several suggestions as to the precise 
mode o f antimicrobial activity o f tetracycline. It is possible the chemical reactivity 
o f the ribosome is altered resulting in defective functioning o f the ribosome 
(Roberts, 1996). It has also been suggested that binding o f tetracycline to the 
ribosome results in changes in the accessibility o f bases within the 16S ribosomal 
RNA as a result o f distortion o f the three dimensional structure o f the ribosome 
(Chopra, 1992). Possibly, once tetracycline has bound to the ribosome it may block 
the entry o f aminoacyl-tRNAs into the ribosome (Taylor et al., 1996). Whatever the 
exact mechanism, it is clear that tetracycline exhibits an antibacterial activity by 
preventing bacterial growth and this is achieved by reversibly binding to ribosomes 
and inhibiting bacterial protein synthesis.
1.6 .3 .4  Mechanisms o f tetracycline resistance
Point mutation o f chromosomal genes has been reported in Neisseria gonorrhoeae 
(Roberts, 1989), leading to treatment failure with tetracycline, however such 
mechanisms o f resistance are rare and resistance is primarily due to acquisition o f 
tetracycline resistance determinants (Roberts, 1996). Twenty-three different 
tetracycline-resistant determinants have been described encoding one o f 3 
mechanisms o f resistance (Roberts, 1998; Villedieu, 2003). Tetracycline resistance 
in bacteria occurs as a result o f (1) active efflux o f the antibiotic from the bacterial 
cell, (2) an altered ribosomal target site that may prevent antibiotic binding, or (3) 
the production o f modifying enzymes that inactivate the antibiotic (Roberts, 1998).
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1.6.3.4.1 Efflux proteins
Gram-positive and Gram-negative bacteria have been shown to employ efflux 
mechanisms. Thirteen genes have been described encoding energy-dependent 
membrane associated proteins (efflux pumps), which export tetracycline out o f the 
cell (Villedieu et al., 2003). The export o f tetracycline reduces the concentration o f 
intracellular tetracycline and protects the ribosome in vivo but not in vitro (Roberts, 
1996; 1998). Genes conferring the efflux mechanism o f resistance can be identified 
from a variety o f oral bacteria including: Capnocytophaga ochracea, Fusobacterium 
nucleatum, Neisseria spp., Porphyromonas gingivalis, Bacteroides spp., Prevotella 
spp., A. actinomycetemcomitans, streptococci and Veillonella spp. (Lacroix and 
Walker, 1995; 1996; Roberts, 1998).
1.6.3.4.2 Ribosome protection proteins
Ribosomal protection proteins confer resistance to tetracycline, doxycycline and 
minocycline (Roberts, 1996). A t present 8 classes o f genes encode ribosome 
protection proteins (Villedieu et al., 2003). It was thought that these proteins may 
simply work by blocking the binding o f tetracycline to the ribosome by binding 
themselves. It has since been demonstrated that tetracycline can bind equally well to 
both protected and unprotected ribosomes (Taylor and Chau, 1996). This suggests 
that preventing tetracycline binding may not be the mechanism that provides 
bacterial resistance. Ribosome protection proteins do share homology to elongation 
factors Tu and G (Sanchez-Pescador et al., 1988; Manavathu et al., 1990) and a 
GTPase activity o f TetM and TetO has been demonstrated (Burdett, 1996; Taylor
56
Introduction
and Chau, 1996). These observations have lead to the suggestion that the ribosome 
protection proteins may function as tetracycline-resistant elongation factors.
1.6.3.4.3 Enzymatic inactivation of tetracycline
The production o f a tetracycline-modifying enzyme has been shown to be encoded 
by tetX on two transposons Tn4351 and Tn4400, isolated from Bacteroides spp. The 
enzyme encodes a cytoplasmic protein that chemically modifies tetracycline in the 
presence o f both oxygen and NADPH. The requirement o f oxygen for this enzyme 
to function in an obligate anaerobic organism suggests that either tetracycline is not 
the natural substrate for this enzyme or that Bacteroides spp. are not the natural 
hosts o f the gene (Speer and Salyers, 1988). More recently, /e/37 has been identified 
(Diaz-Torres et al., 2003) the properties o f which is similar to those o f tetX, 
however, there is no homology between the deduced amino acid sequence o f Tet 37 
and Tet X. This novel resistance determinant was isolated from DNA extracted from 
bacteria present in human saliva and dental plaque, representing cultivable and non- 
cultivable oral bacteria (oral metagenome). It has been reported that a large 
proportion o f the oral microbiota cannot be cultivated (Wade, 2002) and as such, the 
presence o f /e/37 suggests that there may be other antibiotic resistance determinants 
present in non-cultivable bacteria which have yet to be identified.
1 .6 .3 .5  Prevalence o f tetracycline-resistant bacteria
Lacroix and Walker (1995, 1996), using a medium containing 4 pg / ml o f 
tetracycline found the prevalence o f tetracycline-resistant oral bacteria to be
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approximately 12% o f the total viable count. This proportion o f resistant oral 
bacteria agrees with the results o f an earlier study which demonstrated that 
tetracycline was able to inhibit at least 90% o f the viable subgingival microbiota 
(Walker et al., 1983). Resistance to the tetracycline derivative doxycycline (8 pg / 
ml) in bacteria obtained from the saliva o f 20 human subjects has shown that the 
median percentage o f the oral microbiota resistant to this antibiotic was 4.3% 
ranging from 0 -  26% (Edlund et al., 1996). Tetracycline-resistant isolates from the 
dental plaque o f adults with periodontitis include strains o f streptococci {Strep, 
intermedius, Strep, oralis and Strep, sanguis) Actinomyces spp., Prevotella spp., 
Bacteriodes spp., and Veillonella spp. (Lacroix and Walker, 1995).
1.6.4 Vancomycin
Vancomycin is a bactericidal antibiotic obtained from Streptomyces orientales 
which was discovered in the 1950s (Shlaes and Rice, 1994). Although this antibiotic 
has been clinically available for over 40 years it is not until recently that its use has 
increased, the antibiotic is now more pure and less toxic than it initially was. 
Despite this improvement, vancomycin is still potentially toxic and may affect 
hearing (ototoxicity) and renal function (nephrotoxicity) (Bailie and Neal, 1988), 
consequently careful monitoring o f the patient’ s serum level o f vancomycin and 
renal function is carried out during intravenous treatment (van Scoy and Wilson, 
1983). The need for monitoring o f serum vancomycin concentration has been 
questioned (Cantu et al., 1994) and possibly as a result o f improved purity o f 
vancomycin, it has been suggested that the ability o f vancomycin to cause
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nephrotoxicity (Eng et al., 1989; Nahata, 1987) and ototoxicity (Baile and Neal, 
1988) may be less than traditionally thought.
1.6.4.1 Vancomycin structure
Vancomycin is an example o f a glycopeptide antibiotic; it is a large, rigid molecule 
being approximately 3300 daltons in size (Fig. 1.7). The three dimensional structure 
contains a cleft into which peptides o f highly specific configuration (L-amino acid- 
D-Alanine-D-Alanine) can fit, these sequences are only to be found in bacterial cell 
walls, consequently making vancomycin selectively toxic (Reynolds, 1989).
OH
Figure 1.7 Structure o f vancomycin
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1.6 .4 .2  Spectrum o f vancomycin activity and clinical use
Vancomycin is not absorbed from the gastrointestinal tract and must therefore be 
given by injection for the treatment o f systemic infections. Due to its size, it is 
unable to diffuse through the porin channels in the outer layer o f a Gram-negative 
bacterium to reach its target site, consequently they are considered intrinsically 
resistant to vancomycin (Gentry, 1991). Its spectrum o f activity therefore is directed 
towards a wide-range o f aerobic and anaerobic Gram-positive bacteria, including 
methicillin-susceptible and resistant staphylococci, streptococci, enterococci, 
Corynebacterium spp., Bacillus spp., Listeria monocytogenes, Clostridium spp. and 
Actinomyces spp. (Watanakunakom, 1981; Johnson et al., 1990). Vancomycin has 
been shown to be clinically useful in the treatment and prevention o f infective 
endocarditis caused by Gram-positive bacteria in patients who are allergic to 
penicillin (Perry et al., 1999; BNF, 2003). It is the drug o f choice for treating 
infections caused by the highly resistant bacterium Corynebacteriuum jeikeum and 
multi-resistant staphylococci (Woodford and Stigter, 1998). The emergence o f 
multidrug-resistant bacteria has lead to an increased use o f vancomycin (Jarvis, 
1998). An additional use o f this antibiotic is for the treatment o f antibiotic 
associated pseudo-membranous colitis caused by Clostridium difficile when 
vancomycin should be administered orally (BNF, 2003).
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1.6 .4 .3  Vancomycin mode o f action
As with the (3-lactam group o f antibiotics, it is bacterial cell wall synthesis that is the 
target o f vancomycin which is exposed at the cell surface o f Gram-positive bacteria 
(Watanakunakom, 1981). The glycopeptide group o f antibiotics exerts its effect by 
interfering with peptidoglycan synthesis (Watanakunakom, 1981). Vancomycin 
binds specifically to the C-terminal D-alanine o f peptidoglycan precursors by 
hydrogen bonding, thus forming stable complexes (Reynolds, 1989). The formation 
o f the vancomycin plus peptidoglycan precursors complex at the outer surface o f the 
cytoplasmic membrane prevents the transglycosylation step o f cell wall synthesis. 
During transglycosylation, precursors from the lipid carrier are transferred to the 
peptidoglycan; consequently, in the presence o f vancomycin new subunits are not 
inserted into the growing cell wall. The subsequent transpeptidation reaction that 
imparts rigidity to the cell wall is also inhibited, probably as a result o f steric 
hindrance (Arthur et al., 1996). The mechanism o f action in which vancomycin 
binds to the substrate outside the membrane, resulting in the active sites o f two 
enzymes being unable to align themselves correctly, renders the acquisition o f 
resistance to the glycopeptide antibiotics more difficult than is the case with the 
majority o f the other antibiotic groups (Reynolds, 1989).
1.6 .4 .4  Mechanisms o f vancomycin resistance
Gram-negative bacteria are intrinsically resistant to vancomycin due to the large size 
o f these polar molecules which renders them unable to diffuse through outer 
membrane porins (Russell and Chopra, 1990). Vancomycin resistance in Gram-
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positive bacteria is generally due to the production o f modified peptidoglycan 
precursors replacing the D-alanyl-D-alanine (D-Ala-D-Ala) present in susceptible 
bacteria. Two substituted precursors have been identified; D-alanyl-D-lactate (D- 
Ala-D-Lac) and D-alanyl-D-serine (D-Ala-D-Ser). Precursors o f peptidoglycan that 
terminate in D-Lac or D-Ser bind glycopeptide antibiotics with a reduced affinity 
and, consequently, allow synthesis o f the cell wall in the presence o f vancomycin. 
There are three operons which code for the production o f D-Ala-D-Lac; van A, vanB 
and vanD (Dahl et al., 1999; Werner et al., 1997), whereas vanC, vanE and vanG 
code for D-Ala-D-Ser precursors (Fines et al., 1999; Abadia Patino et al., 2002). 
The VanA-phenotype isolates demonstrate inducible resistance to high levels o f 
vancomycin and to moderate-to-high levels o f teicoplanin but not to other cell wall 
inhibitors. Strains with the VanA phenotype include most isolates o f E. faecalis and 
E. faecium. Resistance is generally transferable to susceptible enterococci by 
conjugation. Since 1987, vancomycin-resistant enterococci have been referred from 
more than 1100 patients in almost 100 hospitals to the Public Health Laboratory 
Service, o f these 88% displayed the VanA phenotype (Woodford, 1998). The vanB 
gene mediates the other main mechanism o f acquired vancomycin resistance in 
enterococci. Strains with the VanB phenotype are inducibly-resistant to various 
levels o f vancomycin but are not teicoplanin-resistant (Dahl et al., 1999; Carias et 
al., 1998). The vanB ligase gene encodes a ligase which is closely related to that 
encoded by vanA, with a 76% amino acid identity (Evers et al., 1994). Enterococcus 
gallinarum and Enterococcus casseliflavus-flavescens display intrinsic resistance to 
vancomycin due to the presence o f the chromosomally located vanC operons. The
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VanE- and VanG-type resistance has been reported in Enterococcus faecalis 
conferring low level vancomycin resistance. Transfer experiments with VanE have 
been unsuccessful (Fines et al., 1999) and comparative studies have demonstrated 
that the VanE-type resistance in the strain E. faecalis BM4405 is due to a 
chromosomally located operon related to vanC (Abadia Patino et al., 2002).
1 .6 .4 .5  Prevalence o f vancomycin-resistant bacteria
Vancomycin resistance was first detected in a normally-susceptible bacterium over 
30 years following the clinical use o f this antibiotic (Johnson et al., 1990). Since 
1986, however, vancomycin-resistant bacteria have been increasingly described. 
Boyle et al. in 1990 reported an outbreak o f 213 cases over 36 months due to 
vancomycin-resistant Enterococcus species. The National Committee for Clinical 
Laboratory Standards (NCCLS) states that streptococci should be considered 
resistant to vancomycin i f  their minimal inhibitory concentrations (MICs) are 
greater than 8 pg/ml. The isolates from this outbreak had MICs between 64 and 
>2000 fig/ml, making them highly resistant to vancomycin. Large outbreaks o f 
vancomycin-resistant enterococci (VRE) infections have since occurred as a result 
o f nosocomial spread and have been reported in adult intensive care patients (Boyle 
et al., 1993; Handwerger et al., 1993) and, to a lesser extent, in paediatric patients 
(Henning et al., 1996). Concern with the isolation o f vancomycin-resistant isolates 
increased when it was discovered that many isolates o f vancomycin-resistant 
enterococci also proved to be resistant to 13-lactams and aminoglycosides resulting in 




Metronidazole is classified as a bactericidal agent. It was initially developed in the 
early 1960s for the treatment o f anaerobic protozoan infections (Townson et al., 
1994). It was a further 20 years before its activity against obligate anaerobic bacteria 
was identified. It is now considered as a useful antiparasitic and antibacterial agent. 
Metronidazole is well-tolerated by patients in the short term and long term. The only 
possible exception is the presence o f neuro-toxic effects that are associated with 
high dosage, signs and symptoms o f toxicity are transient and disappear soon after 
withdrawal o f the treatment (Roe, 1985). An additional problem is that it cannot be 
taken in conjunction with alcohol (BNF, 2003).
1.6.5.1 Metronidazole structure
Metronidazole is a nitroimidazole compound (Fig. 1.8). It is a low molecular 
weight, uncharged molecule (Greenstein, 1993). The activity o f the compound is 
dependent on the nitro group attached to the imidazole ring (Townson et al., 1994)
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Figure 1.8 Structure o f metronidazole
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1.6 .5 .2  Spectrum o f activity and clinical use
The antimicrobial activity o f metronidazole is limited to anaerobic bacteria and 
protozoa (Muller et al., 1977; Townson et al., 1994). It is active against anaerobic 
cocci, bacteroides and clostridia. There is no effect on aerobic bacteria and so these 
organisms are intrinsically-resistant to this agent. Metronidazole also demonstrates 
activity against anaerobic protozoa including Entamoeba histolytica and Giardia 
lamblia. Any anaerobic infection may be treated with metronidazole, including deep 
abscesses. Evidence for the efficacy o f systemic metronidazole in the treatment o f 
different periodontal diseases has been reported for adult periodontal diseases 
(Loesche et al., 1992) and aggressive periodontitis (Saxen and Asikainon, 1993). It 
has also been reported that metronidazole may be suitable for the treatment o f 
refractory periodontal diseases with a subsequent improved periodontal health 
(Greenstein, 1993). More recently, localised delivery o f metronidazole has shown to 
be effective in the treatment o f periodontitis (Magnusson, 1998).
1.6 .5 .3  Metronidazole mode o f action
Metronidazole exerts its antibacterial activity within the bacterial cell and to reach 
its target site it enters the cell by diffusion. After entering the bacterial cell, 
reduction o f the molecule results in release o f nitro radicals that are believed to have 
an inhibitory action on DNA synthesis and degrade existing DNA (Walker, 1992). 
The reduction o f the nitro group occurs at the low oxidation reduction potential 
found under anaerobic conditions and is due to a ferredoxin-linked hydrogenase 
(Greenstein, 1993; Roberts, 1998; Townson etal., 1994).
65
Introduction
1.6. S.4  Mechanisms o f m etronidazole resistance
This requirement for a reduced environment limits the use o f metronidazole to the 
treatment o f infections by anaerobic organisms, consequently aerobic organisms are 
resistant to this drug. There have been four genes identified that are able to confer 
moderate to high-level metronidazole resistance, known as nimA, nimB, nimC and 
nimD. Transfer o f metronidazole resistance has been demonstrated by conjugation 
and by transformation. It is likely that the nim genes code for a 5-nitroimidazole 
reductase that reduces the 5-nitroimidazole to a 5-amino derivative (Trinh and 
Reysset, 1996). These genes have been isolated from colonic Bacteroides spp.
1 .6 .5 .5  Prevalence o f m etronidazole-resistant bacteria
Resistance to metronidazole is not widespread among anaerobic organisms. Wexler 
et al. (2002), screened 579 strains o f anaerobic bacteria and found no resistance to 
metronidazole in species o f Bacteroides, Fusobacterium, Porphyromonas and 
Prevotella, however, resistance was demonstrated in some species o f Clostridium. 
Bacteroides strains and Helicobacter have developed metronidazole resistance 
(Ingham et al., 1978; Townson et al., 1994). Little other screening has taken place in 
other species and consequently its prevalence in other obligate anaerobic bacteria 
has yet to be established.
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1.6.6 Summary of antibiotics





Principle clinical use Use in infections 








staphylococcal and pneumoncoccal 













Second line drug to penicillins. 
Respiratory infections including, 
tonsillitis, sinusitis, bronchitis, 
pneumonia, atypical pneumonia, 
diphtheria, whooping cough, 






Chest infections, treatment of acute 
exacerbation of chronic bronchitis, 
atypical pneumonia, Q fever and 
psittacosis





















1.7 Epidemiology of antibiotic resistance
Antibiotic resistance has an increasing worldwide prevalence. This mounting burden 
reflects the emergence o f new resistances, the epidemic transfer o f antibiotic 
resistance genes between bacteria and the epidemic spread o f antibiotic-resistant 
strains among the population. The importance o f these three methods in the 
development o f antibiotic resistance w ill vary depending on the bacterial species 
and the antibiotic involved. However, regardless o f these subtle differences, the 
overall process is driven by the selective pressure o f antibiotic usage. The 
importance o f antibiotic usage in the development o f antibiotic resistance is 
supported by three main observations. Firstly, resistance to new antibiotics develops 
after the introduction o f these agents. Secondly, acquired resistances are not found 
in bacteria which were isolated before the introduction o f antibiotics and finally, 
antibiotic resistance is especially prevalent in clinical settings with high antibiotic 
usage, such as intensive care units (ICU) (SMAC, 1998). This was demonstrated in 
a UK based study in which the prevalence o f resistance to penicillins, 
cephalosporins, ciprofloxacin and aminoglycosides was approximately twice as 
great among isolates o f Pseudomonas aeruginosa from ICU patients as those 
isolated from patients from general wards or out-patients (Chen et al., 1995).
1.7.1 Selection of new resistance
New antibiotic resistance problems can emerge as a result o f species selection, 
mutation and gene acquisition. Species selection alters the relative importance o f
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different pathogenic bacteria whereas both mutation and gene acquisition produce 
resistance in previously susceptible species.
1.7.1.1 Species selection
Antibiotic usage w ill favour the survival o f antibiotic-resistance species or genera 
and this enrichment process may gradually undermine once-valuable antibiotics. 
These shifts may occur in an individual or in the community, as demonstrated by an 
increasingly important role o f opportunistic pathogens in infectious diseases. 
Enterococci are intrinsically-resistant to quinolones and cephalosporins and thus 
have a competitive advantage i f  these antibiotics are used with the removal o f a 
susceptible microbial population allowing the enterococci to dominate the 
microbiota (Woodford et al., 1995). As such the increasing use o f these two 
antimicrobials through the 1980s and 1990s may have promoted the success o f 
enterococci as pathogens. There is also an increasing dominance o f a-haemolytic 
streptococci and coagulase-negative staphylococci as agents o f bacteraemia in 
haematology patients (Oppenheim, 1998). Again, the change in the use o f 
antibiotics may be promoting this microbial shift. Streptococci are inherently 
resistant to fluoroquniolones, which are heavily used as prophylaxis in these patients 
and many coagulase-negative staphylococci have developed a multi-antibiotic 
resistance through mutation and gene acquisition (Livermore, 2000).
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1.7 .1 .2  Epidemiology o f m utational resistance
Antibiotic-resistant bacteria can arise through spontaneous random genetic changes, 
as described previously (1.5.1). In the absence o f an antibiotic pressure these 
mutants have no competitive advantage, however in the antibiotic era the selection 
o f pre-existing antibiotic-resistant mutants can occur and i f  resistance emerges 
rapidly the usefulness o f an antibiotic can be quickly undermined. This was 
demonstrated in the 1980s with the fluoroquniolones which were initially perceived 
as active against MRSA, however, staphylococci have an endogenous efflux pump 
and resistance occurs when this pump is up regulated by mutation in the nor A gene 
(Piddock, 1995). The result is that ciprofloxacin has had a disappointing efficacy 
against staphylococci with most MRSA now resistant to this agent. Once selected in 
one patient, resistant mutants may spread to others, giving rise to strain epidemics. 
Also i f  resistance is obtained by a single point mutation then identical mutants may 
be selected anew in further patients with the potential for the rapid selection o f 
antibiotic resistance.
1.7 .1 .3  Epidemiology o f transferable resistance
The transfer o f antibiotic resistance genes (1.10) can give rise to gene epidemics. 
Plasmids encoding the TEM-1 mediated p-lactamases were first described in 1965, 
by the continued surveillance o f bacteria contain these plasmids, it has been shown 
to have spread to 20-60% o f clinical isolates o f Enterobacteriaceae, to a few strains 
o f Pseudomonas aeruginosa and between 1 - 50 % o f H. influenzae and N. 
gonorrhoeae (Sanders and Sanders, 1992; Livermore, 1995). Single plasmids have
70
Introduction
also been shown to disseminate among multiple host strains in the course o f an 
outbreak. The TEM-3 plasmid encoding an extended spectrum (3-lactamase was 
shown to disseminate among Klebseilla spp, E. coli and Serratia spp. in the hospital 
around Clermont-Ferrand in 1985 -  1987 (Petit et al., 1990). It has been suggested 
that the spread o f these resistance elements may burden the recipient bacterium due 
to the necessity to replicate additional DNA and as such in the absence o f a selective 
pressure the mobile element could be lost or eliminated from the cell. However, due 
to the widespread dissemination o f these resistance determinants it is likely that the 
carriage o f these elements exerts little additional burden to the bacterium.
1.7.2 Dissemination of resistant strains
Patient to patient transfer is also a key factor in the increasing prevalence o f 
antibiotic resistant bacteria. Nosocomial spread o f antibiotic-resistant bacteria is a 
common clinical problem often linked to deficiencies in hygiene such as poor hand 
hygiene, the use o f non-sterile devices or procedures and rarely hospital food (DOH, 
1998). A minority o f antibiotic-resistant strains have established themselves in 
hospitals as demonstrated by surveillance data demonstrating a rising proportion o f 
MRSA isolated from patients with bacteraemia in England and Wale since 1990. 
Until 1993 MRSA comprised 2 % o f isolates, however this proportion has increased 
to 41% o f isolates in 2003 (HPA, 2004). This dramatic increase was largely due to 
the dissemination o f just two strains, EMRSA-15 and -16.
Combating antibiotic resistance w ill required the control and reduced use o f 
antibiotics, the development o f novel antibiotics, and the protection o f the currently
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used agent by limiting the spread of resistance determinants. This must be all be 
supported by a local understanding of the epidemiology of infectious disease and 
antibiotic resistance.
1.8 Factors promoting antibiotic resistance
Many factors have contributed to the development and spread of antibiotic 
resistance (Figure 1.9). To significantly reduce antibiotic resistance we may need to 
do more than target a single factor but may require a global approach targeting all 
factors promoting antibiotic resistance.
Patient antibiotic use and contact
Transfer of antibiotic 
resistance determinants Antibiotic-resistant bacteria
/
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Antibiotic-resistant bacteria from animals can colonise or infect 
the human population by contact or via the food chain




1.8.1 Patient antibiotic use and contact
As previously discussed, we come into contact with antibiotics in a variety o f ways, 
not solely by the use o f prescribed agents. The emergence o f antibiotic-resistant 
bacteria has frequently been reported to be a direct result o f antibiotic usage (Cohen, 
1992; Gould 1994), with resistance relating to per capita consumption o f antibiotics 
in the community and the hospital setting (Cohen, 1992). The association between 
antibiotic use and antibiotic resistance has been demonstrated in a Finnish study. In 
the early 1990s in Finland there was an increase in the number o f erythromycin- 
resistant Lancefield group A streptococci. This observation led to a nation-wide 
recommendation that the use o f macrolide antibiotics in the community should be 
reduced. The consumption o f macrolide antibiotics decreased from 2.4 defined daily 
doses per 1000 inhabitants in 1991 to 1.38 defined daily doses in 1992 and was 
maintained near this lower level until 1996. The alteration in macrolide prescription 
was followed by a steady reduction in the prevalence o f erythromycin-resistant 
Lancefield group A streptococci. The prevalence o f erythromycin-resistant group A 
streptococci isolated from throat swabs and pus samples reduced from 16.5% in 
1992 to 8.6% in 1996 (Finnish study, 1997). In a separate study, patients with adult 
periodontitis who had a recent exposure to penicillin were shown to have a greater 
prevalence o f B-lactamase-producing Bacteroides spp. (Kinder et al., 1986), further 
supporting the hypothesis that antibiotic consumption results in increased antibiotic 
resistance. In Europe, the use o f the glycopeptide avoparcin in animal feeds has also 
been reported to be a contributory factor in increasing antibiotic pressure and 




As discussed, high usage o f antibiotics is thought to be the main driving force 
behind the increasing prevalence o f antibiotic-resistant bacteria (House o f Lords, 
1998) and this is likely to be affected by a number o f socio-economic factors. It has 
been reported that Pakistanis and Indians in the United Kingdom are significantly 
more likely to receive a prescription from their general practitioner compared to 
white ethnic groups (G ill et al., 1995). It has also been shown that patients from 
deprived social groups receive significantly more antibiotics than those from less- 
deprived groups (Gill and Roalfe, 2001). As such, community-acquired antibiotic 
resistance in industrialised countries has polarised in low socio-economic groups 
and minority ethnic communities. There is a growing body o f evidence that 
microbial colonisation by antibiotic-resistant bacteria varies with age, ethnic origin 
and area o f residency (Inostroza et al., 1998; Rodin et al., 1980).
1.8.3 Antibiotic resistance and ethnicity
A significant difference in the antibiotic resistance patterns o f Helicobacter pylori 
isolated from different ethnic groups has been reported (Meyer et al., 2002). A study 
in Northern Australia concerning infection with MRSA, demonstrated that 
aboriginal subjects had a greater risk o f community-acquired infection with these 
resistant strains than non-aboriginal subjects (Maguire et al., 1996). In 1992 in 
South Africa, Weyer and Kleeberg demonstrated that ethnic origin significantly 
influenced drug resistance rates in strains of Mycobacterium tuberculosis. Penicillin 
susceptibility in isolates o f Neisseria gonorrhoeae isolated from 921 patients from
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different ethnic groups was analysed in a UK based study. The results demonstrated 
that Asian men harboured significantly more penicillin-insusceptible strains than 
white men or those o f Caribbean decent (Rodin et al., 1980). More recently, a study 
was carried out examining tetracycline-resistant and non-tetracycline resistant N. 
gonorrhoeae from 400 patients attending the Royal London Hospital Genitourinary 
Medicine Clinic. The ethnic distribution o f patients differed with tetracycline- 
resistant N. gonorrhoeae and non-tetracycline-resistant N. gonorrhoeae. Afro- 
Caribbean patients accounted for 81% o f the patients with tetracycline-resistant N. 
gonorrhoeae compared to white patients who only accounted for 19% o f the 
isolates. For the non-tetracycline-resistant isolates, Afro-Caribbean patients 
accounted for 58% compared to the whites who accounted for 36% o f the isolates 
(Lewis et al., 1996). These surveys suggest a marked difference in the prevalence o f 
antibiotic resistance in different ethnic groups.
1.8.4 Antibiotic resistance due to mercury exposure
It has been previously discussed that antibiotic resistance may be a result o f 
increased antibiotic use. An additional mechanism that may lead to an increase in 
antibiotic-resistant bacteria, may be the presence o f mercury (Hg) in man, released 
from amalgam restorations. The incidence o f mercury-resistant (Hgr) bacteria has 
been shown to increase in mercury-polluted soil and water and in hospitals 
accompanying the use o f mercurial antiseptics (Porter et al., 1982). It has also been 
demonstrated in a primate study that Hg released from amalgam in dental filling 
leads to enrichment in the oral and faecal microbiota o f many different genera o f
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bacteria resistant to Hg and antibiotics (Summers et al., 1993). In the Gram-negative 
bacteria studied, an association between antibiotic resistance and Hgr has been 
demonstrated, this is believed to be due to a genetic linkage o f the resistance genes. 
The occurrence o f such a linkage in the Gram-positive bacteria has not been 
reported in the literature.
1.8.4.1 Exposure to mercury
In the general population, the major source o f mercury exposure is derived from the 
use o f dental amalgam restorations (WHO, 1991). This occurs due to release o f 
mercury vapour (Hg°) from dental amalgam, which is readily inhaled. In addition to 
this, some mercury w ill be dissolved in saliva or swallowed as amalgam particles. 
The levels o f mercury vapour released from dental amalgam restorations may be 
further increased by chewing gum (Sallsten et al., 1996). The typical filling in a 
human molar contains 750-100 mg o f Hg and the body retention is between 3-17 
pg/day (WHO, 1991). Food can also be a source o f mercury, with estimates o f the 
daily dose o f mercury attributable to the intake o f food ranging from 2.3 to 121 pg 
(Becker and Kumpulainen, 1991; Johansen et al., 2000; Urieta et al., 1996). Edlund 
et al. (1996) found that the median concentration o f Hg in the saliva o f 10 adults 
who had never had amalgam fillings was 0.02 ng/g. Higher mercury concentrations 
(1.4 ng/g) in the saliva o f a group o f 43 adults have recently been reported 
(Leistevuo et al., 2001). Such levels o f mercury in the saliva o f individuals without 
amalgam fillings may be sufficient to select for Hg-resistant oral bacteria
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1.8 .4 .2  Mercury resistance
Mercury and mercury compounds are widely distributed and unlike other metals 
which are considered essential for the growth, metabolism and differentiation o f an 
organism, mercury does not appear to serve any biological function and in fact, is 
toxic (Gadd, 1992; Hughes and Poole, 1991). Bacterial resistance to mercury is 
considered an ancient system with a worldwide distribution o f organisms (Osborn et 
al., 1997). It can be demonstrated in both Gram-negative and Gram-positive bacteria 
and, unlike other metal resistances in which the bacteria involved are predominantly 
found in industrial waste and soil, mercury-resistant organisms include members o f 
the normal mammalian microbiota as well as human pathogens (Edlund et al., 1996; 
Wireman et al., 1997).
Hgr operons (mer) have been characterised and at least 14 mer operons from both 
Gram-positive and Gram-negative organisms have been identified (Bogdanova et 
al., 1998; Wireman et al., 1997). The mechanism o f mercury resistance employed by 
a variety o f bacteria is the reduction o f the reactive ionic form Hg11 to the less 
reactive volatile elemental form Hg°. An inducible mercuric reductase enzyme 
mediates this reduction. Narrow spectrum mer operons confer resistance to 
inorganic mercury salts; they encode a mercury response regulatory protein 
designated MerR, one or more mercury transport proteins and the mercury reductase 
enzyme. Broad spectrum mer operons confer resistance to organo-mercurials in 
addition to resistance to inorganic-mercurials (Bogdanova et al., 1998). In Gram- 
negative bacteria, mer operons have often been found on transposons that are 
contained within conjugative plasmids (Wireman et al., 1997). Mercury resistance in
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Gram-positive bacteria has not been as well studied as in Gram-negative organisms; 
consequently little data are available on the transfer o f mer operons.
1.9 Spread of antibiotic-resistant bacteria
The concern o f inappropriate and excessive antibiotic use is fuelled by the changing 
pattern o f antibiotic resistance with reports suggesting that there is a global spread 
o f antibiotic-resistant bacteria. Multi-drug resistant organisms that were initially 
detected in European centres have become more widespread in the US (Burke and 
Pestotnik, 1999). Risk factors for the spread o f resistant bacteria in hospitals and the 
community can be summarised as over-crowding, lapses in hygiene or poor 
infection control practices. Antibiotic-resistant bacteria can be spread primarily by 
direct or indirect person-to-person contact. Independent risk factors can also 
promote this spread and include the use o f broad spectrum antibiotics, 
overcrowding, prolonged hospitalisation, excessive use o f antibiotics, poor 
compliance with antibiotic therapy, delayed diagnosis or treatment, and poor or 
inadequate ventilation and isolation facilities (Payne and Amyes, 1991). There is 
also a growing body o f evidence that antibiotic-resistant bacteria are transferred 
from animals to humans. In 1997, the World Health Organisation’s report on ‘The 
medical impact o f antimicrobial use in Food Animals’ highlighted several cases 
where transfer o f resistance from animals to humans had occurred via direct contact 
with animals, the consumption o f meat and drinking contaminated water 
(Donabedian et al., 2003; WHO, 1997).
introduction
1.10 Spread of antibiotic resistance genes
1.10.1 Transfer of antibiotic resistance
Bacteria can become resistant to antibiotics due to random chromosomal point 
mutations (Roberts, 1998). However, the majority o f antibiotic-resistant bacteria 
acquire their resistance genes from other bacteria. This is possible due to presence 
o f resistance genes within specialised mobile genetic elements that are capable o f 
moving horizontally between different organisms. The movement o f genetic 
material between bacteria other than by descent, where the genetic material travels 
down the generations as the cell divides, is referred to as horizontal genetic 
exchange (Maiden, 1998). By the 1960’s it had been discovered that drug resistance 
could be transferred from one bacterial species to another and that there were three 
main mechanisms by which genetic properties could be transferred between bacteria 
- transformation, conjugation and transduction. (Mitsuhashi,1993).
Transformation - Transformation is the process whereby naked DNA is taken up 
directly by a bacterium; recombination would then occur in the recipient 
chromosome and the genetic material acquired (Mitsuhashi, 1993). Transformation 
is a generalised mechanism so that, in principle, any part o f the chromosome could 
be transferred. DNA may also be acquired from lysed bacteria in the local 
environment (Maiden, 1998). Some bacteria have specialised pathways which 
enable them to take up DNA from their environment, this is referred to as 
competence. As previously discussed naturally competent oral bacteria have 
demonstrated resistance to 13-lactam antibiotics by the development o f altered PBPs 
by interspecies recombination (Clairoux et al., 1992; Dowson et al., 1994).
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Conjugation - Bacterial conjugation is probably the most important method or 
transferring genetic material between distantly related bacteria and is responsible for 
the transfer o f the majority o f antibiotic resistance genes (Mullany, 2000). 
Conjugation occurs when two bacteria come into close contact possibly by means o f 
a conjugation tube (sex pilus) and the genetic material is transferred from one to the 
other (Mitsuhashi, 1993). Conjugation has been shown to be one o f the mechanisms 
responsible for the transfer o f antibiotic resistance genes (Roberts, 1999). 
Transduction - For transduction a bacterial virus known as a bacteriophage is 
required. Bacteriophage DNA directs the production o f proteins required to replicate 
itself and copies o f the bacteriophage genome are packaged into newly assembled 
protein coats. Bacterial cell lysis may then follow with the release o f new 
bacteriophage particles. It is possible for the DNA packing to malfunction leading to 
the packing o f bacterial DNA into bacteriophage particles instead. These new 
bacteriophage particles may then infect other bacteria, antibiotic resistance as well 
as other genetic determinants may then be transferred to a new host (Mitsuhashi, 
1993; Maiden, 1998). Transduction is usually responsible for gene transfer between 
closely related bacteria, due to the specificity o f the bacteriophage receptors for 
particular bacterial strains.
1.10.2 Mobile elements
In the majority o f antibiotic-resistant bacteria, resistance is due to the acquisition o f 
new genes rather than point mutation or creation o f mosaic genes (Roberts, 1998). 
These new genes may be associated with plasmids, conjugative and non-conjugative
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transposons or integrons (Roberts, 1989; 1992; Levy, 1992; Recchia and Hall, 1995). 
Plasmids were first isolated in the 1960s, they are extra-chromosomal pieces o f 
DNA, ranging in size from 2 - >100 mDa (Falkow, 1975). They generally replicate 
autonomously in the bacterial cytoplasm, but may integrate into the bacterial 
chromosome for some species (Roberts, 1998). Plasmids can carry a variety o f 
genes, leading to multi-antibiotic resistance (Kruse et al., 1995). Conjugative 
transfer o f plasmids has been demonstrated in bacteria o f the same species, different 
species and more recently between prokaryotes and eukaryotes (Roberts, 1989; 
1992; 1996; Frost, 1992).
Antibiotic resistance genes can be associated with transposons and conjugative 
transposons (Roberts, 1996). Transposons are defined entities that carry the genes 
necessary for their own transfer from one piece o f DNA to another piece o f DNA 
within a single cell. They may be carried on plasmids or on the host chromosome 
(Roberts, 1998). The end regions may have direct or inverted repeats and the 
transposons can carry genes conferring resistance to different classes o f antibiotics 
(Roberts, 1996). Conjugative transposons (CTns) were first identified as 
chromosomally-bome transposons that were capable o f conjugative transfer. Two 
CTns were originally identified: Tn916 from E.faecalis (Franke and Clewell, 1981) 
and Tn5253 from Streptococcus pneumoniae (Shoemaker et al., 1980). Tn916, in 
common with all other conjugative elements from Gram-positive bacteria, does not 
encode pili and the mechanism o f cell-to-cell contact remains unknown. Transfer o f 
these CTns occurs by excision o f the element by site-specific recombination; 
transfer o f the resulting circular form by conjugation and finally the integration o f
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the element by recombination between a specific site o f this circular form and a site 
in the genome o f their host. Conjugative transposons can transfer from a donor 
bacterium to a recipient bacterium, which may be either a related or unrelated 
species (Roberts, 1998) and are capable o f intra-cellular transposition. Integrons are 
mobile gene cassettes and include over 40 members within the group (Recchia and 
Hall, 1995). Integrons are discrete mobile elements and differ from transposons by 
not being bound by inverted repeats, or being flanked by duplication o f the target 
sequences or carrying proteins conferring independent movement (Roberts, 1998). 
They have been isolated from only a small number o f Gram-negative bacteria and 
have been shown to also confer antibiotic resistance (Roberts, 1998). Plasmids, 
transposons and integrons allow the dissemination o f antibiotic resistance genes, 
within related and unrelated bacterial species.
1.11 The Government's Success?
The British Government’s three year programme targeting antimicrobial resistance 
ended in June 2003. However, infections with antibiotic-resistant bacteria continue 
to increase (Health Protection Agency, 2004) and the global challenge o f controlling 
antibiotic resistance has not been realized. Many areas in the field o f antibiotic 
resistance still need to be researched and understood i f  we are to be successful in the 




The aims o f this PhD were to determine the prevalence and proportion o f antibiotic- 
resistant bacteria in the cultivable oral microbiota isolated from the dental plaque o f 
healthy children (chapter 3) and to investigate factors which may promote antibiotic 
resistance. Such factors may include, previous antibiotic use (chapter 4), ethnicity 
(chapter 5) and cross resistance with heavy metal resistance genes (Chapter 6). To 
investigate tetracycline-resistant oral bacteria more fully, the effect this antibiotic 
has on the antibiotic resistance profile and microbial community o f microcosm 
dental plaques was investigated using an in vitro system (chapter 7). The ability o f a 








2.0 Materials and Methods
The methods outlined in the following chapter were used throughout the project. 




Bacterial strains used in this study are listed in Table 2.1 and were obtained from the 
National Collection o f Type Cultures (NCTC), London, UK. Escherichia coli and 
Staphylococcus spp. were inoculated on to tryptone soya agar (Oxoid Ltd., 
Bassingstoke, UK) slopes and incubated overnight at 37°C. Slopes were then stored 
at 4°C and strains were maintained by subculture every 7 days. H. influenzae and 
Streptococcus spp. were inoculated on to Columbia blood agar (CBA, Oxoid Ltd.) 
plates containing 5% defibrinated horse blood (E and O Laboratories, Bonnybridge, 
UK) and incubated overnight at 37°C in air supplemented with 5% CO2 and 
maintained by subculture every 3 days. Long term storage o f all bacterial isolates 
was carried out by the production o f glycerol stocks (2.1.2).
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Table 2.1 Bacteria used use in this study as control strains for susceptibility 




Escherichia coli NCTC 10418 Antibiotic-susceptibility control
Haemophilus influenzae NCTC 11931 Antibiotic-susceptibility control
Pseudomonas aeruginosa NCTC 10662 Bacterial identification control
Staphylococcus aureus NCTC 6571 Antibiotic-susceptibility control
Staphylococcus aureus NCTC 8325-4 Mercury-susceptibility control 
(Hgs)
Staphylococcus aureus NCTC 50581 Mercury-susceptibility control 
(Hgr) 8325-4 containing mercury- 
resistant plasmid pI258
Streptococcus anginosus NCTC 10713 Bacterial identification control
Streptococcus gordonii NCTC 7865 Bacterial identification control
Streptococcus intermedius NCTC 2227 Bacterial identification control
Streptococcus mitis NCTC 12261 Bacterial identification control
Streptococcus mutans NCTC 10449 Bacterial identification control
Streptococcus oralis NCTC 11427 Bacterial identification control
Streptococcus parasanguis NCTC 55898 Bacterial identification control
Streptococcus pneumoniae NCTC 7465 Antibiotic-susceptibility control, 
Bacterial identification control
Streptococcus salivarius NCTC 8618 Bacterial identification control
Streptococcus sanguis NCTC 7863 Bacterial identification control
Streptococcus sobrinus NCTC 12279 Bacterial identification control
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2.1.2 Storage of Bacterial isolates
Bacterial isolates were inoculated into Brain Heart Infusion (BHI, Oxoid Ltd.) broth 
and incubated for 24 -  48 h at 37°C and were checked for purity before being 
stored. An equal volume o f sterile phosphate buffered saline (Oxoid Ltd.) containing 
20% (v/v) o f sterile glycerol (BDH Chemicals, Poole, UK) was added to the broth 
culture, to give a final concentration o f 10% glycerol. One ml aliquots were 
transferred into sterile cryovials (Sarstedt Ltd., Leicester, UK). Isolates were then 
stored at -70°C as frozen glycerol (10% v/v) stocks.
2.2 Subjects
2.2.1 Ethical Approval
Prior to commencement o f the study, ethical approval was obtained from the Barnet 
Research Ethics Committee, Barnet Health Authority, London, UK (Reference 
number: 98/56).
2.2.2 Subject recruitment
A ll children aged 4 to 5 years attending three reception classes in a North London, 
United Kingdom school between 1999 to 2001 were included in a dental screening 
program. A qualified dentist and community dental nurse recorded the presence o f 
dental caries, restorations and the general oral status in each child. A letter and 
questionnaire was given by the teacher to each child, this was addressed to their 
parents / guardians and requested consent to be included in the study. A support 
telephone helpline and information point was established via the school
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administration office. A ll children that were given written informed parental consent 
were recruited into this study. No child was excluded from the study from which 
positive consent was obtained, and several visits to collect samples were made to 
ensure selection bias on the basis o f attendance did not occur.
2.2.3 Patient data
Patient details regarding name, contact information, age, sex, gender, ethnic group, 
antibiotic use in the previous three months and the presence o f any major medical 
conditions were recorded on a self administered questionnaire. The dental nurse 
stored the questionnaires until the laboratory analysis had been completed. Patient 
data were held in accordance with the Data Protection Act.
2.2.4 Sample collection and processing
Suitable dates were agreed with the school head teacher before collection o f the 
samples began. Plaque samples were taken from the entire dentition o f the 
supragingival region o f each child using a calcium alginate swab (Technical Service 
Consultants Ltd, Heywood, UK). The swab was immediately placed into 4 ml o f 
pre-reduced Calgon-Ringer solution (Oxoid Ltd.) in a sterile bijou (Sarstedt Ltd.) 
containing 5 sterile 2 mm diameter glass beads (BDH Chemicals). Samples were 
labelled with a reference number and sent to the laboratory via a courier. Upon 
receipt each sample was vortex-mixed for a minimum o f 30 seconds or until the 
calcium alginate had dissolved. A 10-fold serial dilution o f the sample was prepared 
in pre-reduced tryptone soya broth (Oxoid Ltd). To calculate the total number o f
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cultivable bacteria in the specimen samples were inoculated onto Isosensitest agar 
(Oxoid Ltd) containing 5% defibrinated horse blood. To determine the number o f 
Antibiotic-resistant bacteria samples were inoculated onto Isosensitest agar 
containing 5% defibrinated horse blood supplemented with antibiotics (Sigma, 
Poole, UK). In accordance with the NCCLS guidelines (NCCLS, 1993) the 
following antibiotic concentrations were used, 4 mg/1 (penicillin), 8 mg/1 
(ampicillin), 1 mg/1 (erythromycin), 8 mg/1 (tetracycline) or 8 mg/1 (vancomycin). 
Plates were incubated in an anaerobic chamber (MACS 1000, Don Whitley 
Scientific Ltd, Shipley, UK) at 37°C for 5 days, a duplicate set was incubated in air 
supplemented with 5% carbon dioxide at 37°C for 2 days. After incubation, the 
antibiotic-resistant morphotypes were enumerated separately. These were then 
subcultured and incubated under both aerobic and anaerobic conditions to ascertain 
atmospheric requirements. Antibiotic-resistant isolates were stored at -70°C as 
previously described (2.1.2) for further identification and susceptibility testing.
2.3 Identification of antibiotic-resistant bacteria
Bacteria were initially characterized by determining their atmospheric growth 
requirement, Gram-stain, haemolysis, catalase (2.3.1) and oxidase (2.3.2) reaction, 
requirement for growth factor X (haemin) and V (coenzyme I; 2.3.3), optochin 
(2.3.4) and metronidazole (2.3.5) susceptibility (Oxoid Ltd). Subsequently, they 





Using a sterile toothpick, growth from the centre o f a colony was transferred to the 
surface o f a clean glass slide. 20 pi o f 3% (v/v) hydrogen peroxide (Sigma) was 
subsequently added to the colony. The smear was observed for bubble production. 
A rapid sustained appearance o f bubbles / effervescence was reported as positive.
The following control strains were used:
Positive control: Staph, aureus (NCTC 6571)
Negative control: Strep, pneumoniae (NCTC 7465)
2.3.2 Oxidase test
A solution o f tetramethyl-/?-phenylenediamine (Sigma) was prepared in 1 ml o f 
sterile distilled water prior to each batch o f tests. A sterile swab was placed into the 
solution to soak the end o f the cotton bud. The cotton bud was then touched onto the 
surface o f the test colony. A positive reaction was recorded by the development o f a 
purple colour within 20 seconds.
The following control strains were used:
Positive control: Ps. aeruginosa (NCTC 10662)
Negative control: E. coli (NCTC 10418)
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2.3.3 Requirement for growth factor X and V
Colonies suspected to be Haemophilus spp were tested for their requirement for two 
growth factors X (haemin) and V (coenzyme I). A suspension o f the test colonies 
equivalent to McFarlands standard 4.0 was prepared in sterile PBS. Using a sterile 
swab the suspension was inoculated onto the whole surface o f a sterile blood agar 
base (without blood) plate. Three disks were then placed onto the agar surface, the 
first disk containing only growth factor X, the second disk only V and the third disk 
contained both X and V growth factors (Oxoid Ltd.). Plates were then incubated at 
37°C in air supplemented with 5% CO2 and examined after 24 h for the presence o f 
growth around the diagnostic disks. The requirement for these growth factors was 
used to presumptively differentiate species (Table 2.2).
Table 2.2 Growth factors for Haemophilus species.
Factor required Species
Xand V H. influenzae, H. aegyptius, H. haemolyticus
X H. ducreyi
V H. parainfluenzae, H. parahaemolyticus
2.3.4 Optochin susceptibility
A ll alpha-haemolytic streptococci were tested for their susceptibility to optochin. 
CBA plates were inoculated with test colonies and a diagnostic disk impregnated 
with optochin (Oxoid) was placed onto the agar surface. Plates were then incubated 
at 37°C in air supplemented with 5% CO2 and examined after 24 h for the presence
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or absence o f growth around the diagnostic disk. The susceptibility to optochin was 
used to presumptively differentiate species (Table 2.3).





A ll presumptive anaerobic bacteria were tested for their susceptibility to 
metronidazole. Fastidious anaerobic agar (FAA; LabM, Bury, UK) plates were 
inoculated with test colonies and a diagnostic disk impregnated with metronidazole 
(Oxoid Ltd.) was placed onto the agar surface. Plates were then incubated at 37°C in 
an anaerobic environment and examined after 24 h for the presence or absence o f 
growth around the diagnostic disk. Metronidazole-sensitive isolates were 
presumptively identified as obligate anaerobes and metronidazole-resistant isolated 
were presumptively identified as facultative anaerobes.
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2.4 16S rRNA gene typing
After microbiological identification techniques had been carried out all antibiotic- 
resistant bacteria were identified using partial 16S rRNA gene typing. DNA was 
extracted from the antibiotic-resistant bacteria (2.4.1), this was used as a template to 
amplify the 16S rRNA gene using global primers (27f and 1492r, Genosys, Sigma, 
UK) via the polymerase chain reaction (2.4.4). Subsequent partial DNA sequencing 
o f their 16S rRNA gene was carried out using a single global primer (27f, 357f or 
1492r) via the polymerase chain reaction (2.4.5, 2.4.6). Sequences were analysed 
using the Ribosomal Database project II and BLAST at the National Centre for 
Biotechnological Information. DNA sequencing was carried out using an ABI310 
Genetic Analyser (PE Biosystems, Warrington, UK).
2.4.1 Extraction of Genomic DNA
The genomic DNA extraction kit was obtained from Gentra Systems, (Minneapolis, 
USA) and supplied by Flowgen. Usually 1- 2 ml from an overnight broth culture 
grown in the appropriate medium containing relevant antibiotics was used. The cells 
were pelleted by centrifugation at 17089 g in a bench top micro-centrifuge for 1 min 
and resuspended in 600 pi o f Cell Suspension Solution. 3 pi o f Lytic Enzyme was 
added to the tubes, which were inverted 25 times. The tubes were incubated for 30 
min at 37°C to digest the cell walls. The samples were inverted occasionally during 
this 30 min incubation. The cells were centrifuged at 17089 g for 1 min and the 
supernatant discarded. The cell pellet was resuspended in 600 pi o f Cell Lysis 
Solution and incubated at 80°C for 5 min to complete cell lysis. This was followed
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by the addition o f 3 pi o f RNase A to the cell lysate which was mixed by inverting 
the tube 25 times and incubating at 37°C for 15 min - 1 h. The sample was cooled to 
room temperature and 200 pi o f Protein Precipitation Solution added to the lysate. 
This was vortexed vigorously at high speed for 20 seconds to ensure even mixing 
and centrifuged at 17089 g for 3 min. After this step the protein was visible as a 
small white pellet. The supernatant from this step was poured into a new 
microcentrifuge tube containing 1.5 ml o f 100% isopropanol, the samples were 
mixed by inverting the tube 50 times. The tube was centrifuged at 17089 g for 1 min 
and the supernatant poured off. The DNA was washed by adding 600 pi o f 70% 
ethanol and inverting several times. The tube was centrifuged at 17089 g for 1 min 
and the supernatant discarded. The DNA pellet was air dried and dissolved 
overnight in a suitable volume (100 pi) o f DNA Hydration Solution.
2.4.2 Agarose Gel Electrophoresis
DNA samples were mixed with 0.1 volume o f sample buffer (0.25% bromophenol 
blue, 0.25% xylene cyanol FF, 40% sucrose in sterile distilled water) and were 
analysed by agarose (Amresco, Solo, Ohio, USA) gel electrophoresis (Sambrook et 
al., 1982). Gels were prepared with agarose at the relevant percentage in TBE buffer 
(0.045 M Tris-Borate, 0.001 M EDTA) (Sambrook et al., 1989). Gels contained 
ethidium bromide (Promega) at a concentration o f 0.5 pgml'1. Gels were run at an 
appropriate voltage for an appropriate length o f time depending on the size o f the 
DNA. The DNA was visualised using an ultraviolet transilluminator operating at 
320nm. Gel images were produced using Alphalmager equipment and computer
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software (Innotech Corporation, distributed through Flowgen, Ashby de la Zouch, 
UK).
2.4.3 PCR Template Production from Single Colonies.
To avoid the necessity o f carrying out a DNA preparation on each sample a direct 
colony technique could also be used. One colony or part o f a colony o f the 
bacterium to be identified was used as a template was added to 50 pi o f sterile 
distilled water in a microcentrifuge tube. The tubes were used directly as a PCR 
template.
2.4.4 Standard PCR Protocol
The total reaction volume was determined (usually 100 pi per reaction). This 
provided the basis for the calculations concerning buffer, MgCh, dNTPs and DNA 
polymerase enzyme used. A typical program for PCR is as follows. 94°C for 5 min 
to ensure denaturing o f the template DNA and any secondary structures which may 
have formed in the primers. This was followed by 29 cycles o f 94°C for 1 min, 52°C 
for 30 sec, 72°C for 1 min. After the cycling an extension o f 72°C for 5 min 
followed by cooling to 4°C until the samples were analysed. A ll o f the temperatures 
and times are variable. The denaturing step was usually carried out at 94 - 96°C. The 
annealing step is dependant on the melting temperatures o f the primer which is 
given by the equation;
Tm = 2°C x (A+T) + 4°C x (G+C)
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The annealing step was followed by the extension step which is usually 68 - 72°C 
the times o f which are dependant on the length o f the product that is being 
amplified. Usually 1 min for each 1 kbp is allowed.
2.4.5 Oligonucleotide Synthesis
The synthesis o f all oligonucleotides was carried out by Genosys Biotechnologies 
(Europe) Ltd (Pampisford, U.K.). Sequences o f the 16S rRNA gene primers used 
throughout this study are shown in table 2.4.
Table 2.4 Primers used for 16S rRNA gene amplification and sequencing.
Primer Sequence
27f 5’ AGAGTTTGATCMTGGCTCAG 3’
1492r 5’ TACGGYTACCTTGTTACGACTT 3’
357f 5’ CTCCTACGGGAGGCAGCAG 3’
M = C:A , Y = C:T
2.4.6 DNA Sequencing
The sequencing o f PCR products and double stranded plasmid DNA was carried out 
according to the PE Biosystems (Warrington, UK) instructions with the following 
modifications. 2 pi o f 1:4 diluted ABI BigDye Terminator Ready Reaction M ix was 
used per reaction, 5 pmoles o f primer per reaction and 200-400 ng o f DNA in a final
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volume o f 5-7 pi reaction volume. This was used in the following program. Rapid 
thermal ramp to 95°C; held for 10 min. Rapid thermal ramp to 50°C; held for 5 sec. 
Rapid thermal ramp to 60°C; held for 4 min. These four steps are repeated for 99 
cycles followed by a rapid thermal ramp to 4°C and held until the samples were 
ready to purify.
2.4.7 Purification of Sequencing Products
For each sample 13 pi o f H2O, 2pl o f 3M NaAc and 50 pi 100% ethanol (~20°C) 
was added to the 7 pi sequence reaction. This was incubated on ice for 20 min. The 
sample was centrifuged at 17089 g in a microcentrifuge for 25 min, the supernatant 
was discarded and the pellet washed with 70% ethanol (-20°C). The sample was 
then air dried and dissolved in 20 pi template suppression reaction buffer (PE 
Biosystems), denatured at 95°C for 2 min and incubated on ice for 5 min. The 
sample was briefly vortexed and transferred to a new sequencing tube and loaded 
into the 310 ABI Genetic analyser (PE Biosystems).
2.5 Identification of oral streptococci by microbiological 
methods
Due to similarity o f the 16S rRNA gene sequence in the oral streptococci, it was 
also necessary to determine the identification o f these bacteria by carbohydrate 
fermentation and enzyme utilisation tests (Whiley and Beighton, 1998).
Materials and Methods
2.5.1 Carbohydrate Fermentation Tests
Streptococci colonies from CBA plates were checked for purity and any mixed or 
contaminated cultures were subcultured until pure. Colonies were suspended in 1 ml 
o f sterile PBS equivalent to a turbidity o f 0.5 McFarlands standard and 500 pi o f 
this was transferred into the well o f the multipoint inoculator tray. This suspension 
was then applied to the surface o f a range o f carbohydrate-containing peptone media 
(Prolab Diagnostics, Cheshire, UK) by the use o f a multipoint inoculator (Scan 400; 
Mast group, Bootle, UK). This technique allowed up to 32 different test isolates plus 
3 controls and a PBS sterility check to be simultaneously inoculated onto a series o f 
agar plates. The inoculated carbohydrate plates were incubated at 37°C aerobically 
for 18-24 h, a change in the colour o f the medium from blue/green to yellow around 
the bacterial isolate indicated a positive result. Tests that remained blue/green were 
recorded as negative (Badawi et al., 2003).
2.5.2 Hydrolysis of Aesculin
Aesculin hydrolysis was determined by an agar method, using aesculin agar (Oxoid 
Ltd.). The isolates were inoculated on to the agar surface via a multipoint inoculator 
as described for the carbohydrate fermentation tests. Aesculin hydrolysis was 




2.5.3 Detection of Pre-formed Enzyme Activity
To test for the presence o f enzyme activity, each broth was cultured on CBA and 
incubated anaerobically for 24 to 48 hours. Colonies o f each isolate were removed 
from the CBA plates with a sterile cotton swab and suspended in 1.5 ml o f 50 mM 
N - tris (hydroxymethyl) 2-aminoethanesulfonic acid (TES) buffer pH 7.5 at an 
optical density (O.D.) o f 0.1 at 620 nm. This suspension was used to determine the 
ability o f each isolate to hydrolyse a series o f 4-methylumbelliferyl (MU -) linked 
substrates (Beighton et al., 1991). These substrates were: MU - p fucoside, MU - p - 
N  - acetylgalactosaminide, MU - a  - neuraminate, MU - a fucoside, MU - p - N  - 
acetylglucosaminide, MU - a - glucoside, MU - p - glucoside, MU - a - galactoside, 
MU - a - arabinoside and MU - p - galactoside. Each enzyme substrate was 
prepared from powder that was initially dissolved in 0.5 ml o f dimethyl sulphoxide. 
This was added to 9.5 ml o f TES buffer to make a 1 mg/ml stock solution. The 
working concentration o f 100 pg/ml was prepared by adding 1 ml o f the stock 
solution to 9 ml o f TES buffer. The stock solutions were stored at - 20°C and the 
working solutions at 4°C. To detect enzyme activity, 20 pi o f enzyme substrate and 
45 pi o f bacterial suspension were added to a well in a single non-sterile, flat 
bottomed microtitre tray. The plates were incubated aerobically at 37°C for 3 hours. 
Substrate hydrolysis was determined by measuring the fluorescence on a Perkin 
Elmer fluorimeter using excitation emission at wavelengths o f 380 nm and 460 nm 
respectively. Presence o f enzyme activity was positive i f  there was an increase in 
fluorescence o f 50 arbitrary units above the control. This increase in fluorescence o f 
the fluorophore methylumbelliferone, resulted in the liberation o f approximately 20
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nmoles o f substrate being degraded. The last row in each series o f plates was the 
control and contained enzyme substrate only.
2.5.4 Identification and quality control
The combined results o f the carbohydrate fermentation tests and the tests for 
presence o f pre-formed enzymes were used to identify the viridans streptococci 
isolates, by comparing them with those reported in the literature (Beighton et al., 
1991; Whiley and Beighton, 1998) and with type strains o f the organisms. Any 
organism with an inconclusive profile was subjected to repeat testing. Regular 
quality testing was carried out by culturing type strains (Table 2.1) in the same 
manner as the test isolates.
2.6 Antibiotic sensitivity testing
Susceptibility testing was performed by an agar dilution method (NCCLS, 2003; 
BSAC 2001).
2.6.1 Antibiotic stock solutions
The six antibiotics used throughout this study were ampicillin, penicillin, 
erythromycin, metronidazole tetracycline and vancomycin; all were supplied by 
Sigma. Stock solutions o f these antibiotics were prepared at concentrations o f 64 
mg/ml, 8 mg/ml and 1 mg/ml in the receptive solvent (Table 2.5) according to the 
manufacturer’s instructions. Each stock solution was aseptically filter-sterilised 
using a 0.2 pm syringe filter (Nalgene Europe Ltd., Herefordshire, UK) into a sterile
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universal (Sarstedt Ltd). Aliquots (1 ml) o f these stocks were subsequently 
dispersed into sterile, previously labelled cryovials and stored at -20°C for a 
maximum period o f 28 days.
Table 2.5 Antibiotics and corresponding solvents and diluents.
Antibiotic Solvent Diluent
Penicillin V Deionised Water Deionised Water
Ampicillin Deionised Water Deionised Water
Erythromycin 100% Methanol Deionised Water
Metronidazole Deionised Water Deionised Water
Tetracycline 50% Ethanol Deionised Water
Vancomycin Deionised Water Deionised Water
2.6.2 Preparation of agar plates
For antibiotic susceptibility testing, 15 agar plates were prepared for each batch o f 
bacteria to be tested. Isosensitest agar or Muller-Hinton agar was used as the culture 
medium as recommended by BSAC, 2001 and NCCLS 2003, respectively. Agar 
was cooled to 46°C in a thermostatically controlled water bath after sterilisation by 
autoclaving at 121 °C for 15 minutes. Antibiotic stocks were allowed to thaw and 
equilibrate to room temperature before use. The test antibiotic was then incorporated 
into the agar supplemented with 5% (v/v) defibrinated horse blood, the final 
concentration o f the antibiotic in each plate was; 0, 0.06, 0.125, 0.25, 0.5, 1, 2, 4, 8,
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16, 32, 64, 128, 256, 512 mg/1. Plate pouring was performed in a laminar flow 
cabinet (Medical A ir Technology, Manchester, UK). After preparation the plates 
were air dried overnight and stored at 4-8°C. Antibiotic-containing plates were only 
stored for a maximum o f 14 days before being discarded. The sterility o f each batch 
o f plates was confirmed by testing the first and last plate poured for the absence o f 
bacterial growth after incubation in air at 37°C for 24 and 48 hours confirmed 
sterility.
2.6.3 Inoculation procedure
Prior to inoculation all agar plates were air-dried and allowed to reach room 
temperature before use. Aerobic bacteria to be tested were grown overnight on CBA 
in air supplemented with 5% CO2 . Anaerobic and facultative-anaerobic bacteria 
were grown for 3 days on FAA in an anaerobic cabinet. Bacteria were diluted in 2 
ml o f sterile Isosensitest broth to produce an inoculum at 0.5 McFarlands standard 
(BioMerieux, Basingstoke, UK) equivalent to ca 108 cfu/ml. This suspension was 
then diluted 1:10 with sterile Isosensitest broth giving a final concentration o f 107 
cfu/ml. Once the adjusted inoculum was prepared inoculation o f the agar plates was 
performed within 30 min using a multipoint inoculator (Mast, Merseyside, UK). 500 
pi from each inoculum was transferred to one o f the thirty-six sterile wells in the 
inoculation tray. The inoculation tray was then placed onto the multipoint inoculator 
housing and the inoculum was applied to the agar surface by the prongs o f the 
multipoint inoculator. Each prong delivered a standardised inoculum (approximately 
1 pi) o f bacterial suspension from the well to the agar surface, yielding
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approximately 104 cfu/ml per inoculum spot. Control plates, antibiotic-free 
isosensitest, CBA and FAA were inoculated at the start and end o f each batch o f 
plates inoculated to serve as controls, additionally, the lowest concentration o f an 
antibiotic was inoculated first in each batch. Plates were allowed to stand until all 
these inocula were completely absorbed by the medium, then inverted and incubated 
for 24-48 h in an appropriate atmosphere. The Minimum Inhibitory Concentration 
(MIC) was defined as the lowest concentration o f the antibiotic that inhibited visible 
growth. An isosensitest broth sterility control plus control strains (Table 2.1) were 
included in every batch o f susceptibility tests.
2.7 The Constant-depth film fermenter
In order to model the microbial population in the oral cavity over a period o f time, 
an artificial system was required. For this purpose a constant-depth film  fermenter 
(CDFF) was used (Figure 2.1). The CDFF used throughout this study was a 
modified version o f the fermenter first described by Peters and Wimpenny (1988) 
and was engineered by John Parry-Jones Engineering (Cardiff, UK).
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Figure 2.1 Constant-depth film fermenter (CDFF) attached to a motor housing 
unit.
A stainless steel turntable holds fifteen polytetrafluoroethylene (PTFE) pans (Figure 
2.2) located flush around its rim. Each pan is inserted and held flush with the
turntable by silicone rubber ‘O’ rings. Each o f the 
pans contains 5 cylindrical holes, 5 mm in diameter, 
which contain PTFE plugs and a central threaded hole 
into which a sampling tool is inserted for the removal 
or replacement o f the pans. Biofilms were grown on 5Figure 2.2 CDFF pan
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mm bovine enamel disks (cut from bovine incisors that had been polished flat; 
Biomaterials Department, Eastman Dental Institute) supported by these plugs. The 
disks sit on the PTFE plugs and can be accurately recessed to 300 pm using a 
recessing tool. The removal o f each pan produces a maximum o f 5 replica biofilm 
samples, allowing statistical variation to be determined. The steel turntable was 
attached to a vertical central spindle running through the base plate via an 
autoclavable bearing assembly. The base plate is supported by three stainless steel 
legs to accommodate a detachable gearbox motor. The gearbox is driven by a 15V 
power supply (BBH Power Products) housed in the support in which the fermenter 
sits. The steel disk rotating at 3 revolutions per 
minute (r.p.m.), passes beneath two angled PTFE 
scraper blades (Figure 2.3) which are forced onto 
the surface o f the steel disk by pressure exerted 
from loaded springs. A QVF borosilicate glass 
tubing section, sealed to the top and the bottom 
plates by PTFE seals, surrounds and completely encloses the turntable and scraper 
blades assembly. The top plate is fitted with a number o f inlets for the addition o f 
the bacterial inoculum, growth medium or antibiotic agent; in addition there is a 
sample port and an air inlet. The air inlet had two Hepa-vent 0.2 pm pore filters 
(Whatman, Maidstone, UK) attached. The bottom plate is fitted with an effluent 
medium outlet (Figure 2.4).
Samples were taken using sterile sampling tools. Firstly the film pan was positioned 
into place by reducing the voltage on the power supply to zero, and then the
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sampling tool was inserted through the sample port and screwed into the appropriate 
film  pan before the pan was removed.
air inlet
area o f luotilin growth
disk o f  material
PTFE plug
JA
Figure 2.4 Schematic vertical section through the fermenter showing the stainless 
steel turntable, film pans and film  plugs.
2.8 CDFF experimental set-up
The fermenter was inoculated using different volumes o f medium, over various time 
periods depending on the number o f organisms used for a specific run.
Materials and Methods
2.8.1 Artificial saliva
The nutrient source for the fermenter-based studies was artificial saliva, the 
composition o f which was based on work by Russell and Coulter (1975) and Shellis 
(1978).
Table 2.6 Composition o f artificial saliva.
Product Volume per litre of 
dHnO
‘Lab-lemco’ powder 1.0 g
Yeast extract 2.0 g
Proteose peptone 5.0 g
Mucin type III: partially purified from porcine stomach* 2.5 g
Sodium chloride 0.35 g
Calcium chloride 0.2 g
Potassium chloride 0.2 g
2.8.2 Continuous flow
After the 8h inoculation, the inoculation vessel was disconnected and the medium 
reservoir containing sterile artificial saliva was connected to the CDFF. The 
artificial saliva was delivered via a peristaltic pump (Watson-Marlow, Falmouth,
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UK) at a rate o f 0.5 ml per min., corresponding to the resting salivary flow rate in 
man (Bell et al., 1980, Guyton, 1991, Lamb et al., 1991).
At the same time a waste port was connected to a 10 litre effluent bottle. To prevent 
contamination o f the sterile medium a grow-back trap (Hampshire Glassware Co., 
Southampton, UK) was used between the length o f silicone tubing connecting the 
peristaltic pump and the CDFF.
2.8.3 Culture methods
Pans were removed from the CDFF at various time intervals depending on the 
experiment, and the disks aseptically removed and placed into 1 ml PBS. The disks 
were vortex mixed for 1 minute to disrupt the biofilm.
2.9 Statistical analysis
2.9.1 Measurement of normality: skewness and kurtosis
The distribution o f the raw data counts (CFU m l'1) were checked for skewness (i.e. 
the degree o f asymmetry o f a distribution around the mean) and kurtosis (i.e. the 
degree o f smoothness o f the distribution curve) prior to analysis. I f  a set o f data was 
normally distributed then parametric analyses were used; i f  data were not normally 
distributed then nonparametric analyses were used. Specific details o f tests carried 




Three methods were used to calculate the diversity o f the antibiotic-resistant 
bacteria isolated. In this thesis the all o f the bacteria isolated from a defined group 
o f patients were ranked and their prevalence recorded on a data base in accordance 
with the data protection act. These groups o f data were then analysed to determine 
the diversity o f these data by calculating the number o f different species present 
(species richness, S), the Shannon-Weaver index and the evenness measure (E). The 
Shannon-Weaver Index o f diversity (H), was used to determine the species diversity 
o f antibiotic-resistant bacteria by using the function H =  -E (P i ln[Pj]), where Pj = n /
N, n is the number o f an individual species, and N is the total number o f all species 
isolated (Shannon and Weaver, 1963). //equals zero when only 1 species is present 
and increases with diversity. Previous workers have used this measure to investigate 
microbial diversity between individual samples (Morris et al., 2002; Ibekwe et al., 
2001) and also between pooled microbial samples (Lasse et al., 2001) from different 
environments, including the oral cavity (Martin, 2002; Kroes et al., 1999). The 
evenness measure (E) was used to determine how similar the abundance o f different 
species was by using the equation E = H  / (lnS). I f  there were similar proportions o f 
all species then the evenness score would be one, but when the abundance was very 
dissimilar (some rare and some common species) then the value decreases, giving a 
score approaching 0.
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Chapter 3
Prevalence, proportions and 
identities of antibiotic-resistant 
bacteria in the oral microbiota of
healthy children
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3.1 Introduction
The commensal microbiota o f the oral cavity can act as a reservoir o f antibiotic- 
resistant microorganisms, some o f which are capable o f causing local and systemic 
diseases (Brook, 1996; M illar et al., 2001; Roberts, 1998). Antibiotic therapy is 
often administered for the treatment o f these infections and the presence o f resistant 
bacterial strains raises concerns about the effective use o f antibiotics for both 
medical and dental practitioners. Many studies have demonstrated a high prevalence 
o f antibiotic-resistant bacteria in hospitalised groups, with serious complications for 
infected patients (Kling et al., 1989; Sjostedt et al., 1990). However, antibiotic
resistance in the community can also have detrimental consequences for the patient. 
Patients in the community that are infected with antibiotic-resistant bacteria have a 
higher incidence o f hospitalisation, longer duration in hospital and have increased 
mortality compared to those infected with antibiotic-sensitive strains (Holmberg et 
al., 1987). A recent U.K. study has demonstrated that the oral cavity o f healthy 
children living in the community can harbour pathogenic antibiotic-resistant bacteria 
(M illar et al., 2001). It has also been shown that children have a higher prevalence 
o f penicillin-resistant streptococci compared to adults (Guiot et al., 1994) and that 
children under 4 years o f age are more likely to harbour B-lactamase producing 
strains o f Haemophilus influenzae than older children (Manninen et al., 1997). This 
may be a result o f higher antibiotic usage in children compared to adults. Most 
antibiotic resistance studies have investigated the carriage o f pathogenic bacteria 
with little or no information on antibiotic resistance in the normal microbiota. 
However, antibiotic resistance in the normal microbiota may also be important as
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oral bacteria have been shown to be reservoirs o f mobile genetic elements encoding 
antibiotic resistance some o f which are able to transfer antibiotic resistance to 
different bacterial species (Roberts, 1998; Roberts et al., 1999; 2001).
The aims o f this part o f the study were to determine the prevalence and identity o f 
antibiotic-resistant oral bacteria in community based children aged 4-5 years old.
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3.2 Materials and Methods
3.2.1 Subjects
A ll 4-5 year old children attending three reception classes o f a North London School 
(U.K.) were included in a dental screening programme. Seventy-seven children were 
given a dental examination, a consent form and a questionnaire to determine their 
previous use o f antibiotics and the presence o f any major medical problems. Fifty- 
five (71%) o f the children screened were given parental consent for the collection o f 
dental plaque. Seventeen children were excluded from the study due to antibiotic 
use in the previous three months and 3 children were unavailable for sampling. 
Samples were obtained from 35 children (21 female and 14 male). The results o f the 
dental examination showed that the majority o f the 35 children were caries free, did 
not have dental restorations and had a good standard o f oral health. The parental 
questionnaires stated that none o f the 35 children had a serious medical condition 
and that none o f the parents, guardians or children had taken antibiotics in the three 
months prior to the sample collection.
3.2.2 Bacterial isolation, identification and susceptibility testing
Plaque samples were taken from the entire dentition o f each child, diluted, plated 
onto antibiotic-free and antibiotic-containing media and the total microbiota and 
antibiotic resistant bacteria were enumerated (2.2.4) and antibiotic-resistant bacteria 
were identified by a combination o f biochemical and molecular methods (2.3 -  
2.5.3). Susceptibility testing was carried out on all antibiotic-resistant bacteria to 
confirm antibiotic resistance by an agar dilution method (2.6 -  2.6.3).
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3.2.3 Species diversity
The species diversity o f the antibiotic-resistant bacteria was determined by 
calculating the Shannon-Weaver Index o f diversity (//), the evenness score (E) and 
the number o f different species present (2.10).
3.2.4 Phylogenetic Trees
The 16S rRNA gene sequences were aligned with ClustalW (Guiot et al., 1994). 
Manual editing was performed to remove excess bases at the 3’ and 5’ end o f the 
aligned sequences, followed by phylogenetic analysis which was performed with the 
PHYLIP suite o f programmes (Phylogeny Inference Package, version 3.5c. Seattle: 
Department o f Genetics, University o f Washington.); a distance matrix was 
constructed with DNADIST using the Jukes-Cantor model which assumes that the 
four bases have equal frequencies, and that all substitutions are equally likely (Page 
and Holmes, 1998). A phylogenetic tree was constructed with NEIGHBOR and the 
resulting tree was displayed with TreeView (Page, 1996).
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3.3 Results
3.3.1 Frequency of antimicrobial resistance in the oral microbiota
A ll 35 children harboured bacteria resistant to ampicillin, erythromycin, 
metronidazole and vancomycin in their oral cavity with the majority o f children 
harbouring organisms resistant to penicillin and tetracycline (Table 3.1). However, 
all o f the 172 metronidazole-resistant isolates were able to grow in the presence o f 
oxygen (air supplemented with 5% CO2). Consequently, none o f these 
metronidazole-resistant oral isolates were obligate anaerobic bacteria and would 
therefore be considered intrinsically-resistant to this antibiotic. Similarly, all o f the 
257 vancomycin-resistant bacteria isolated were identified as Gram-negative 
bacteria and as such would be intrinsically-resistant to this antibiotic.
Table 3.1 Prevalence and proportions o f antibiotic-resistant bacteria isolated from 
35 healthy subjects.
Subjects harbouring antibiotic- Percentage of total microbiota
resistant isolates resistant to antibiotics (%)
Antibiotic Number % Median Range
Ampicillin 35 100 1.4 0.1-23
Erythromycin 35 100 13.2 1-45
Penicillin 34 97 1.4 0-14
Tetracycline 34 97 1.9 0-88
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The median count o f the total oral microbiota was 4.4 x 106 cfu m l'1 (range 6.5 x 105 
-  6.9 x 107). Figure 1 shows the distribution o f the counts for the total oral 
microbiota and the antibiotic-resistant counts obtained from the 35 children studied. 
These counts vary from subject to subject, and this variation is particularly marked 
in the tetracycline-resistant bacteria, with counts obtained ranging from < 5 cfu m l'1
7  1in one patient to 4.4 x 10 cfu ml' in another. The median percentage o f the oral 
microbiota resistant to each o f the antibiotics in the 35 subjects ranged from 0% for 
the non-intrinsically metronidazole-resistant and vancomycin-resistant bacteria to 
13.2% o f the oral microbiota being resistant to erythromycin (Table 3.1). The 
percentage o f the oral microbiota resistant to each antibiotic varied greatly from 
subject to subject, for example, 1 child had less than 0.0001% o f their total 
cultivable microbiota resistant to tetracycline present in their oral cavity whereas 
another child had 89% o f their oral microbiota resistant to this broad-spectrum 
antibiotic.
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Figure 3.1 Counts obtained from the 35 children for the total cultivable oral 
microbiota and the penicillin-, erythromycin-, ampicillin-, tetracycline- and 
vancomycin-resistant microbiota. Horizontal lines represent the median count.
3.3.3 Identity of antibiotic-resistant bacteria
In total 432 antibiotic-resistant isolates were recovered from the 35 subjects (Figure 
3.2). These comprised o f a diverse community ( / /=  3.2) o f 18 different genera and 
47 different species. Examining all 432 isolates showed that the antibiotic-resistant 
microbiota consisted o f 35% Streptococcus spp., 31% Veillonella spp., 10% 
Haemophilus spp., 9% Neisseria spp., 4% Staphylococcus spp., 3% 
Capnocytophaga spp., 2% Prevotella spp. and 1 % Actinobacillus spp.
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3.3.4 Diversity of antibiotic-resistant bacteria
Table 3.2 shows the identity and the species diversity o f the 154 ampicillin-resistant, 
61 erythromycin-resistant, 157 penicillin-resistant and 60 tetracycline-resistant 
bacteria isolated. The greatest diversity was seen in the ampicillin-resistant 
microbiota which consisted o f 24 species and had a Shannon-Weaver index o f 2.6 
and an evenness score o f 0.8. In contrast, although more species were present (26) 
penicillin resistance was found in a less diverse population than the ampicillin- 
resistant microbiota with a Shannon-Weaver index o f 1.4. This reduction in 
diversity was mainly due to an uneven distribution o f the isolates (E = 0.4) as 
demonstrated by the observation that only three species constituted 56% o f all the 
penicillin-resistant isolates (Veillonella parvula, 22%; Veillonella dispar, 19% and 
Streptococcus mitis, 15%). The erythromycin-resistant and the tetracycline-resistant 
isolates were less diverse (H  = 0.6), with S. mitis constituting 36% o f the 
erythromycin-resistant bacteria and 38% o f the tetracycline-resistant bacteria.
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Table 3.2: Identification o f antibiotic-resistant oral bacteria isolated from 35 children. 









Actinobacilllus spp. 1 (0.6) 3 (4.9) 2(1.3) 0(0)
Bacillus licheniformis 0(0) 1(1.6) 1 (0.6) 0(0)
Bacteroides ureolyticus 1 (0.6) - 1 (0.6) 0(0)
Capnocytophaga spp. 3(1.9) 3 (4.9) 7(4.5) 0(0)
Eubacterium saburreum 0(0) 0(0) 0(0) 2 (3.3)
Fusobacterium spp. 0(0) - 2(1.3) 0(0)
Granulicatella elegans 0(0) 0(0) 0(0) 1(1.7)
Haemophilus spp. 37 (24.0) - - 7(11.7)
Leptotrichia buccalis 0(0) - 0(0) 2 (3.3)
Moraxella catarrhalis 0(0) 1 (1.6) 0(0) 0(0)
Neisseria spp. 14(9.1) 14 (23.0) 10(6.4) 1 (1.7)
Pasturella aerogenes 1 (0.6) 0(0) 1 (0.6) 0(0)
Porphyromonas spp. 0(0) - 2(1.3) 0(0)
Prevotella spp. 4(2.3) - 5 (3.2) 0(0)
Staphylococcus spp. 7 (4.5) 3 (4.9) 7(4.5) 1(1.7)
Stomatococcus mucilaginosus 2(1.3) 0(0) 0(0) 0(0)
Streptococcus spp. 41 (26.6) 36 (59.0) 37 (23.6) 38 (63.3)
Veillonella spp. 43 (27.9) - 82 (52.2) 8(13.3)
Total 154(100) 61 (100) 157(100) 60(100)
Number o f species present (S) 24 15 26 16
Shannon-Weaver Index (H) 2.6 0.6 1.4 0.6
Evenness (E) 0.8 0.2 0.4 0.2
(-) Indicates isolates not included in antibiotic resistance guidelines (NCCLS, 2003).
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3.3.5 Multi-resistant isolates
Multi-resistant bacteria were frequently isolated (Table 3.3) with 111 (27.8%) 
isolates resistant to 2 or more antibiotics. 13-lactam resistance (ampicillin and 
penicillin) was commonly observed in all isolates, notably all o f the staphylococci 
isolated were resistant to these antibiotics. Combined tetracycline and erythromycin 
resistance was common in all streptococcal species and most frequent in Strep, 
oralis with 8 isolates (40%) resistant to these two antibiotics.
Table 3.3: Multi-resistance profiles -  number (%) o f antibiotic-resistant bacteria 
resistant to three additional antibiotics
Number Ampicillin Erythromycin Penicillin Tetracycline
Ampicillin- 
resistant bacteria
154 - 25 (16.2) 93 (60.4) 18(11.7)
Erythromycin- 
resistant bacteria
61 23 (37.7) - 22 (36.1) 24 (39.3)
Penicillin- 
resistant bacteria
157 89 (56.7) 22(14.0) - 14 (8.9)
Tetracycline- 
resistant bacteria
60 17(28.3) 20 (33.3) 10(16.7) -
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3.4 Discussion
The majority o f the antibiotic-resistant bacteria isolated were members o f the 
normal oral microbiota. Interestingly, there was an absence o f Lactobacillus spp. 
and Actinomyces spp. isolated from the children, 2 genera which are frequently 
isolated from dental plaque (Marsh and Martin, 1999; Sonbol et al., 2001). This 
absence may be due to these 2 genera being susceptible to the antibiotics tested or it 
may be that they were in too low numbers to be detected. Some opportunistic and 
pathogenic bacteria were also isolated, including organisms which cause; 
pneumonia, otitis media, sinusitis, meningitis, deep-seated abscesses, endocarditis 
and dental diseases including caries and periodontal diseases. The carriage o f these 
pathogenic and opportunistic pathogens is o f clinical importance as infection caused 
by such antibiotic-resistant bacteria could result in treatment failure and lead to a 
chronic infection.
A ll o f the children in this study harboured antibiotic-resistant bacteria, 
demonstrating the potential o f the oral cavity to act as a reservoir o f antibiotic- 
resistant organisms. A few o f the subjects had very high percentages o f their oral 
microbiota resistant to specific antibiotics, with one subject having 88% o f their oral 
microbiota resistant to tetracycline. The presence o f children with extremely high 
percentages o f their oral microbiota resistant to specific antibiotics suggests that 
there is a subset population that could act as a reservoir o f antibiotic-resistant 
bacteria.
The British National Formulary guidelines state that tetracycline should not be 
administered to children under 12 years o f age (British National Formulary, 2003)
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and, as all o f the children in this study were aged 5 or under, they should never have 
received this antibiotic. However, only 1 o f the subjects did not harbour detectable 
numbers o f tetracycline-resistant bacteria. It is possible that the tetracycline-resistant 
bacteria isolated from these children were acquired from family members and may 
have been maintained in the oral cavity due to co-selection by exposure to other 
antibiotics licensed for use in children. In our study, many o f the isolates were 
resistant to both tetracycline and erythromycin and it has previously been shown 
that tetracycline and erythromycin resistance genes are commonly found on the 
same genetic element (Mullany, 2000). Erythromycin is frequently prescribed for 
use in children (British National Formulary, 2004; M illar et al., 2001) and exposure 
to this antibiotic may co-select for tetracycline-resistant bacteria. In chapter 7 it is 
shown that the addition o f tetracycline in a model oral system not only increases the 
proportions o f bacteria resistant to tetracycline, but also to erythromycin, ampicillin 
and vancomycin.
The diversity o f the antibiotic-resistant bacteria as measured by the Shannon- 
Weaver index ranged from 0.6 -  2.6, in a previous study by Kroes et al. (1999), 
subgingival dental plaque was sampled from 2 teeth from a single individual, pooled 
and analysed by culture and molecular methods, they identified 59 distinct taxa and 
the Shannon-Weaver index was 3.2 (Martin, 2002). The lower diversity detected in 
this study may be the result o f the culture only method being employed and the 
selection o f the antibiotic-resistant bacteria rather than the total microbiota. In this 
study the ampicillin-resistant isolates comprised the most diverse population. In 
contrast, the tetracycline-resistant and the erythromycin-resistant isolates were the
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least diverse, with both having a dominant single species. The reduced diversity 
among the erythromycin-resistant bacteria is partly explained by intrinsic resistance 
in many Gram-negative isolates with the absence o f breakpoint MIC guidelines 
available. Consequently, the Haemophilus spp. and the obligate Gram-negative 
anaerobes although resistant to erythromycin, have been excluded from these data 
and this has reduced the diversity index. The lower diversity o f the tetracycline- 
resistant isolates compared to the ampicillin-resistant isolates is not due to a 
particular genus being excluded from these data or the lack o f breakpoint MIC 
guidelines. However, these differences suggest that ampicillin resistance genes are 
widely distributed throughout different genera and species o f the oral microbiota 
whereas tetracycline resistance is only disseminated within a more limited bacterial 
population.
Previous work has shown that Veillonella spp. are generally susceptible to B-lactams 
and it has been suggested that the use o f penicillin or other B-lactam antibiotics 
would be the preferred treatment for a Veillonella infection (Barnhart et al., 1983; 
Brook, 1996; Sutter and Finegold, 1976). However, these results do not support this 
recommendation, as over 50% o f the penicillin-resistant isolates were Veillonella 
spp. This higher frequency o f penicillin resistance concurs with the results o f a 
previous study, which demonstrated that over 80% o f Veillonella spp. were not 
susceptible to penicillin (Reig et al., 1997). Ampicillin-resistant Veillonella spp. 
have rarely been reported in the literature, with ampicillin resistance being found in 
0 -  5% o f isolates (Reig et al., 1997; Sutter and Finegold, 1976). However in this 
study 40% o f the penicillin-resistant Veillonella spp. were also ampicillin-resistant
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and 28% o f the ampicillin-resistant isolates were Veillonella spp. Resistance to B- 
lactam antibiotics can occur due to impermeabilitity, (3-lactamase production and 
modification o f penicillin binding proteins (PBPs). Reig et al. screened 40 
Veillonella isolates and found that none o f the isolates produced (3-lactamases, 
suggesting that this may not be an important mechanism o f resistance for Veillonella 
spp. Recently Theron et al. (2003) reported resistance in Veillonella spp. due to 
alterations in a PBP, which may explain the rapid emergence o f resistance.
This section has demonstrated that antibiotic-resistant bacteria can be readily 
isolated from healthy children and in some subjects can dominate their oral 
microbiota, even in those individuals who had not been administered antibiotics 
during the preceding 3 months.
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Chapter 4
Prevalence of antibiotic-resistant 
oral bacteria in children with 
previous antibiotic exposure
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4.1 Introduction
The increasing incidence o f antibiotic resistance in bacterial pathogens is seriously 
challenging our ability to treat human infections both in the community and in 
hospitals. Many studies have demonstrated a high prevalence o f antibiotic resistant- 
bacteria in hospitalised groups, with serious complications for patients infected with 
antibiotic-resistant bacteria (Holmberg et al., 1987; Sanches et al., 1998; Simor et 
al., 2002). To ensure the future effectiveness o f antimicrobial agents, we need to 
determine the factors that promote antibiotic resistance. One such factor that has 
been investigated is the general use o f antibiotics in the population, this has been 
shown to contribute to the emergence o f antibiotic resistance in the indigenous 
microbiota o f outpatients and hospitalised patients (Hawkey, 1986; Levy et al., 
1988; Stark et al., 1993; London et al., 1994). Antibiotics are prescribed 
disproportionately, with higher use in children and the elderly. In particular, 
children less than five years o f age are the most likely age group to receive a 
prescription for an antibiotic, with the broad-spectrum penicillins such as 
amoxicillin comprising 60% o f the total antibiotic prescriptions in this age group 
(ONS, 2003). Amoxicillin is not only heavily used in medicine but is also frequently 
prescribed in dentistry and is currently recommended for the chemoprophylaxis o f 
infective endocarditis prior to specific dental procedures (BNF, 2003). The oral 
microbiota is an important reservoir o f antibiotic-resistant bacteria and several 
studies have shown that antibiotic-resistant bacteria are carried in the oral cavity 
(Packer et al., 1999; M illar et al., 2001; Chapter 3). Indeed in the previous chapter, 
all o f the children investigated were shown to harbour antibiotic-resistant bacteria in
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their oral cavity. Other studies have demonstrated that the use o f amoxicillin, 
erythromycin, josamycin and tetracycline can increase the number and/or the 
proportion o f antibiotic-resistant oral bacteria (Harrison et al., 1985; Woodman et 
al., 1985; Sefton, 1999; Chapter 7). However, these studies were carried out in adult 
populations or in a model oral system and not in young children.
The aim o f this part o f the investigation was to study the effect o f amoxicillin use on 
the prevalence, proportions and identities o f antibiotic-resistant bacteria in the oral 
cavity o f children aged 4-5 years old.
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4.2 Materials and Methods
4.2.1 Subjects
Fifty-seven children aged 4-5 years (26 male and 31 female) were given parental 
consent for the collection o f dental plaque and were recruited into this part o f the 
study. Study group #1 comprised 35 children that had not used any class o f 
antibiotic in the three months prior to sampling and the second group consisted o f 
15 children that had used amoxicillin in the three months prior to sampling. Seven 
children were excluded from this study as they had taken an antibiotic other than 
amoxicillin in the three months prior to sampling. The Research and Ethics 
Committee o f Barnet Health Authority, London, England, approved the study.
4.2.2 Bacterial isolation, identification and susceptibility testing
Plaque samples were taken from the entire dentition o f each child, diluted, plated 
onto antibiotic-free and antibiotic-containing media and the total microbiota and 
antibiotic resistant bacteria were enumerated (2.2.4) and antibiotic-resistant bacteria 
were identified by a combination o f biochemical and molecular methods (2.3 -
2.5.3). Susceptibility testing was carried out on all antibiotic-resistant bacteria to 
confirm antibiotic resistance by an agar dilution method (2.6 -  2.6.3).
4.2.3 Data analysis
The Shannon-Weaver Index o f diversity (//), was used to determine the species 
diversity o f antibiotic-resistant bacteria by using the function H  = - I  (Pj ln[Pj]) as
described previously (2.10). To calculate the percentage o f the cultivable microbiota
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resistant to each antibiotic, the total number o f resistant isolates was compared with 
the total number o f CFU for each sample. Generally these distributions were 
skewed, consequently these data were analysed using non-parametric tests. Analysis 
o f antibiotic resistance data for children with and without amoxicillin use in the 
previous three months was carried out using the Mann-Whitney U test. To 
determine an association between the percentage o f the microbiota resistant to each 
antibiotic the 2-tailed Pearson correlation test was used. Additionally, the Chi- 
squared test was used to assess any difference in the prevalence or proportion o f 
antibiotic-resistant oral bacteria in children with and without amoxicillin use in the 
previous three months. Data were analysed using SPSS software (SPSS, 2000) and 
the 5% level o f statistical significance was used throughout these analyses.
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4.3 Results
4.3.1 Frequency of antibiotic resistance
A ll o f the children harboured bacteria resistant to ampicillin and erythromycin in 
their oral cavity with the majority o f children harbouring organisms resistant to 
penicillin and tetracycline (Table 4.1). There was no significant difference in the 
number o f children harbouring antibiotic-resistant bacteria in the 2 groups with and 
without amoxicillin use in the three months prior to sampling.
Table 4.1: Prevalence o f antibiotic-resistant bacteria in children with and without 
amoxicillin use in the previous three months.
Percentage of children harbouring antibiotic- 
resistant bacteria - (No.)
Agent no amoxicillin use amoxicillin use
Penicillin 97.1 (34) 100(15)
Ampicillin 100 (35) 100(15)
Erythromycin 100 (35) 100(15)
Tetracycline 97.1 (34) 93.3 (14)
Vancomycin 0(0)a 0(0)a
Metronidazole 0(0)a 0(0)a
a Intrinsic resistance eliminated from these data.
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A ll o f the isolates which were apparently resistant to metronidazole were able to 
grow in the presence o f air supplemented with 5% CO2 therefore they were not 
obligate anaerobes and were considered intrinsically-resistant to this antibiotic. 
Similarly, all o f the isolates apparently resistant to vancomycin were identified as 
Gram-negative bacteria and as such would be intrinsically-resistant to this antibiotic. 
Table 4.2 shows the median total viable counts and the viable counts o f the 
antibiotic-resistant bacteria present. There was no significant difference in the total 
viable count o f the oral microbiota between the two study groups. However, the use 
o f amoxicillin in the three months prior to sampling significantly increased the total 
viable count o f ampicillin-resistant bacteria (p < 0.01; Table 4.2). Although there 
was an increase in the number o f penicillin-resistant bacteria isolated from children 
who had taken amoxicillin in the previous three months, this was not significant. 
However, the use o f antibiotics in the previous three months significantly (p <0.05) 
increased the proportion o f the oral microbiota resistant to penicillin (1% to 3%), 
ampicillin (1% to 11%) and erythromycin (13% to 32%) as shown in Table 4.2.
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Table 4.2: Viable counts and proportions o f total microbiota and antibiotic-resistant 
bacteria in children with and without amoxicillin use in the previous three months.
Median total viable counts (range) -  cfu/ml Median% (range) o f 
antibiotic-resistant bacteria
Agent no amoxicillin use amoxicillin use no amoxicillin amoxicillin
use use
Total count 4.4 x 106 3.2 x 106 - -
(6.5 x 105 -  6.9x 107) (1.2 x 10s — 3.0 x 107)
Penicillin 6.3 x lO 4 1.2 x 10s 1.4 3.3
(0 -4 .5  xlOs) (5.9 x 104 — 7.3 x 105) (0-13.5) (0.3-48.7)*
Ampicillin 6.2 x 104 6.0 x 105 1.3 10.9
(3.3 x 103-4 .4  x 106) (5.1 x 104 -  2 .8x 106)* (0.1-22.5) (0.8-97.3)*
Erythromycin 6.4 x lO 5 5.2 x lO 5 13.2 31.8
(9.5 x 104 -  5.1 x 106) (3.3 x 105 -  2.8 x 106) (1.1-45.2) (4-88)*
Tetracycline 1.1 x 10s 6.3 x 104 1.9 3.3
(0 -4 .4 x  107) (0 -  5.7 x 10s) (0-88) (0-10.9)
Vancomycin Not detected Not detected < 0.0001 <0.0001
Metronidazole Not detected Not detected <0.0001 <0.0001
* p  < 0.05
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4.3.2 Bacterial identification
A total o f 432 (mean o f 12.3 isolates per child) antibiotic-resistant bacteria were 
isolated from children that had not taken antibiotics and 201 (mean o f 13.4 isolates 
per child) bacteria were isolated from children with previous amoxicillin use (Table
4.3).
Table 4.3: Identification o f bacteria isolated from children with and without 
antibiotic exposure in the previous three months.
Percentage bacterial distribution - (No.)
no amoxicillin use amoxicillin use
n = 432 n = 201
Gram-positive bacteria 39.4(170) 38.8 (78)
Gram-negative bacteria 60.6 (262) 61.2(123)
Actinobacillus spp 0.9 (4) 0(0)
Capnocytophaga spp. 3.0(13) 1.0(2)
Fusobacterium spp. 1.4(6) 1.0(2)
Haemophilus spp. 10.2 (44) 18.9 (38)*
Leptotrichia buccalis 1.2 (5) 3.0 (6)
Neisseria spp. 9.0 (39) 5.0(10)
Prevotella spp. 1.9(8) 3.0 (6)
Staphylococcus spp. 3.9(17) 0 (0 )*
Streptococcus spp. 34.9(151) 37.3 (75)
Veillonella spp. 31.0(134) 29.4 (58)
Others 2.5(11) 2.0 (4)
Number o f species present 48 31
Shannon Weaver Diversity Index (H) 3.1 2.9
* p < 0.05
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The distribution o f the main genera isolated was similar in the oral microbiota o f 
children with or without previous amoxicillin use with the exception o f 
Haemophilus spp. and Staphylococcus spp. (Table 4.3). Haemophilus spp. were 
more prevalent {p = 0.002) in the oral microbiota o f subjects that had taken 
amoxicillin and Staphylococcus spp. were more prevalent (p = 0.015) in the oral 
microbiota o f subjects that had not used an antibiotic in the three months prior to 
sampling (Table 4.3). The streptococci were the predominant genus comprising 35 -  
40% o f all the isolates, with the Veillonella spp. being the second most prevalent 
group o f antibiotic-resistant bacteria. The bacteria isolated from subjects without 
previous amoxicillin use comprised 48 different species compared to 31 in subjects 
with previous amoxicillin use, with 28 species common to both groups (Table 4.3). 
The Shannon Weaver diversity index, which corrects for the distribution o f the 
species in a population gave similar values for the antibiotic-resistant isolates from 
the two study groups, with a value o f 3.1 for the bacterial population isolated from 
children without amoxicillin use and 2.9 for the population isolated from children 
with amoxicillin use. As these values are both greater than 0 this demonstrates a 
diverse population present in the two study groups.
4.3.3 Antibiotic resistance patterns
To determine i f  amoxicillin use affected the multi-resistance profile o f the isolates 
the percentage o f the antibiotic-resistant isolates (from children with and without 
previous amoxicillin use) being resistant to penicillin, ampicillin, erythromycin,
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tetracycline, resistant to any two antibiotics and resistant to three or more antibiotics 
was compared. It was demonstrated that resistance to penicillin, ampicillin and 
tetracycline was o f a similar magnitude whether isolated from subjects with or with 
out amoxicillin use in the previous three months (Table 4.4). However, resistance to 
erythromycin was more commonly found in bacteria isolated from subjects that had 
taken amoxicillin in the three months prior to sampling (p = 0.011). Interestingly, 
the multi-resistance profiles differed, with significantly more bacteria isolated from 
subjects with amoxicillin being resistant to 3 or more antibiotics (Table 4.4; p  = 
0.012).
Table 4.4 Percentage (number) o f bacteria resistant to four antibiotics isolated from 
children with and without amoxicillin use in the previous three months.
Antibiotic-resistant bacteria -% (No.)
Agent no amoxicillin use amoxicillin use
Penicillin 46.3 (200) 45.8 (92)
Ampicillin 35.4(153) 35.8 (72)
Erythromycin 56.5 (244) 67.2(135)*
Tetracycline 20.4 (88) 24.9 (50)
2 antibiotics 30.1 (130) 30.3 (61)
3 or more antibiotics 19.4 (84) 28.9 (58)*
* p  < 0.05
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4.4 Discussion
Amoxicillin is used in dentistry for the treatment o f dental alveolar abscesses, 
endodontic infections, advanced forms o f periodontal diseases and infective 
endocarditis prophylaxis. This antibiotic is also used in medicine for the treatment 
o f otitis media, sinusitis, bronchitis and community acquired pneumonia (BNF, 
2003). Consequently, factors that promote an increase in antibiotic resistance in the 
oral microbiota due to the use o f this antibiotic are o f concern to both dental and 
medical practitioners. Antibiotic resistance studies have generally relied on the 
isolation o f bacteria on antibiotic-free plates and subsequent susceptibility testing to 
a range o f antibiotics. This methodology selects for the detection o f resistance in the 
predominating microbiota. In this study, the use o f antibiotic-containing plates 
allowed the isolation o f resistant bacteria which ranged from 0.01% to 97% o f the 
total cultivable oral microbiota. The use o f amoxicillin did not increase the number 
o f subjects harbouring antibiotic-resistant bacteria, due to the high prevalence in the 
population. With 100% o f the children harbouring antibiotic-resistant bacteria, this 
part o f the study has demonstrated the potential o f the oral cavity to act as a 
reservoir o f antibiotic-resistant organisms. Amoxicillin use however, significantly 
increased the proportions o f oral bacteria resistant to penicillin, ampicillin and 
erythromycin antibiotics that are prescribed for the treatment o f childhood 
infections, as demonstrated with one child having 97% of their microbiota resistant 
to ampicillin. This co-selection for an increase in the proportions o f bacteria 
resistant to other related and unrelated antibiotics is supported by a separate part o f 
this study in which the addition o f tetracycline to a model oral biofilm resulted in an
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increase not only in the proportions o f the microbiota resistant to tetracycline but 
also to ampicillin, erythromycin and vancomycin (Chapter 7). This co-selection is 
not surprising, as multiple-resistant bacteria were frequently isolated in this study 
and consequently, the use o f amoxicillin would not only select for resistance to itself 
but may increase the overall level o f resistance in a microbial population. The use o f 
amoxicillin, did not affect the percentage o f the total oral microbiota resistant to 
tetracycline, an antibiotic not prescribed for use in children under 12 years o f age 
(BNF, 2004). However, although none o f the children should have received 
tetracycline, only 2 (3.8%) o f the children did not harbour detectable numbers o f 
tetracycline-resistant bacteria. The use o f amoxicillin significantly increased both 
the total number o f amoxicillin-resistant bacteria and the proportions o f the oral 
microbiota resistant to amoxicillin. Previous studies have shown amoxicillin use can 
increase the number o f amoxicillin-resistant oral streptococci isolated from the oral 
cavity (Woodman et al., 1985; Harrison et al., 1985) and that the use o f beta-lactam 
antibiotics can increase the carriage o f penicillin-resistant Strep, pneumoniae 
(Guillemot et al., 1998). Interestingly, the counts for the total microbiota did not 
significantly increase with amoxicillin use which suggests that there was a loss o f 
the amoxicillin-susceptible microbiota that was replaced by a significant increase in 
amoxicillin-resistant bacteria.
Previous studies have shown that concentrations o f amoxicillin found in the oral 
cavity after a single antibiotic dose range between 0.1 -  0.5 mg f 1 in saliva (Stewart 
et al., 1970; Nelson et al., 1981) and 1 - 14 mg I '1 in gingival crevicular fluid 
(Akimoto et al., 1985; Tenenbaum et al., 1997). The children in this study would
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have received amoxicillin as an oral suspension (125 mg / 5 ml) rather than in the 
tablet form which is used in adults. Therefore, in addition to the presence o f 
amoxicillin in the saliva and gingival crevicular fluid, it is possible that young 
children have an additional antibiotic challenge, as the antibiotic suspension may be 
able to persist in the oral cavity. Other studies have demonstrated that oral 
suspensions o f carbohydrates can remain in the oral cavity in excess o f 1 hour (Luke 
et al., 1999) and that young children ( 3 - 7  years old) have a slower salivary 
clearance than older children and adults (Crossner et al., 1991). Multi-antibiotic 
resistant bacteria were frequently seen and the use o f amoxicillin in the children 
significantly increased the number o f amoxicillin-resistant isolates which were also 
resistant to erythromycin.
The bacteria isolated from both patient groups were diverse and included species 
from 3 o f the 4 phyla that contain oral bacteria, being phyla 1, 2, and 6 (Tanner et 
al., 1994). Only phylum 5, the nutritionally-fastidious or non-cultivable spirochaetes 
were not observed in either group, which would not have been isolated by the 
methods used in this study. The antibiotic-resistant bacteria comprised o f 51 
different species and 19 different genera o f which the vast majority are considered 
members o f the normal oral microbiota, however, some pathogenic and 
opportunistic pathogenic bacteria were isolated. Antibiotic-resistant bacteria were 
isolated that are important agents o f community acquired pneumonia, otitis media, 
sinusitis, meningitis, deep-seated abscesses, endocarditis and dental diseases 
including caries and periodontal diseases. The carriage o f these pathogenic and 
opportunistic pathogens is o f clinical importance as infection caused by such
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antibiotic-resistant bacteria could result in treatment failure and lead to a chronic 
infection. In addition, the microbiota isolated from subjects that had taken 
amoxicillin differed with significantly more Haemophilus spp. present and the 
staphylococci were only isolated from subjects without previous amoxicillin use.
In this part o f the study the children in the amoxicillin use group were shown to 
have an increased proportion o f amoxicillin-resistant bacteria, an altered bacterial 
composition and significantly more (P < 0.05) o f their amoxicillin-resistant isolates 
were also resistant to erythromycin. However, the role o f other confounding factors 
including previous hospitalisation, differences in the antibiotic doses, the frequency 
o f doses and/or the duration o f treatment within this group were not investigated in 
this study. It is hoped that this work w ill support the development o f a larger study 
to take into consideration all o f these additional factors.
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Chapter 5
Prevalence of antibiotic-resistant 
oral bacteria in children from 
different ethnic groups
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5.1 Introduction
It has previously been demonstrated in Chapter 3 that the microbiota o f the oral 
cavity constitutes a reservoir o f antibiotic-resistant bacteria. Some o f these bacteria 
may cause local infections (periodontitis, abscesses) as well as infections at other 
sites (infective endocarditis, lung infections, brain abscesses) (Roberts, 1998). More 
recently, oral bacteria have been implicated in the aetiology o f cardiovascular 
disease (Kuramitsu et al., 2001) and in the induction o f pre-term birth and low birth 
weight neonates (Lopez et al., 2002). Oral bacteria can easily reach other body sites 
(by swallowing and via the bloodstream) and also spread to other individuals 
(coughing, kissing etc.). Antibiotic-resistant oral bacteria, therefore, have the 
opportunity for rapid dissemination through a population and to transfer their 
resistance genes to other bacterial species.
An increase in use o f antibiotics is thought to be the main driving force behind the 
increasing prevalence o f antibiotic-resistant bacteria (House o f Lords, 1998) and it 
has been demonstrated that an increase in the proportions o f the oral microbiota 
resistant to ampicillin occurs after treatment with amoxicillin (Chapter 4). However, 
other issues such as socio-economic and environmental factors may also promote an 
increase in antibiotic resistance. Ethnicity is one such reported factor as a significant 
difference in the antibiotic resistance patterns o f Helicobacter pylori isolated from 
different ethnic groups has been shown (Meyer et al., 2002). In this part o f the study 
the aims were to determine the prevalence and proportions o f antibiotic-resistant 
bacteria in the mouths o f children from different ethnic groups.
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5.2 Materials and Methods
5.2.1 Subjects
A ll 4-5 year old children attending the reception classes in a North London school 
between 2001-2002 were included in a dental screening programme. The children 
were given a dental examination and, via a self-administered parental questionnaire, 
the child’s ethnic background, past use o f antibiotics and the presence o f any major 
medical problems were determined. Fifty three children (28 female and 25 male) 
who did not suffer from any medical problem and had not taken any antibiotic 
during the previous three months were recruited into the study. Children were 
divided into three study groups, White-European (n = 27), South-Asian (n = 14) and 
Japanese (n = 10). Informed consent was used and the local Health Authority 
Research and Ethics Committee gave approval for the study.
5.2.2 Bacterial isolation, identification and susceptibility testing
Plaque samples were taken from the entire dentition o f each child, diluted, plated 
onto antibiotic-free and antibiotic-containing media and the total microbiota and 
antibiotic resistant bacteria were enumerated (2.2.4) and antibiotic-resistant bacteria 
were identified by a combination o f biochemical and molecular methods (2.3 -
2.5.3). Susceptibility testing was carried out on all antibiotic-resistant bacteria to 
confirm antibiotic resistance by an agar dilution method (2.6 -  2.6.3).
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5.2.3 Statistical analysis and Species diversity
The total cultivable microbiota and antibiotic-resistant bacteria were analysed using 
a non-parametric test - Mann-Whitney U test. Additionally, the Chi-squared test was 
used to assess any difference in the prevalence or proportion o f antibiotic-resistant 
oral bacteria in children from the three ethnic groups. Data were analysed using 
SPSS software (SPSS, 2000) and the 5% level o f statistical significance was used 
throughout these analyses. The Shannon-Weaver Index o f diversity (H) and the 
evenness measure (E) was used to determine the species diversity o f antibiotic- 
resistant bacteria (2.10).
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5.3 Results
5.3.1 Carriage of antibiotic-resistant bacteria
In the 53 recruited children there were 27 (51%) white European children and 31 
(49%) children o f other ethnic backgrounds, comprising; 14 (26%) South Asian, 10 
(19%) Japanese, 1 (2%) Afro-Caribbean and 1 (2%) other. The prevalence o f 
antibiotic-resistant bacteria in these healthy children who had not recently been 
administered antibiotics was very high (Table 5.1). A ll o f the children harboured 
oral bacteria resistant to erythromycin while 92%, 94% and 98% o f the children had 
oral bacteria resistant to penicillin, ampicillin and tetracycline respectively. No 
significant differences were found between the three groups in terms o f the numbers 
o f children harbouring organisms resistant to any o f these antibiotics.
Table 5.1 Proportion o f children harbouring oral bacteria resistant to antibiotics
Ethnic group No. % (No.) o f children harbouring bacteria resistant to:
penicillin ampicillin erythromycin tetracycline
White 27 96 (26) 96 (26) 100 (27) 96 (26)
South Asian 14 93(13) 93 (13) 100(14) 100(14)
Japanese 10 90 (9) 90 (9) 100(10) 100(10)
Other 2 50(1) 100 (2) 100(2) 100 (2)
Total population 53 92 (49) 94 (50) 100 (53) 98 (52)
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5.3.2 Proportions of oral microbiota resistant to four antibiotics
There was no significant difference in the total viable count o f the oral microbiota 
between white European, South Asian and Japanese children (4.85 xlO6 cfu m l'1, 
2.20 xlO6 cfu m l'1 and 4.58 X106 cfu m l'1, respectively). The median proportions o f 
oral bacteria resistant to a particular antibiotic are shown in Figure 5.1. The median 
proportions o f oral bacteria resistant to ampicillin or penicillin were low (no greater 
than 1.2% or 1.3% respectively) in the children and there was no significant 
difference between the three ethnic groups. In contrast, the median proportion o f the 
oral microbiota displaying resistance to erythromycin was considerably higher 
(between 13.2% and 16.3%) in the study groups although, again, there was no 
significant difference between the three groups. The median proportion o f oral 
bacteria resistant to tetracycline showed considerable variation (from 0.8% to 6.8%) 
between children from the three different ethnic groups and these differences were 
significant. Hence, the median percentage o f bacteria resistant to tetracycline was 
greater in the South Asian and Japanese children than in the white European children 
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Figure 5.1 Median (%) o f the total cultivable oral microbiota resistant to penicillin, 
ampicillin, erythromycin or tetracycline in children from three ethnic groups (*p  < 
0.05; **/?< 0.01).
5.3.3 Identity of antibiotic-resistant bacteria
Five hundred and thirty-three antibiotic-resistant bacteria were isolated from the 53 
children studied. These comprised 312 isolates from white European children, 145 
isolates from South Asian children and 76 isolates from Japanese children. These 
oral isolates comprised 18 genera and 47 different species (Table 5.2). A diverse 
community o f antibiotic-resistant bacteria was isolated from white European 
children (H = 3.5), with a similar prevalence o f different species (E = 0.96). The 
antibiotic-resistant bacteria isolated from the South Asian and Japanese children
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were less diverse, H =  2.54 and 1.97, respectively (Table 5.2). Chi-squared analysis 
demonstrated significant differences in the number o f different species o f antibiotic- 
resistant isolates from the three main ethnic groups. In the Japanese children only 6 / 
76 (8%) o f the isolates were identified as Haemophilus species compared to 61 / 312 
(20%) o f the antibiotic-resistant isolates from white-European children (p < 0.05). 
An increase in the number o f antibiotic-resistant isolates which were staphylococci 
was particularly marked in the South Asian group (p < 0.05). O f the 145 antibiotic- 
resistant bacteria isolated from South Asian children, 8 (5.5%) were staphylococci 
compared to only 1 / 3 1 2  (0.6%) isolates from white children and none o f the 
Japanese children harboured antibiotic-resistant staphylococci. Although, the overall 
number o f antibiotic-resistant bacteria that were identified as Veillonella spp. were 
similar in the three study groups, there was a marked difference in the number o f 
isolates which were identified as V dispar and V parvula (Table 5.2). V. dispar 
comprised 10% and 14% o f all o f the antibiotic-resistant isolates from white and 
South Asian children, respectively, whereas this species only comprised 3% o f the 
antibiotic-resistant isolates from Japanese children. In Japanese children the 
predominant antibiotic-resistant Veillonella species isolated was V parvula which 
comprised 24% of all the isolates recovered from these children compared to 15% 
and 10% o f the isolates from white and South Asian children, respectively.
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Table 5.2 Percentage o f antibiotic-resistant genera and species isolated from white 
European, South Asian and Japanese children.
Genera / Species White South Asian Japanese
European
Abiotrophia elegans 0.3 0.0 0.0
Actinobacillus 0.6 0.0 0.0
actinomycetemcomitans
Actinobacillus delphinicola 0.3 0.0 0.0
Actinobacillus minor 0.0 0.0 2.6
Total Actinobacillus spp. 0.3 0.0 2.6
Bacillus licheniformis 0.3 0.0 0.0
Bacteroides urelolyticus 0.0 0.7 0.0
Unspeciated Bacteroides 0.0 0.0 1.3
Total Bacteroides spp. 0.0 0.7 1.3
Capnocytophaga granulosus 1.6 0.0 0.0
Capnocytophaga gingivalis 0.3 0.7 0.0
Capnocytophaga sputigena 0.0 0.7 0.0
Unspeciated Capnocytophaga 0.3 0.0 2.6
Total Capnocytophaga spp. 2.2 1.4 2.6
Fusobacterium naviforme 1.3 0.0 0.0
Fusobacterium nucleatum 0.6 0.0 0.0
Unspeciated Fusobacterium 0.0 0.7 0.0
Total Fusobacterium spp. 1.9 0.7 0.0
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Haemophilus aphrophilus 0.3 0.0 0.0
Haemophilus influenzae 2.6 4.1 1.3
H. parainfluenzae 7.0 5.5 5.3
H  paraphrophilus 5.4 5.5 1.3
H. paraphrohaemolyticus 0.3 0.0 0.0
Haemophilus segnis 1.9 0.0 0.0
Unspeciated Haemophilus 1.9 0.0 0.0
Total Haemophilus spp. 19.5 15.2 7.9
Leptotichia buccalis 2.2 0.7 0.0
Moraxella catarrhalis 0.0 0.0 1.3
Neisseria elongata 1.0 0.0 0.0
Neisseria flavescens 0.0 0.0 1.3
Neisseria mucosa 1.3 2.1 2.6
Neisseria pharyngis 1.3 2.8 1.3
Unspeciated Neisseria 3.2 2.1 3.9
Total Neisseria spp. 6.7 6.9 9.2
Pasturella aerogenes 0.3 0.0 0.0
Porphyromonas catoniae 0.3 0.0 0.0
Prevotella melaninogenica 0.6 0.7 2.6
Unspeciated Prevotella 0.3 0.0 0.0
Total Prevotella spp. 0.9 0.7 2.6
Staphylococcus epidermidis 0.3 1.4 0.0
Staphylococcus hominis 0.0 2.8 0.0
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Staphylococcus pasteuri 0.0 1.4 0.0
Staphylococcus wameri 0.3 0.0 0.0
Total Staphylococcus spp. 0.6 5.5 0.0
Streptococcus cristatus 0.3 1.4 0.0
Streptococcus gordonii 0.3 0.0 0.0
Streptococcus infantis 2.6 2.1 3.9
Streptococcus intermedius 0.0 2.1 0.0
Streptococcus mitis 16.9 13.8 11.8
Streptococcus mutans 0.0 0.7 0.0
Streptococcus oralis 4.8 4.1 5.3
Streptococcus parasanguis 0.3 1.4 2.6
Streptococcus peroris 0.6 0.0 0.0
Streptococcus pneumoniae 1.0 0.0 0.0
Streptococcus salivarius 1.6 5.5 2.6
Streptococcus sanguis 2.2 3.4 3.9
Unspeciated Streptococcus 0.3 0.0 0.0
Total Streptococcus spp. 31.0 34.5 30.3
Stomatococcus mucilaginosus 0.3 0.0 3.9
Veillonella atypica 3.2 1.4 2.6
Veillonella dispar 10.2 13.8 2.6
Veillonella parvula 14.7 9.7 23.7
Veillonella ratti 0.6 0.7 0.0
Unspeciated Veillonella 2.9 8.3 6.6
Total Veillonella spp. 31.6 33.8 35.5
Number o f Species present (S) 38 28 22
Evenness score 0.96 0.75 0.64
Shannon-Weaver Index (H) 3.53 2.54 1.97
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5.3 Discussion
Although a number o f surveys o f the prevalence o f antibiotic-resistant respiratory 
pathogens in children have been published, there is little information available 
regarding the prevalence o f antibiotic resistance among members o f the indigenous 
oral microbiota. The results o f this part o f the study have revealed a high prevalence 
o f oral bacteria that are resistant to antibiotics frequently prescribed for children as 
well as to tetracycline, an antibiotic which is not recommended for this patient 
group.
While there was no significant difference between the ethnic groups with regard to 
the number o f children harbouring oral bacteria resistant to any o f the four 
antibiotics investigated, the results o f this study showed that the load o f oral bacteria 
resistant to tetracycline was significantly higher in both Japanese and South Asian 
children than in white children. The reasons for the observed relationship between 
ethnicity and the oral load o f tetracycline-resistant bacteria remain to be ascertained. 
As none o f the children surveyed had received antibiotics during the previous three 
months, different levels o f antibiotic usage by the children themselves in the three 
different ethnic groups cannot explain the greater load o f antibiotic-resistant oral 
bacteria. However, oral bacteria have previously been shown to be acquired by 
transmission from parent to child (Emanuelsson, 2001), hence differences in 
antibiotic usage among the parents (and other family members) o f the children may 
have been a contributory factor.
It has been reported that Pakistanis and Indians in the United Kingdom are 
significantly more likely to receive a prescription from their general practitioner than
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individuals from white ethnic groups (Gill et al., 1995). It has also been shown that 
patients from deprived social groups receive significantly more antibiotics than those 
from less-deprived groups (Gill and Roalfe, 2001). In a study o f community- 
acquired infections due to methicillin-resistant Staphylococcus aureus, it was found 
that community-acquired antibiotic resistance spread across communities which had 
crowded living conditions, hygiene difficulties and high levels o f use o f broad 
spectrum antibiotics (Maguire et al., 1996).
The composition and development o f dental plaque is well characterized in humans, 
however, the majority o f studies have involved Western Caucasian populations, with 
limited information on other ethnic groups. In the present study, the antibiotic- 
resistant isolates from white children comprised the most diverse population. In 
contrast the antibiotic-resistant isolates from Japanese children were the least 
diverse, having a dominant single species (V. parvula). The reduced diversity among 
antibiotic-resistant bacteria isolated from South Asian and Japanese subjects is partly 
explained by the smaller study groups. The more subjects in a study group, the 
greater the likelihood o f finding species which are less prevalent in the oral cavity. 
However, the distribution index (E) showed a lower evenness score in the isolates 
from these two ethnic groups compared to the score o f the antibiotic-resistant 
isolates from white European subjects. This suggests that there is an over 
representation in the number o f isolates in a few species, rather than an even 
distribution in the number o f isolates throughout a wide range o f species among 
antibiotic-resistant bacteria isolated from South Asian and Japanese subjects.
153
Antibiotic-resistant bacteria in children front different ethnic groups
Significant differences were observed in the number o f antibiotic-resistant isolates o f 
Haemophilus spp., Staphylococcus spp. and Veillonella parvula recovered from the 
three ethnic groups. Surprisingly few studies concerning the microbiota o f dental 
plaque in different ethnic groups have been published to date. The studies which 
have been carried out focus either on patients with periodontitis, subgingival plaque 
or adult populations (Cao et al., 1990, Schenkein et al., 1993; Sedgley and 
Samaranayake, 1994; Zee et al., 1996). The results from these studies have shown 
that the prevalence o f a limited number o f bacterial species may be influenced by the 
ethnicity and oral health o f the subject group. Frequently, the microbial differences 
observed were explained by disparities in oral hygiene between the ethnic groups. 
However, the children in the present study were predominantly caries-free with a 
good level o f oral hygiene and, as such, oral health status should not have influenced 
these data.
In conclusion, the results from these surveillance data have demonstrated that oral 
bacteria resistant to penicillin, ampicillin, erythromycin and tetracycline have a very 
high prevalence in children from diverse ethnic groups, the oral load o f bacteria 
resistant to tetracycline was significantly greater in the Japanese study group and the 
South Asian study group when compared to the white study group and the identity o f 
some o f the antibiotic-resistant isolates also varied within these groups. The reasons 
for the observed differences remain to be established, and it is likely that 
confounding factors other than the subject’s ethnicity are important, these may 
include hopsitalisation, diet, duration o f stay in this country, socioeconomic
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inequalities, overcrowding and disparities in antibiotic use among the among the 
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Antibiotic resistance genes are often found on the same mobile genetic element as 
genes coding for resistance to metals such as mercury (Hg) (Grinsted et al., 1990; 
Wireman et al., 1997). It has been suggested that the levels o f Hg encountered by 
man could promote and maintain antimicrobial resistance in the indigenous 
microbiota o f humans (Wireman et al., 1997; Edlund et al., 1996). I f  Hg were to be 
promoting an increase in antibiotic resistance in oral bacteria then this would be o f 
concern to dental practitioners as antimicrobial agents are used in the treatment o f 
dental infections including the advanced forms o f periodontal diseases which affect 
approximately 15% o f the UK. It would also be o f concern to medical practitioners 
as oral bacteria such as viridans streptococci are a major cause o f infective 
endocarditis, a disease with a high mortality requiring antibiotic treatment. 
Amalgam restorations contain approximately 50% Hg and are considered to be one 
o f the main sources o f Hg in individuals with such restorations. It would be 
expected, therefore, that individuals who had never had their teeth restored with 
such fillings would have few or no Hg-resistant oral bacteria present. Although this 
is a controversial area which has generated much speculation (Wireman et al., 1997; 
Edlund et al., 1996; Pike, et al., 2002), surprisingly few studies concerning the 
prevalence o f Hg-resistant oral bacteria in humans have been published (Edlund et 
al., 1996; Pike, et al., 2002; Leistevuo et al., 2000). These studies have concentrated 
mainly on Hg resistance in bacteria isolated from adults (Edlund et al., 1996; 
Leistevuo et al., 2000), from hospital referred patients (Pike, et al., 2002) or in the 
isolation o f a specific species (Leistevuo et al., 2000).
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The aims o f this part o f the study were to determine the levels o f Hg-resistant 
bacteria in healthy community-based children who had never been exposed to Hg 
amalgam restorations and to determine whether, i f  present, these organisms were 
also resistant to antibiotics.
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6 . 2  M a t e r i a l s  a n d  M e t h o d s
6.2.1 Subjects
A ll 4-5 year old children attending reception classes o f a North London School over 
an 18-month period were included in a dental screening programme. One hundred 
and fifty-nine children were given a dental examination. The subjects were given a 
consent form and a questionnaire to determine their own, and parental, use o f 
antibiotics in the previous three months and the presence o f any major medical 
problems. Eighty-four o f these children (response rate 53%) were given parental 
consent for the collection o f dental plaque and were recruited into the study. Two 
children were excluded from the study due to the presence o f amalgam restorations 
and 6 children were unavailable for sampling. Samples were obtained from 76 
children (40 female and 36 male). The Research and Ethics Committee o f Barnet 
Health Authority, London, England, approved the study.
6.2.2 Bacterial isolation, identification and susceptibility testing
Plaque samples were taken from the entire dentition o f each child, diluted, plated 
onto antibiotic-free media and the total cultivable oral microbiota was enumerated 
(2.2.4). Susceptibility testing was carried out on all antibiotic-resistant bacteria to 
confirm antibiotic resistance by an agar dilution method (2.6 -  2.6.3). The isolation 
o f mercury-resistant bacteria was achieved by sample inoculation onto Iso-sensitest 
broth plus purified agar (Oxoid Ltd) containing 5% defibrinated horse blood and 
350pM mercuric chloride. Control, Hg-resistant (NCTC 50581) and Hg-sensitive 
(8325-4) strains o f Staphylococcus aureus were inoculated onto each set o f plates.
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Hg-resistant bacteria were enumerated and were then identified by a combination o f 
biochemical and molecular methods (2.3 -  2.5.3). Confirmation o f Hg resistance 
and Hg-susceptibility testing was also performed by an agar dilution method. 
Mercuric chloride was added to Muller Hinton agar at concentrations ranging from 
0.125 pM to 512 pM. Bacteria with a HgCh MIC o f > 32pM were regarded as 
being Hg-resistant (Pike et al., 2002). Antibiotic-susceptibility testing was carried 
out on all Hg-resistant bacteria by an agar dilution method (2.2.5).
6.2.3 Statistical analysis
To calculate the percentage o f the cultivable microbiota resistant to mercury, the 
total number o f resistant isolates was compared with the total number o f CFU for 
each sample. The distribution was skewed, consequently these data were analysed 
using a non-parametric test. Analysis o f the proportions o f mercury-resistant oral 
bacteria in children with and without a history o f antibiotic use was carried out 
using the Mann-Whitney U test. Analysis o f the number o f children harbouring 
mercury-resistant oral bacteria with and without a history o f antibiotic use was 
carried out using chi-squared analysis. A p  value less than 0.05 was considered to be 












6 . 3  R e s u l t s
6.3.1 Prevalence of mercury resistant oral bacteria
O f the 76 children, 54 (71%) harboured oral bacteria resistant to mercuric chloride. 
The median total viable count o f the oral microbiota was 4.3x106 cfu/ml and the 
median viable count o f Hg-resistant bacteria was 1.3x102 cfu/ml. Consequently, the 
proportion o f the cultivable oral microbiota resistant to mercuric chloride was low 
and only 10 (13%) o f the children had more than 0.5% o f their oral microbiota 
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Figure 6.1: Histogram o f the proportions o f the total cultivable oral microbiota 
resistant to mercury in 76 children.
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The median percentage o f the cultivable oral microbiota resistant to mercuric 
chloride was 0.007% (range 0-5.3%). O f the 76 children, 18 (24%) o f them had 
taken antibiotics in the previous three months, there was no significant difference in 
the number o f children harbouring Hg-resistant oral bacteria or in the proportions o f 
Hg-resistant oral bacteria between subjects with and without a history o f self or 
parental antibiotic use.
6.3.2 Identity of Hg-resistant bacteria
In total, 92 presumptive mercury-resistant isolates were obtained from the 76 
subjects. On subsequent confirmatory testing, 87 isolates were shown to be Hg- 
resistant (MIC > 32 pM). In addition to those shown in Table 6.1, single isolates o f 
Pseudomonas stutzeri, Streptococcus cristatus, Streptococcus infantis and 
Streptococcus parasanguis were recovered. The majority (86%) o f these isolates 
were streptococci with Strep, mitis being the predominant species. Only 4 o f the 
isolates were Gram-negative species, none o f which are regarded as members o f the 
indigenous oral microbiota.
6.3.3 Antibiotic resistance of Hg-resistant bacteria
As can be seen from Table 6.2, most o f the mercury-resistant isolates (60%) were 
also resistant to at least one o f the four antibiotics tested - penicillin, ampicillin, 
erythromycin and tetracycline. Resistance to tetracycline was the most frequently 
encountered, with 40% o f the isolates being resistant to this antibiotic. O f the 87 
Hg-resistant isolates 26% were also resistant to two or more o f the four antibiotics
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tested. Table 6.3 shows the different resistance factors found together in the viridans 
streptococci with 5% o f these isolates being resistant to penicillin, erythromycin and 
tetracycline.
Table 6.1 MIC range, M IC 50 and MIC90 values for mercuric chloride (pM), 
penicillin (mg/1), ampicillin (mg/1), erythromycin (mg/1) and tetracycline (mg/1) for 
Hg-resistant bacteria isolated from children without amalgam restorations.
Hg-resistant Antim icrobial M IC  range M IC 50 M IC 90 Number (% )
bacteria agent resistant *’ b
mercuric chloride 6 4 64 6 4 3 ( 1 0 0 )
Citrobacter spp. penicillin 3 2 -1 2 8 32 128 c
(n = 3) ampicillin 1 2 8 -2 5 6 2 5 6 2 5 6 3 (1 0 0 )
erythromycin 3 2 -1 2 8 64 128 c
tetracycline 0 .2 5 -1 2 8 0 .5 128 1 ( 3 3 )
mercuric chloride 3 2 -6 4 32 6 4 5 ( 1 0 0 )
Coagulase- penicillin < 0 .1 2 -1 2 8 6 4 128 4 ( 8 0 )
negative ampicillin 16 -1 2 8 64 128 c
staphylococci erythromycin 0 .1 2 -0 .5 0 .25 0 .5 2 ( 4 0 )
(n = 5) tetracycline 1-32 8 32 4 ( 8 0 )
mercuric chloride 64 64 6 4 3 (1 0 0 )
Gemella penicillin 0 .1 2 -0 .5 0 .5 0 .5 2 ( 6 7 )
haemolysans ampicillin 0 .5 -2 1 2 c
(n -  3) erythromycin 0 .5 -2 1 2 2 ( 6 7 )
tetracycline 4 4 4 3 (1 0 0 )
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mercuric chloride 32-64 32 64 2(100)
Streptococcus penicillin <0.12 0.12 0.12 0(0)
gordoni? ampicillin 0.12-0.25 0.12 0.25 c
(n = 2) erythromycin <0.12 0.12 0.12 0(0)
tetracycline <0.12-1 0.12 1 0(0)
mercuric chloride 32-256 32 64 34 (100)
Streptococcus penicillin <0.12-64 0.12 0.12 2(6)
mitis6 ampicillin <0.12-64 0.12 0.25 C
(n = 34) erythromycin <0.12-4 0.12 4 5(15)
tetracycline <0.12-64 0.5 16 12(35)
mercuric chloride 32-512 32 512 7(100)
Streptococcus penicillin <0.12-0.5 0.12 0.5 1 (14)
oralis6 ampicillin <0.12-2 1 2 c
(n = 7) erythromycin <0.12-4 0.5 4 3(43)
tetracycline <0.12-4 2 4 4(57)
mercuric chloride 32-64 64 64 12(100)
Streptococcus penicillin <0.12-4 0.12 0.12 1(8)
salivarius ampicillin <0.12-4 0.12 0.12 C
(n = 12) erythromycin <0.12-8 0.12 8 5(42)
tetracycline <0.12-4 0.12 1 1(8)
mercuric chloride 32-128 32 64 11 (100)
Streptococcus penicillin <0.12-64 0.12 64 4(36)
sanguis6 ampicillin <0.12-64 1 32 C
(n ~ 11) erythromycin <0.12-4 0.25 1 2(18)
tetracycline <0.12-8 1 8 5(46)
Other mercuric chloride 32-64 32 64 6(100)
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unspeciated penicillin <0.12-4 0.12 4 3(50)
viridans ampicillin <0.12-4 1 4 c
streptococci erythromycin <0.12-256 16 256 5(83)
( n -  6) tetracycline 0.5-128 32 128 4(67)
A ll viridans mercuric chloride 32-512 32 64 62(100)
group penicillin <0.12-64 0.12 4 11(18)
streptococci ampicillin <0.12-64 0.12 4 c
(n = 62) erythromycin <0.12-256 0.12 4 16(26)
tetracycline <0.12-128 1 32 26 (42)
mercuric chloride 32-512 32 64 87(100)
AH isolates penicillin <0.12-64 0.12 4 18(21)
(n = 87) ampicillin <0.12-64 0.12 4 3(4)
erythromycin <0.12-256 0.12 4 25 (29)
tetracycline <0.12-128 0.5 32 35 (40)
aMIC breakpoints (mg/1) were as follows: Citrobacter spp.; resistance to ampicillin,
>16; tetracycline, >2. Staphylococci; resistance to penicillin, >0.25; erythromycin,
>0.5; tetracycline, >2. Streptococci and G. haemolysins; resistance to penicillin,
>0.25; erythromycin, >1; tetracycline >2.12
bMercury resistance for all isolates, breakpoint MIC >32 pM.4
°No breakpoint defined by the BSAC.12
dSpecies included in viridans group o f streptococci.
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Tab le  6.2 Resistance to antibiotics o f Hg-resistant bacteria





Resistant to two or more antibiotics 23 (26)
Resistant to any antibiotic 52 (60)
Table 6.3 Multi-resistance o f viridans streptococci isolates.













Concern has been expressed regarding the possibility that mercury released from 
dental amalgam fillings could lead to the selection o f Hg-resistant and, thereby, 
antibiotic-resistant oral bacteria. However, in this study the majority (71%) o f a 
group o f children without amalgam fillings were found to harbour Hg-resistant oral 
bacteria, albeit generally at low levels. This may be due to the ubiquitous presence 
o f mercury in the environment and food. Estimates o f the daily dose o f mercury 
attributable to the intake o f food range from 2.3 to 121 pg (Becker and 
Kumpulainen, 1991; Johansen et al., 2000; Urieta et al., 1996). Edlund et al. (1996) 
found that the median concentration o f Hg in the saliva o f 10 adults who had never 
had amalgam fillings was 0.02 ng/g. Higher mercury concentrations (1.4 ng/g) in the 
saliva o f a group o f 43 adults have recently been reported (Leistevuo et al., 2001). 
Such levels o f mercury in the saliva o f individuals without amalgam fillings may be 
sufficient to select for Hg-resistant oral bacteria. As children can acquire oral 
bacteria by transmission from family members (Li and Caufield, 1995; Long and 
Swenson, 1976) it is also possible that the Hg-resistant organisms isolated were 
acquired from the child’s parents or siblings. These results suggest that recent 
antibiotic use is not an important factor in the maintenance o f Hg-resistant bacteria 
as antibiotic use by the child or parent did not affect either the prevalence or 
proportions o f Hg-resistant bacteria. Resistance to antibiotics was found in the 
majority o f the Hg-resistant isolates, with 60% o f the isolates resistant to one or 
more antibiotics. The majority o f the Hg-resistant isolates were viridans group 
streptococci and were frequently resistant to tetracycline, erythromycin or penicillin.
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Several studies have examined antibiotic resistance in viridans streptococci. 
Tetracycline resistance is often found in viridans streptococci with previous studies 
reporting 12-23% of isolates resistant to this antibiotic (Doern et al., 1996; 
Ioannidou et al., 2001; Azavedo et al., 1999), however, in this study 42% o f the 
viridans streptococci were tetracycline-resistant. However, the proportions o f 
isolates resistant to erythromycin (26%) and penicillin (18%) in this study are 
similar to those reported in previous studies (erythromycin, 23-39%; penicillin, 6- 
15%) (Doern et al., 1996; Ioannidou et al., 2001; Azavedo et al., 1999; Kuriyama et 
al., 2002). Interestingly, as tetracycline is not administered to children under 12 
years o f age, it could be expected that the proportion o f tetracycline-resistant 
isolates would be low. However, this was not the case and it may be that mercury 
resistance genes are linked to tetracycline resistance genes. This association with 
tetracycline resistance was previously shown in Gram-negative bacteria isolated 
from the faeces o f primates and humans, tetracycline resistance was found in 44% 
o f Hg-resistant strains and in only 27% o f Hg-susceptible strains (Wireman et al., 
1997).
O f concern was the finding that a high proportion (26%) o f the Hg-resistant isolates 
were also resistant to two or more antibiotics. While 3 o f these 23 isolates 
(Citrobacter spp.) are not regarded as being members o f the indigenous oral 
microbiota, the remaining multi-resistant isolates were streptococci and coagulase- 
negative staphylococci all o f which are regularly isolated from the human oral 
cavity. These findings concur with previous results, which demonstrated that Hg-
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resistant faecal bacteria were more likely to be multi-antibiotic-resistant than Hg- 
susceptible bacteria (Wireman et al., 1997).
The results o f this study have shown that Hg-resistant oral bacteria have a high 
prevalence in children who have never been exposed to amalgam fillings and, 
furthermore, that such isolates are also often resistant to one or more antibiotics.
It has been suggested that amalgam restorations are the major source o f mercury, 
however, the evidence from this study on which a high prevalence o f Hg-resistant 
bacteria was found in children without amalgam restorations suggest that other 
sources o f mercury must be important.
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Chapter 7
Composition and antibiotic 
resistance profile of microcosm 
dental plaques before and after 
exposure to tetracycline
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7.1 Introduction
The tetracyclines came into clinical use over 50 years ago (Duggar, 1948) and are 
considered a relatively safe group o f bacteriostatic antibiotics (Smilack, 1999). With a 
broad spectrum o f activity, few side effects and low cost they are a popular group o f 
antibiotics for clinical use. In 1998, 8.7% o f the antibiotics prescribed in the UK were 
tetracyclines (73,388 prescriptions; ONS, 2003). This group o f antibiotics are used for 
the treatment o f a range o f bacterial infections including those o f the skin, oral cavity 
and respiratory tract and are widely used in dentistry. Although there has been some 
variability in the success o f clinical treatment (Chaves et al., 1995; Ng and Bissada, 
1998; Schroeder et al., 1992), topically- and systemically-administered tetracyclines 
have been, and still are, used for the treatment o f periodontal and endodontal 
infections.
There is growing concern over the emergence o f antibiotic-resistant bacteria. Lacroix 
and Walker (1996) showed that from 68 patients with adult periodontitis, the numbers 
o f tetracycline-resistant bacteria from subgingival plaque samples represented 
approximately 12% of the total viable count. In a separate study, the median percentage 
of the oral microbiota resistant to doxycycline, a tetracycline derivative, was shown to 
be 4.3%, ranging from 0 -  26% in the saliva o f 20 human subjects (Edlund et al., 
1996). The extensive use o f antimicrobials both in the community and in hospitals has 
accelerated the emergence o f antibiotic-resistant organisms (Gould, 1994; Nisbet, 
1982; Slocombe, 1994). This has caused increasing concern in the medical and 
scientific community as to the level o f antibiotic use in the general population and the 
degree of inappropriate antibiotic prescription. The biofilm mode o f growth can also
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affect antibiotic-susceptibility. Bacteria living in biofilms in general are less susceptible 
to antimicrobial agents than free-living bacteria (Nichols, 1991). When Pseudomonas 
aeruginosa cells that were susceptible to tobramycin were grown as a biofilm, there 
was an approximately 1000-fold reduction in susceptibility to this antibiotic (Nickel et 
al., 1985). The attachment o f Klebsiella pneumoniae to the surface o f a glass slide 
resulted in a 150-fold decrease in susceptibility to hypochlorous acid (Widmer et al., 
1990). When treating biofilm-associated Porphyromonas gingivalis with metronidazole 
the minimum inhibitory concentration (MIC) values were 160 times higher than those 
obtained for planktonic cells (Wright et al., 1997). Another study has reported that in 
order to eliminate bacteria grown as biofilms, MICs greater than 500 times the MIC 
determined for planktonic culture may be required (Larsen and Fiehn, 1996).
The aims for this part of the study were firstly to determine i f  the bacterial composition 
and the antibiotic susceptibility o f microcosm dental plaques grown in a CDFF 
modelled the results obtained from the school studies (Chapters 3, 4 and 5). Secondly, 
to determine i f  the microbial composition and resistance to penicillin, ampicillin, 
erythromycin, chloramphenicol, tetracycline and vancomycin altered after the addition 
o f tetracycline.
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7.2 Materials and Methods
7.2.1 Inoculum
Human saliva was used as an inoculum to provide a multi-species biofilm consisting 
o f organisms found in the oral cavity. The saliva was collected from 10 healthy 
individuals who had not taken antibiotics in the previous three months, an equal 
volume from each o f the subjects was pooled. Aliquots o f 1 ml were stored at -80°C 
for subsequent use.
7.2.2 Production of biofilms and Inoculation of the CDFF
Biofilms were grown in a Constant Depth Film Fermenter (CDFF) as described 
previously (2.7-2.8.3). The biofilms were grown on bovine enamel discs, 5 mm in 
diameter and 1 mm in depth and the nutrient source for the experiments was a 
mucin-containing artificial saliva (2.8.1). Seven hundred and fifty  microlitres o f the 
pooled saliva was added to 500 ml o f artificial saliva. This was mixed and pumped 
into the CDFF for 8 h. After this time, the inoculation vessel was disconnected and 
the medium reservoir containing sterile artificial saliva was connected to the CDFF. 
The artificial saliva was delivered via a peristaltic pump (Watson-Marlow, 
Falmouth, UK) at a rate o f 0.5 ml per min., corresponding to the resting salivary 
flow rate in man (Bell et al., 1980; Guyton, 1991; Lamb et al., 1991).
7.2.3 Antibiotic delivery
Experiments were carried out with and without the addition o f tetracycline. For the 
administration o f tetracycline, 100 ml o f sterile artificial saliva containing 2 mg/1
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tetracycline (Sigma, Poole, UK) was pumped into the CDFF for 2 h via a second 
peristaltic pump (Figure 7.1). After this period, the concentration o f tetracycline was 
increased to 12 mg/1 for 1 h which was subsequently followed by a 2 h addition o f 2 
mg/1 concentration o f tetracycline. These levels o f antibiotic were selected as they 
mimic the peak concentration o f tetracycline found in the oral cavity after a single 











Figure 7.1 Continuous CDFF system set up and tetracycline delivery
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7.2.4 Culture methods
Pans were removed from the CDFF before and after the addition o f tetracycline, the 
bovine enamel disks were aseptically removed and placed into 1 ml o f phosphate- 
buffered saline (Sigma), and then vortexed for 1 min to disrupt the biofilm. Three 
discs from each pan were used for determining the bacterial composition o f the 
biofilms, spread-plating o f each biofilm was carried out in duplicate. The total 
anaerobic count was performed on Fastidious Anaerobic Agar (FAA; LabM, Bury, 
UK) containing 5% defibrinated horse blood (E and O Laboratories, Bonnybridge, 
UK). Lactobacilli were isolated from FAA plates on the basis o f colonial 
morphology, Actinomyces spp. were isolated on cadmium fluoride-acriflavin-
tellurite agar plates (Table 7.1; Zylber and Jordan, 1982), and streptococci were
isolated on Mitis Salivarius agar (Difco Laboratories, Detroit, MI, USA). A ll o f the
plates were incubated anaerobically for 3 days at 37°C. Antibiotic-resistant
organisms were isolated, enumerated (2.2.4) and antibiotic-resistant bacteria were 
identified by a combination o f biochemical and molecular methods (2.3-2.5.3). 
Susceptibility testing by an agar dilution method (2.6-2.6.3) was carried out on all 
antibiotic-resistant bacteria to confirm their antibiotic resistance profiles.
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Table 7.1 Composition o f C F A T  medium
Product Volume per litre o f dHnO
Tryptone soya broth powder 30 g
Agar technical powder 15g
Glucose 5g
Sheep blood 50 ml
Cadmium sulphate 13 mg
Sodium fluoride 80 mg
Neutral acriflavin 1.2 mg
Potassium tellurite 2.5 mg
Basic fuschin 0.25 mg
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7.3 Results
7.3.1 Composition of biofilms
At 216 h immediately before the addition o f tetracycline the microcosm plaques had 
a mean total viable anaerobic count o f 7 x 107 + 3.6 x 107 cfu per biofilm (Figure 
7.2). This value changed after the pulse o f tetracycline to the fermenter, there was an 
immediate reduction in the total viable anaerobic count to 1.3 x 107 cfu per biofilm. 
This was further reduced with a 94% k ill to 6 x 106 cfu per biofilm 24 h (240 h) after 
the addition o f tetracycline. The total anaerobic viable count never fully recovered to 
the pre-tetracycline level (Figure 7.2). There was no obvious effect on the numbers 
o f lactobacilli immediately after pulsing with tetracycline. However, 24 h after 
pulsing, the numbers o f viable lactobacilli reduced to 1.5 x 106 cfu per biofilm, 
which was followed by an increase in the viable lactobacilli count up to 8 days post­
delivery. The greatest reductions in the viable counts were seen for the streptococci, 
with a reduction o f 98.5%, reducing from 1.3 x 107 to 1.9 x 105 cfu per biofilm 
(Figure 7.2) immediately after tetracycline delivery. The number o f Actinomyces 
spp. also decreased after the addition o f tetracycline with a reduction o f 96% at 24 h 
post-antibiotic delivery.
The relative proportions o f bacteria in the biofilm changed dramatically after the 
addition o f tetracycline to the fermenter (Table 7.2). The composition changed from 
a community in which streptococci predominated to one in which Lactobacillus was 
the predominant genus. These compositional changes were not observed in the 
control biofilms grown in the absence o f tetracycline (Figure 7.2).
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Figure 7.2 Total viable counts before and after the addition o f tetracycline, 
designated by filled symbols; total anaerobic count ♦ ,  lactobacilli ■, streptococci 
A and actinomycetes # .  Dotted lines represent control experiment in which 
tetracycline was not added. Symbols denote; total anaerobic count O , lactobacilli 
□ , streptococci A  and actinomycetes O. Error bars represent standard deviations.
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Time (h)
Species 72 216 221 240 336 408
Lactobacillus spp. 0.1 6.7 30.6 24.6 30.1 31.6
Streptococcus spp. 1.7 18.7 1.5 12.0 13.4 3.3
Actinomyces spp. 1.2 2.1 3.1 1.0 4.3 4.3
Table 7.2 Percentage microbial composition o f microcosm plaques, compared to 
the total anaerobic count, before (72 h and 216 h) and after (221 h, 240 h, 336 h and 
408 h) the addition o f tetracycline (5 h addition o f tetracycline between 216 h and 
221 h).
7.3.2 Antibiotic resistance profile.
Throughout this study there were 11 vancomycin-resistant isolates recovered. 
Theses were 11 isolates all identified as Lactobacillus fermentum, which are 
intrinsically resistant to this antibiotic. The 21 tetracycline-resistant isolates 
recovered throughout this study were identified as L. fermentum, Streptococcus 
gordonii, Strep, mitis, Strep, oralis, Strep, parasanguis, Strep, salivarius and Strep, 
sanguis. Multi-antibiotic resistant bacteria were readily isolated, o f the tetracycline- 
resistant isolates, 67% were also resistant to erythromycin and 11% were 
intrinsically vancomycin-resistant.
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Immediately before and after tetracycline delivery all antibiotic-resistant viable 
counts were similar. However, although the numbers o f antibiotic-resistant isolates 
were unaffected immediately after the addition o f tetracycline, the antibiotic 
resistance profile o f the community dramatically changed 24 h post-tetracycline 
delivery (240 h). The numbers o f erythromycin-resistant isolates had decreased by 
92.6%, and remained depressed throughout the study. The tetracycline-resistant 
microbiota mirrored the response o f the erythromycin-resistant isolates, at 8 days 
post-tetracycline addition the numbers o f viable tetracycline-resistant isolates had 
reduced by 92%.
In contrast, the number o f vancomycin-resistant isolates remained constant up to 24 
h post antibiotic delivery, being 6.5 x 10s cfu per biofilm. The viable counts for the 
vancomycin-resistant bacteria then increased over time reaching 2.7 x 106 cfu per 
biofilm. The microcosm altered in composition from one where a tetracycline- and 
erythromycin-resistant microbiota predominated, to one at 8 days post-pulsing 
where the vancomycin-resistant bacteria were the greatest component. There was a 
slight increase in the number o f ampicillin-resistant bacteria immediately after 
tetracycline delivery. Penicillin-resistant and chloramphenicol-resistant isolates were 
undetectable.
The percentage o f the cultivable microbiota that was resistant to the four different 
antibiotics changed substantially after the addition o f tetracycline (Figure 7.3). 
Tetracycline-resistant isolates showed an immediate increase after the 5 hour 
tetracycline pulse from 6% to 45% o f the cultivable microbiota, however this 
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level just below that obtained before the pulse (4.5%). The percentage o f 
erythromycin-resistant isolates also increased after the tetracycline pulse (from 5% 
to 28%), which also subsequently reduced over time. Initially there was a slight 
increase in the percentage o f vancomycin-resistant isolates from 1% to 5% 
immediately after the addition o f tetracycline. This increase continued with the 
vancomycin-resistant isolates reaching a maximum o f 30% o f the total cultivable 
microbiota.
o Be






Figure 7.3 Percentage o f cultivable bacteria resistant to one o f four different 
antibiotics before (0 h,72 h and 216 h) and after the addition o f tetracycline (221 h, 
240 h, 336 h and 408 h).
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Duplicate test runs were carried out, each over a 408 h period. For each run, the 
addition o f tetracycline altered the composition and increased the proportions o f 
antibiotic-resistant bacteria. In the control biofilms grown in the absence o f 
tetracycline, the proportions o f antibiotic-resistant bacteria did not vary over 408 h. 
The mean percentage o f the oral microbiota resistant to each o f the antibiotics in the 
control biofilms was; ampicillin 0.01% (range 0 - 0.02%), erythromycin 0.7% (0.3 - 
2.0%), tetracycline 2.6% (1.4 -  5.8%) and vancomycin 2.3% (1.4 -  3.8%).
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7.4 Discussion
The proportions o f the cultivable microbiota resistant to ampicillin (0.1%), 
erythromycin (5%) and tetracycline (6%) were within the ranges found in the school 
study groups, being 0.1 - 23%, 1 -  45% and 0- 88%, respectively (Chapter 3). 
Penicillin-resistant isolates were not isolated in this study, which was also observed 
in one subject in the school study (Chapter 3). These similarities in the proportions 
o f antibiotic-resistant bacteria found in this in vitro study and the previous school 
study demonstrates the suitability o f the CDFF as a model system for investigating 
antibiotic resistance in the oral cavity. The main aim o f this part o f the study was to 
determine the effect o f a single tetracycline pulse on the viability, composition and 
antibiotic resistance profile o f microcosm dental plaques. The addition o f 
tetracycline to the model system in levels that can be obtained in the oral cavity was 
found to have a profound effect on the composition o f the biofilms. The total 
anaerobic count was unable to recover to that observed prior to pulsing and 
remained depressed throughout the study. The reduction in susceptible populations 
was in part responsible for the observed increase in the proportions o f antibiotic- 
resistant bacteria. Preus et al. (1995), demonstrated a similar reduction in total 
numbers o f cultivable bacteria after topical application o f minocycline in a clinical 
study. Tetracycline-susceptible oral bacterial species are defined as having minimum 
inhibitory concentrations (MICs) o f < 4 mg/1 (NCCLS, 1993). The administration o f 
12 mg/1 tetracycline, only 3-fold-higher than this, reduced the total anaerobic count 
by 94% indicating that the majority o f the bacteria existing in the biofilm were 
susceptible to clinically-obtainable levels o f tetracycline (Gordon et al., 1981). Other
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studies have reported that to eliminate bacteria grown in biofilms, MICs greater than 
500-times or even 1000-times the MIC found in batch culture may be required 
(Nickel et al., 1985; Larsen and Fiehn, 1996). In this study, a single pulse o f 
tetracycline was sufficient to alter the microbial composition o f the microcosm 
plaques with a notable change from a microbiota dominated by streptococci to one 
where lactobacilli predominated. The lactobacilli were identified as strains o f L. 
fermentum, an organism which has been shown to have cariogenic potential 
(Fitzgerald et al., 1981; Ooshima et al., 1994).
The presence o f tetracycline also resulted in a change in the antibiotic-resistance 
profile o f the biofilms. The emergence o f antibiotic-resistant bacteria has frequently 
been reported to be a direct result o f antibiotic usage (Gould, 1994; Cohen, 1992) 
and in this study the addition o f tetracycline resulted in an increase in the 
proportions o f ampicillin-, erythromycin-, tetracycline- and vancomycin-resistant 
isolates, members o f four different classes o f antibiotics. These results concur with 
those found in the patient study groups (Chapter 4) in which the use o f an antibiotic 
not only increased the proportions o f resistant bacteria to the same antibiotic but also 
to other related and unrelated antibiotics. The ampicillin-resistant microbiota before 
the addition o f tetracycline comprised less than 0.5% o f the total anaerobic count, 
consistent with results obtained from other studies which demonstrated that 
ampicillin-resistant bacteria constitute only a low percentage o f the cultivable oral 
microbiota (Edlund et al., 1996; Walker et al., 1983). In this study, it was not until 
the addition o f tetracycline to the system that the percentage o f ampicillin-resistant 
isolates increased reaching a maximum o f 4% o f the cultivable microbiota.
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These data show that a pulse o f tetracycline selects for organisms that are resistant to 
multiple antibiotics. This is not surprising, as multiple-resistant bacteria are 
frequently isolated so that selection for one resistance w ill increase the overall level 
o f resistance in a population. Furthermore, it has been shown that Tn9/6-like 
elements are present in the tetracycline-resistant oral streptococci isolated (Roberts 
et al., 2001). These conjugative transposons have been shown to transfer within the 
laboratory-grown biofilms (Roberts et al., 2001; Chapter 8) and this may also 
account for the observed increase in the proportions o f antibiotic-resistant bacteria. 
These transposons commonly contain resistances to antibiotics other than 
tetracycline (especially erythromycin) and tetracycline can stimulate the transfer o f 
these elements. Therefore pulsing the oral cavity with tetracycline could lead to the 
spread o f these genetic elements though the oral microbiota. It has been shown that 
i f  people are fed low doses o f tetracycline, their faecal enteric microbiota can 
acquire tetracycline resistance, and may also become multi-resistant (Roberts, 1998). 
The antibiotic profile data demonstrate that there was also a dramatic increase in the 
percentage o f vancomycin-resistant bacteria after the addition o f tetracycline. This 
increase reflects an increase in proportions o f the lactobacilli, as all the vancomycin- 
resistant bacteria isolated in the study were members o f the Lactobacillus genus in 
particular L. fermentum.
Tetracycline antibiotics may be administered for the treatment o f a range o f bacterial 
infections and for their non-antibacterial properties. Tetracycline’s are anti­
inflammatory, immunosuppressive, reduce phagocytic function o f 
polymorphonucear leukocytes, suppress antibody production in lymphocytes, reduce
185
Antib iotic resistance in microcosm dental plaques
leukocyte and neutrophil chemotaxis, enhance gingival fibroblast cell attachment, 
inhibit lipase and collagenase activity and may have antitumour activity (Roberts, 
1998). These non-antibacterial properties have encouraged the use o f these 
antibiotics in the treatment o f non-infection diseases, such as Parkinson’s disease 
(Thomas and Le, 2004). This investigation has demonstrated that the addition o f 
tetracycline to a model oral biofilm at clinically-obtainable levels not only 
substantially alters its bacterial composition, but also the antibiotic-resistance profile 
o f the community.
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Chapter 8
Prevalence of Tetracycline resistance
in Veillonella spp. isolated 
from school children
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8.1 Introduction
The tetracyclines are considered a relatively safe group o f bacteriostatic antibiotics with a 
broad-spectrum o f activity against a wide range o f Gram-positive and Gram-negative 
bacteria (Smilack, 1999). With a low cost and a good activity these antibiotics have been 
used throughout the world for the treatment o f skin, respiratory and oral infections. 
However, increasing bacterial resistance to this group o f antibiotics has begun to lim it 
their usefulness. The oral cavity harbours a diverse community o f microorganisms and 
has been shown to be a reservoir for antibiotic-resistant bacteria (Edlund et al., 1996, 
Lancaster et al., 2003; Ready et al., 2003). Previous studies have shown that between 1% 
and 12% o f the total cultivable oral microbiota is resistant to tetracycline (Edlund et al., 
1996; Lacroix and Walker, 1996; Lancaster et al., 2003; Ready et al., 2003). The most 
widespread resistance gene identified in oral bacteria is tet(M) and the presence o f this 
gene has been demonstrated in a diverse collection o f bacteria (Lancaster, 2003; Villedieu 
et al., 2003). The tet{M) gene is usually found on conjugative transposons (cTn) o f the 
Tn916/Tnl545 family (Clewell et al., 1995). A wide host range for conjugative 
transposons has been shown, with Tn976-like elements being found in over 50 different 
species and 24 different genera (Clewell et al., 1995) and the transfer o f tetracycline 
resistance mediated by Tn9/6-like elements has been observed between oral streptococci 
(Hartley et al., 1984; Kuramitsu et al., 1984, Roberts et al., 2001). However, the role o f 
oral bacteria other than streptococci in the transfer o f tetracycline resistance genes has not 
been investigated.
Previous work has shown that after the oral streptococci the most prevalent group o f 
tetracycline-resistant bacteria is the Veillonella spp. (Lancaster, 2003). Veillonella spp.
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are small, non-fermentative, anaerobic, Gram-negative cocci and include members o f the 
microbiota o f the oral cavity, gastrointestinal tract, and vagina. The aims o f this study 
were to determine the prevalence o f tetracycline resistance in isolates o f Veillonella spp., 
to establish what tetracycline resistance genes were present in these bacteria and to 
determine i f  tetracycline resistance was able to transfer from a strain o f Veillonella dispar 
to other oral bacteria.
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8.2 Materials and Methods
8.2.1 Subjects
A ll 4-5 year old children attending reception classes o f a North London School over an 
18-month period were included in a dental screening programme. One hundred and fifty- 
nine children were given a dental examination. The subjects were given a consent form 
and a questionnaire to determine their own, and parental, use o f antibiotics in the 
previous three months and the presence o f any major medical problems. Eighty-four o f 
these children (response rate 53%) were given parental consent for the collection o f 
dental plaque and were recruited into the study. Twenty children were excluded from the 
study due to the use o f antibiotics in the previous 3 months and 6 children were 
unavailable for sampling. Samples were obtained from 58 children (33 female and 27 
male). The Research and Ethics Committee o f Barnet Health Authority, London, 
England, approved the study.
8.2.2 Bacterial isolation, identification and susceptibility
Plaque samples were taken from the entire dentition o f each child, diluted and plated onto 
antibiotic-free agar (2.2.4). The isolation o f Veillonella spp. was achieved by sample 
inoculation onto Iso-sensitest agar (Oxoid Ltd, Basingstoke, UK) containing 5% 
defibrinated horse blood (E and O Laboratories, Bonnybridge, UK) and 8 pg'ml 
vancomycin (Sigma-Aldrich, Poole, UK). Plates were incubated for 3 - 5 days in an 
anaerobic chamber (MACS 1000, Don Whitley Scientific Ltd, Shipley, UK) at 37°C. The 
total cultivable microbiota and the presumptive Veillonella spp. were enumerated (2.2.4) 
and identified by a combination o f biochemical and molecular methods (2.3-2.5.3).
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Tetracycline-susceptibility testing was carried out on all Veillonella spp. by an agar 
dilution method (2.6-2.6.3).
8.2.3 Detection of tetracycline resistance determinants
A ll o f the tetracycline-resistant isolates were tested for the presence o f tetracycline 
resistance genes by PCR using the primers (Genosys, Sigma, UK) listed in table 8.1.
Table 8.1 PCR primers targeting tet genes
Gene targeted Amplicon Sequence o f forward (F) and reverse (R) primers
size (bp) (5’ - 3 ’)
F  - GCT ACA TCC TGC TTG CCT TC 
R - CAT AGA TCG CCG TGA AGA GG 
F  - TTG GTT AGO GGC AAG TTT TG 
R - GTA ATG GGC CAA TAA CAT CG 
F  - CTT GAG AGC CTT CAA CCC AG 
R  - ATG GTC GTC ATC TAC CTG CC 
F  - TCG ATA  GGA ACA GCA GTA 
R - CAG CAG ATC CTA CTC CTT 
F - TCG TTA GCG TGC TGT CAT TC 
R - GTA TCC CAC CAA TGT AGC CG 
F - GTG GAC AAA GGT ACA ACG AG 
R - CGG TAA AGT TCG TCA CAC AC 
F - AAC TTA GGC ATT CTG GCT CAC 
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tet(Q) 904 F - TTA TAC TTC CTC CGG CAT CG
R - ATC GGT TCG AGA ATG TCC AC
tet{ S) 667 F - CAT AGA CAA GCC GTT GAC C
R - ATG TTT TTG GAA CGC GAG AG
tet( T) 169 F - AAG GTT TAT TAT ATA AAA  GTG
R - AGG TGT ATC TAT GAT ATT TAC
tet( W) 168 F - GAG AGC CTG CTA TAT GCC AGC
R - GGG CGT ATC CAC AAT GTT AAC
8.2.4 Organisms for mating experiments
Veillonella dispar (34.2A) was isolated from a child enrolled in this study and was used 
throughout these experiments as the tetracycline resistance donor. This organism carried 
a Tn9/6-like conjugative element containing a tet{M) gene which conferred tetracycline 
resistance. This donor was mated to a consortium o f 21 tetracycline-susceptible bacteria. 
These recipient bacteria were; Actinomyces meyeri (clinical isolate), Actinomyces 
odontolyticus (ATCC 17929) Actinomyces viscosus (NCTC 10951), Capnocytophaga 
gingivalis (ATCC 33624), Capnocytophaga granulosa (ATCC 51502), Capnocytophaga 
haemolytica (ATCC 51501), Capnocytophaga ochracea (ATCC 27872), 
Capnocytophaga sputigena (ATCC 33612), Fusobacterium nucleatum (NCTC 11326), 
Neisseria subflava (clinical isolate), Streptococcus anginosus (NCTC 10713), 
Streptococcus gordonii (NCTC 7865), Streptococcus intermedius (NCTC 2227), 
Streptococcus mitis (NCTC 12261), Streptococcus mutans (NCTC 10449), Streptococcus 
oralis (NCTC 11427), Streptococcus parasanguis (NCTC 55898), Streptococcus
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pneumoniae (NCTC 7465), Streptococcus salivarius (NCTC 8618) Streptococcus sanguis 
(NCTC 7863) and Streptococcus sobrinus (NCTC 12279).
8.2.5 Mating using an in vitro model
Initial mating experiments were carried out in a constant-depth film  fermenter (CDFF; 
University o f Wales, Cardiff, UK). Anaerobic bacteria were grown for 48 h on Fastidious 
Anaerobic Agar (FAA) (LabM, Bury, UK) containing 5% defibrinated horse blood in an 
anaerobic chamber at 37°C for 3 days. Facultative and obligate aerobes were grown on 
Columbia blood agar (CBA, Oxoid Ltd) containing 5% defibrinated horse blood in air 
supplemented with 5% CO2 at 37°C for 2 days. Plates were checked for purity before the 
organisms were harvested for mating. A ll o f the growth on a plate was harvested with a 
sterile swab and suspended in 1 ml o f PBS. Each 1 ml suspension was subcultured to 
ensure purity o f the donor and recipients. The suspended bacteria were pooled and added 
to 500 ml o f sterile artificial saliva aseptically. This was pumped over the pans in the 
CDFF at a pump setting o f 34 units equivalent to 2 ml per minute (inoculation time: 4 h 
10 minutes). After this time the CDFF was fed with sterile artificial saliva (2.8.1) via a 
peristaltic pump (Watson-Marlow, Falmouth, U.K.) at a rate o f 0.5 ml per min., 
corresponding to the resting salivary flow rate in man (Bell et al., 1980, Guyton et al., 
1991, Lamb etal., 1991).
8.2.6 Selection of transconjugants
Pans were removed from the fermenter at 24 hours. A serial dilution was carried out in 
sterile PBS to 10'6 and 50 pi samples were spread onto FAA plates containing
193
Tetracycline resistance in Veillonella spp..
tetracycline at 8 mg I"1 and incubated aerobically and anaerobically. Plates were counted 
and bacteria were subcultured to tetracycline-containing agar to ensure resistance and 
purity. Isolates were stored at -80°C for further analysis.
8.2.7 Filter Mating
The donor bacterium Veillonella dispar (34.2A) was grown in an anaerobic cabinet 
overnight in Brain-Heart Infusion (BHI) broth containing tetracycline (5 mg I '1). The four 
recipient bacteria {Strep, oralis, Strep, mitis, Strep, parasanguis and Strep, salivarius) 
were grown overnight in air supplemented with 5% CO2 in antibiotic-free BHI broth. 100 
pi o f the overnight culture was used to inoculate 10 ml o f antibiotic free BHI broth and 
left to grow at 37°C until the cells were in mid-exponential phase (OD6oo=0.4 -  0.6). The 
BHI cultures were then centrifuged for 10 min at 1910 g and the supernatant was 
discarded. The cells were resuspended in 1ml o f BHI broth containing 50pg DNase 
(Christie et al., 1987) and a 100 pi aliquot from the donor was added to a 100 pi aliquot 
from one o f the recipients and then spread onto 0.45 pm nitrocellulose filter (Fisher 
Scientific, London, UK) which had been previously opened and placed on thick 
antibiotic-free FAA. These filter plates were then incubated anaerobically overnight at 
37°C. The filters were removed from the agar plates and placed in 20 ml universal bottles 
containing 1 ml o f sterile, pre-warmed BHI broth and vortexed for 10-20 seconds. 
Aliquots o f 100 pi were then spread on CBA plates containing tetracycline (8 mg I'1). 
These plates were incubated 37°C for 48 h in air supplemented with 5% CO2 . Plates were 
counted and bacteria were subcultured to tetracycline-containing agar to ensure resistance 
and purity. Isolates were stored at -80°C for further analysis.
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8.2.7.1 Filter mating controls
Five antibiotic-free FAA plates containing 0.45 pm nitrocellulose filters were inoculated 
with 100 pi o f one o f the recipients. These plates were incubated anaerobically overnight 
at 37°C. The filters were removed from the agar plates and resuspended in 1 ml o f sterile, 
pre-warmed BHI broth. Aliquots o f lOOpl from the recipients were placed on CBA plates 
containing tetracycline (8 mg f l) and incubated for 48 h at 37°C in air containing 5% 
CO2 to confirm i f  spontaneous tetracycline-resistant mutants arose.
To determine the level o f acquisition o f tetracycline genes via transformation (the process 
whereby naked DNA is taken up directly by a bacterium) 375 ng o f plasmid DNA 
(pAM l20) containing the tet(M) tetracycline resistance gene was added to filters 
inoculated with each o f the four recipients. To ensure that DNase prevented the 
acquisition o f tetracycline genes via transformation 375 ng o f pAM120 DNA was added 
to filters inoculated with each o f the four recipients in the presence o f 50 pg o f DNase. 
A ll o f the filters were removed from the agar plates and resuspended in 1 ml o f sterile, 
pre-warmed BHI broth and lOOpl aliquots were spread on CBA plates containing 
tetracycline (8 mg I '1), these were incubated for 48 h at 37°C in air containing 5% CO2 
and enumerated to determine the number o f transformants present.
8.2.8 Identification of antibiotic-resistant isolates
Tetracycline-resistant bacteria were enumerated (2.2.4) and identified by a combination 
o f biochemical and molecular methods (2.3-2.5.3). Tetracycline-susceptibility testing 
was carried out on all isolates by an agar dilution method (2.6-2.6.3).
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8.3 Results
8.3.1 Prevalence of Veillonella spp.
O f the 58 children, 56 (96.6%) harboured detectable numbers o f Veillonella spp. in their 
oral cavity. The median total viable count o f the oral microbiota was 4.7 x 106 cfu/ml 
(range 6.5 x 105 to 7.8 x 107 cfu/ml) and the median viable count o f Veillonella spp. was
1.3 x 105 cfu/ml (0 to 5.8 x 106 cfu/ml). The proportion o f the cultivable oral microbiota 
which comprised Veillonella spp. ranged from <0.001% in two subject to a maximum o f 
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Figure 8.1 Histogram o f the proportions o f the total cultivable oral microbiota 
comprising Veillonella spp in 58 children
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8.3.2 Identity of Veillonella spp, and susceptibility to tetracycline
In total, 96 Veillonella isolates were obtained from the 58 subjects. The majority (54%) 
o f these isolates were Veillonella parvula (Table 8.2). Veillonella dispar comprised 39% 
o f the isolates and only 3% o f the isolates were identified as Veillonella atypica. Due to 
similarity at the 16S rRNA gene level four isolates could not be identified to species 
level. On subsequent confirmatory testing, 12 o f the 96 isolates (12.5%) were shown to 
be tetracycline-resistant (MIC > 16 mg'l) in which 5 different tetracycline-resistant genes 
were detected (Table 8.2). The most common tetracycline resistance gene identified was 
te/(M) which was found in 67% o f all o f the tetracycline-resistant Veillonella spp. with 
tet(S) being the second most common, demonstrated in 42% o f the isolates. None o f the 
isolates were positive for tet(B), tet(C), tet{K), tet(Q), tet(T) or tet(W).
Table 8.2 Distribution o f tetracycline resistance genes among Veillonella spp.
No. o f isolates from which tetR 
were isolated
genes
Identity o f 
bacterium
No. No. (%) 
resistant to 
tetracycline
tet{ M) tet{ S) tet( 0 ) tet(A) tet{ L) No. o f isolates with 
more than one tetR 
gene
V parvula 52 6(11.5) 3 3 0 1 1 1 [tet{M) plus tet(L)] 
1 [/e/(S) plus tet(A)]
V dispar 37 5(13.5) 4 2 1 0 0 1 [tet{M) plus tet(0 )] 
1 [tetQA) plus tef(S)]
V. atypica 3 0(0) 0 0 0 0 0 0
Unspeciated
Veillonella
4 1 (25.0) 1 0 0 0 0 0
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8.3.3 Transfer of tetracycline resistance
8.3.3.1 Transfer in the CDFF
At inoculation the CDFF contained twenty-one tetracycline-susceptible species (MIC <
0.125 mg‘1; tet(M) negative) and one tetracycline-resistant V. dispar (MIC 32 mg'I; 
tet(M) positive). After 24 hours, tetracycline-resistant putative transconjugants o f Strep, 
mitis (M IC 32 mg‘1), Strep, oralis (MIC 32 mg‘l), Strep, parasanguis (MIC 32 mg‘1) and 
Strep, salivarius (MIC 64 mg‘1) were isolated from biofilms derived from the CDFF. PCR 
and sequence reaction analysis demonstrated that all four putative transconjugants 
contained the integration regions (int and xis) o f Tn916 and the tetiM) gene present in the 
donor bacterium and absent in the recipients (Figure 8.2).
1
 500 bp 
406 bp
Figure 8.2 /e/(M) PCR products using /e/(M) forward and reverse primers.
Lanes: M -  100 bp molecular weight marker, 1 -  negative control, 2 -  tet{M) positive control (pAM 120), 3 
-  V. dispar (donor), 4 -  Strep, mitis (recipient), 5 - Strep, mitis (transconjugant), 6 -  Strep, oralis 
(recipient), 7 - Strep, oralis (transconjugant), 8 -  Strep, parasanguis (recipient), 9 -  Strep, parasanguis 
(transconjugant), 10 -S trep, salivarius (recipient), 11 -  Strep, salivarius (transconjugant).
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8.3.3.2 Transfer via fitter mating
To confirm the results obtained from the CDFF, filter-mating experiments were carried 
out between each o f the original tetracycline-susceptible recipients {Strep, mitis, Strep, 
oralis, Strep, parasanguis and Strep, salivarius) and the donor bacterium (V. dispar). 
DNase was added to the mating reactions to ensure that transfer occurred via conjugation 
and not transformation. Transconjugants arose from each o f the mating experiments 
(Table 8.3). PCR and sequence analysis demonstrated that the donor and all 
transconjugants contained identical integration {int and xis) genes and tet{M) genes.
Table 8.3 Filter mating results
Filter mating experiment Number o f tetR isolates Transfer frequency
S. mitis No spontaneous tetR mutants -
S. mitis + V. dispar + DNase 2.9 x 103 tetR transconjugants 4.1 x 10"6 per recipient
S. mitis + pAM120 + DNase No tetR transformants -
S. mitis + pAM120 29 tetR transformants 7.8 x 10'2 per ng DNA
S. oralis No spontaneous tetR mutants -
S. oralis + V. dispar + DNase 6.7 x 104 tetR transconjugants 5.7 x 10'5 per recipient
S. oralis + pAM120 + DNase 6 tetR transformants 1.6 x 10‘2 per ngDNA
S. oralis + pAM120 3120 tetR transformants 8.4 per ng DNA
S. parasanguis No spontaneous tetR mutants -
S. parasanguis + V dispar + DNase 8.0 x 103 tetR transconjugants 5.2 x 10*6 per recipient
S. parasanguis + pAM120 + DNase 5 tetR transformants 1.3 x 10‘2 per ng DNA
S. parasanguis + pAM120 512 tetR transformants 1.4 per ng DNA
S. salivarius No spontaneous tetR mutants -
S. salivarius + V. dispar + DNase 4.6 x 103 tetR transconjugants 4.5 x 10*5 per recipient
S. salivarius + pAM120 + DNase No tetR transformants -
S. salivarius + pAM120 22 tetR transformants 5.9 x 10'2 per ng DNA
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8.4 Discussion
Veillonella spp. were found to be widespread among the children studied with only two 
o f the fifty-eight subjects not harbouring these bacteria at detectable levels with V 
parvula and V dispar being the two most commonly isolated species. O f the 96 
Veillonella spp. isolated 12.5% were resistant to tetracycline, which agrees with the 
results obtained previously by Sutter and Finegold (1976) in which 15% o f the 48 
Veillonella spp. investigated were classified as tetracycline-resistant.
Five different genes encoding tetracycline resistance were identified. The tet{M) gene 
was found most commonly in the Veillonella spp., other workers have also shown that 
tet(M) is the most frequently isolated tetracycline resistance gene found in oral bacteria 
(Lancaster et al., 2003; Villedieu et al., 2003). The genes tet{M), tet(S), tet{A) and tet{L) 
identified in this study have previously been found in Veillonella spp. by other workers 
(Roberts and Hillier, 1990; Pang et al., 1994; Lancaster et al., 2003; Villedieu et al., 
2003). A single isolate o f V dispar contained the tet{O) gene and this gene has not 
previously been found in Veillonella spp. The tet{O) gene is generally found in Gram- 
positive bacteria rather than Gram-negative organisms, with an isolate o f Neisseria sp. 
previously being the only exception to this (Villedieu et al., 2003).
Other studies have demonstrated the transfer o f tetracycline-resistance between oral 
streptococci (Hartley et al., 1984; Kuramitsu et al., 1984; Roberts et al., 2001). However, 
the potential o f Veillonella spp. to transfer antibiotic resistance had not been shown 
previously. In this study tetracycline resistance was shown to transfer from V. dispar by 
bacterial conjugation to four different oral streptococci by the use o f a model system and 
via filter mating experiments with between 2.9 x 103 -  6.7 x 104 transconjugants arising.
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Interestingly, the transfer occurred in the absence o f tetracycline as a selective pressure, 
previous CDFF studies have included the use o f an antibiotic which may promote transfer 
(Roberts et al., 1999; Roberts et al., 2001) as it has been shown that tetracycline induced 
transfer can occur at sub-inhibitory concentrations o f this antibiotic (Doucet-Populaire et 
al., 1991).
Mating experiments with pAM120 in the absence o f DNase generated between 22 -3120  
transformants, which suggests that a low level o f transformation may occur. DNase was 
added to the mating experiments to eliminate this mode o f transfer, however, 6 and 5 
transformants were isolated for mating experiments with pAM120 and Strep, oralis and 
pAM120 and Strep, parasanguis, respectively. This was a lower level than in the 
presence o f DNase and may have been due to rapid uptake o f pAM120 before the DNase 
had an opportunity to degrade this element.
The finding that Veillonella spp which are considered part o f the normal oral microbiota 
can harbour and disseminate tetracycline resistance in the absence o f this antibiotic is 
important. The oral cavity is a heavily colonised environment and tetracycline-resistant 
Veillonella spp. have the opportunity to come into close contact with and consequently 
transfer resistance elements to other oral bacteria and also bacteria which pass through 
the oral cavity. Oral bacteria have the opportunity to transfer from person to person (via 
kissing etc.) and this transfer could allow the spread o f a resistant bacterium to a new host 









The white paper, "Resistance to Antibiotics and other Antimicrobial agents" was 
presented to the British Parliament by the Secretary o f State for Health in 1998. This 
stated that “ antimicrobial resistance is a major public health threat and even though 
resistance is an inevitable consequence o f antimicrobial use, there are ways to slow 
or delay its emergence and lim it its spread.” Surveillance, prudent antimicrobial use 
and infection control, were the focus o f this paper and following the report there has 
been extensive research in these areas. However, there are key questions which still 
need to be addressed. For example, the surveillance o f antibiotic resistance requires 
standardisation; much o f the current research has focused primarily on hospital 
patients, adults and pathogenic bacteria (generally isolated from patients with active 
disease). Fewer studies are available on either antibiotic resistance in the normal 
microbiota, healthy community subjects or children (Laissine et al., 1999; M illar et 
al., 2001; Nyfors et al., 2003a; 2003b). This skew o f the current literature leaves us 
with the simple question “ how much antibiotic resistance is there in the majority o f 
bacteria (normal microbiota) carried by the majority o f people? (healthy people 
living in the community)”  poorly answered.
9.2 Surveillance of antibiotic resistance
The surveillance o f antibiotic resistance firstly requires the definition o f what is an 
antibiotic-resistant bacterium. Generally the growth o f a bacterium at or above a 
defined concentration o f an antibiotic is used to determine i f  it is resistant to this 
antibiotic. Unfortunately, there are very few oral bacteria currently included in any
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o f the national or international guidelines (NCCLS, 2003; BSAC 2001). With the 
exception o f Strep, pneumoniae, none o f the oral streptococci are included in the 
UK antibiotic guidelines (BSAC, 2003). This lack o f guidance is surprising as these 
bacteria are important aetiological agents o f infective endocarditis, an infection 
which, without antibiotic therapy has a 100% fatality rate. Additionally, it is 
recommended in the UK to give prophylactic amoxicillin to patients at risk o f 
infective endocarditis before they undergo specific dental procedures, however, 
using the current UK guidelines it is impossible to classify oral streptococci as 
susceptible to this antibiotic (BNF, 2004; BSAC, 2001). This results in patients 
routinely being given antibiotic treatment and prophylaxis without any guidance as 
to which bacteria are susceptible and which are resistant to the agents used.
An additional problem in surveillance studies is the lack o f a single defined 
guideline for testing and reporting bacteria as resistant or susceptible. In the USA 
there is one recommended guideline (NCCLS, 2003) in Europe however, each 
country generally has its own guidelines and even within these countries some w ill 
use the USA guidelines and some their own countries recommendations. This makes 
comparison o f surveillance data d ifficult as the same bacterium may be defined as 
susceptible, intermediate or resistant depending on which guidelines were used.
9.3 Prevalence of antibiotic-resistance in the community
In this study, a total o f 82 children were investigated and each child harboured 
antibiotic-resistant bacteria as part o f their oral microbiota. This finding has 
demonstrated the potential o f the normal oral microbiota to act as a reservoir o f
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antibiotic-resistant bacteria. Even in the absence o f recent antibiotic use, some 
children had extremely high percentages o f their viable oral microbiota resistant to 
specific antibiotics, with one subject having 88% o f his oral microbiota resistant to 
tetracycline. It may be possible that these children harbouring high percentages o f 
their oral microbiota resistant to antibiotics could act as a potent source o f 
transferable drug resistance. In hospital studies, patients who are colonised with 
antibiotic-resistant bacteria have been shown to provide a reservoir from which the 
organisms may spread easily to other susceptible patients (Sanches et al., 1998; 
Simor et al., 2002). In the community setting, bacteria can be readily spread when 
people are in close contact, previous work has demonstrated that day care centres 
and infant schools are a suitable environment for the spread o f Strep, pneumoniae 
and H. influenzae (Boken et al., 1995; Peerbooms et al., 2002). The horizontal 
spread o f microorganisms causing respiratory and gastrointestinal infections in the 
school environment has also been widely reported (Master et al., 1997; Roberts et 
al., 2000). As these pathogenic organisms are able to transfer rapidly in the school 
environment it is also possible that antibiotic-resistant bacteria may be spread 
throughout these institutions. Hospital infection control measures used to combat the 
spread o f antibiotic-resistant bacteria rely heavily upon hand washing and this has 
been shown to reduce the prevalence o f communicable infections in schools (Master 
et al., 1997; Roberts et al., 2000). As such, general personal hygiene measures may 




9.4 Factors promoting antibiotic resistance
The introduction o f antibiotics into clinical practice is arguably the most significant 
medical achievement o f the 20th century and factors that reduce the usefulness o f 
these antibiotics should concern us all. The role o f previous antibiotic use, ethnicity 
and combined heavy metal resistance to promote an increase in antibiotic resistance 
was investigated in this study.
9.4.1 Antibiotic use
This study has demonstrated that the use o f two different antibiotics can promote 
antibiotic resistance. In the school surveillance study (Chapter 4) the use o f 
amoxicillin by the children increased the proportions o f the viable oral microbiota 
which were resistant to ampicillin. As many o f the children harboured tetracycline- 
resistant bacteria, the effect o f tetracycline on the oral microbiota was also 
investigated. Because the use o f this antibiotic is not advised in children under the 
age o f 12 years (BNF, 2004) an in vitro fermenter study (Chapter 7) was used to 
investigate the effects o f tetracycline use. The presence o f tetracycline in the model 
system resulted in an increase in the proportions o f ampicillin-, erythromycin- and 
tetracycline-resistant isolates. The results from these two chapters have 
demonstrated that a significant increase in the antibiotic-resistant oral load occurs 
after antibiotic use. Antibiotics are frequently prescribed for use in the UK 
population and children under five years o f age have been shown to be the most 
likely age group to receive a prescription for an antibiotic (ONS, 2003). Therefore, 
the government’s scheme encouraging prudent antimicrobial use appears to be an
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essential objective in controlling antibiotic-resistance. In this study it has been 
demonstrated that antibiotic use increases antibiotic resistance, unfortunately it has 
been shown by other workers that the reduction in the use o f antibiotics w ill not 
always result in a decline in the prevalence o f antibiotic-resistant bacteria (Carbon 
and Bax, 1998). Therefore, it may be that even the national scheme aimed at 
reducing antibiotic use may only prevent a further increase in resistance rather than 
result in reducing our current levels o f resistance any further.
9.4.2 Ethnicity
The oral load o f bacteria resistant to tetracycline was shown to be significantly 
higher in both Japanese and South Asian children than in white children (Chapter 5). 
This difference was not attributable to disparities in the use o f antibiotics by the 
children, as none o f the children had received antibiotics in the previous three 
months. The reasons for this remain to be established, and it was not possible within 
this study to conclude that ethnicity was the sole factor promoting these observed 
differences. Is likely that confounding factors other than the subject’s ethnicity are 
important, these may include hopsitalisation, diet, duration o f stay in this country, 
socioeconomic inequalities, overcrowding and disparities in antibiotic use among 
the parents and siblings o f these different ethnic groups.
These levels o f tetracycline resistance were unexpected, as children in the UK under 
the age o f 12 are not prescribed tetracycline, as it can stain the teeth or intercalate 
into growing bones causing physiological abnormalities (BNF, 2004). This suggests 
that although it has been shown that tetracycline use can increase the oral load o f
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tetracycline-resistant bacteria (as demonstrated in the in vitro model system; 
Chapter 7) the high oral loads o f tetracycline-resistant bacteria found in some 
children are the result o f a factor other than the use o f tetracycline. It is likely that 
the children acquired these bacteria from their parents as it is well documented that 
young children can acquire oral bacteria such as mutans streptococci via maternal 
saliva (Kononen et al., 1994; Li and Caufield, 1995). One study which investigated 
Staph. aureus acquisition during infancy, demonstrated that a child’s mother was the 
normal source o f the bacterium (Peacock et al., 2003). I f  these resistant bacteria are 
obtained from parents or even the child’s siblings, then antibiotic use, particularly o f 
tetracyclines by the parents, may be an important factor promoting this raised oral 
load in the Japanese and South Asian children. Other close contacts may also be 
important in the acquisition o f resistant bacteria, such as other adults (relatives, 
teachers, older siblings) or from other children that have acquired these organisms 
from their parents. However, it is unclear why the tetracycline-resistant bacteria are 
maintained in the oral cavity after they have been acquired by the children and the 
selective pressure for maintaining these bacteria remains to be ascertained. It may be 
that i f  these resistant bacteria do not have a disadvantage they w ill be maintained in 
the absence o f selective pressure, i f  not indefinitely, at least for a long time. 
Alternatively, tetracyclines have been heavily used in the food industry including 
use as growth promoters in the meat industry and as pesticides in the fruit industry 
(McManus et al., 2002; Miranda et al., 2003). Perhaps the ingestion o f food 
contaminated with antibiotic residues may be sufficient to allow the continued 
selection o f these bacteria. It is also possible that co-resistance to other antibiotics or
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heavy metals (including mercury) may also allow the selection o f these bacteria and 
by selecting for resistance to mercury potentially by the placement o f amalgam 
restorations an increase in antibiotic-resistant bacteria also occurs.
9.4.3 Combined mercury-resistance
In this study the majority (71%) o f a group o f children without amalgam fillings 
were found to harbour Hg-resistant oral bacteria, albeit generally at low levels. As 
most o f these Hg-resistant isolates were also resistant to at least one antibiotic it is 
feasible that a selective pressure promoting the presence o f the Hg-resistant bacteria 
would co-select for antibiotic-resistant bacteria. Consequently any factor that 
increased the levels o f Hg in the oral cavity (and thereby Hg-resistant bacteria) 
could also increase the prevalence o f antibiotic-resistant oral bacteria. Studies in 
humans (Edlund et al., 1996) and primates (Summers et al., 1993) have 
demonstrated that the placement and, indeed, extraction o f amalgam restorations 
(which contain approximately 50% Hg) can result in peak concentrations o f Hg in 
saliva and faeces. However, only a few studies have investigated a possible 
association between amalgam restorations and antibiotic resistance. Edlund et al. 
(1996) were unable to demonstrate a significant difference in the relative number o f 
faecal bacteria resistant to mercury and antibiotics after the removal o f amalgam 
restorations. Other studies have given conflicting findings with one demonstration 
o f an increase in Hg- and antibiotic-resistant bacteria after amalgam placement 
(Summers et al., 1993) and another study not being able to demonstrate any increase 
in Hg or antibiotic-resistance (Pike et al., 2001). However, this study has
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demonstrated that there is a reservoir o f Hg-resistant bacteria which are frequently 
co-resistant to antibiotics in the majority o f the children studied and so mercury 
amalgam constitutes a potential selective pressure for maintaining antibiotic- 
resistant bacteria in the oral cavity.
9.5 Transfer of antibiotic resistance
The results from this study have shown that the oral cavity harbours a diverse 
collection o f antibiotic and Hg-resistant bacteria and that antibiotic use and ethnicity 
can increase the load o f resistant oral bacteria. The final objective o f this study was 
to answer the question “ can oral bacteria transfer antibiotic resistance genes?” 
Previous studies have demonstrated the transfer o f tetracycline-resistance between 
oral streptococci (Hartley et al., 1984; Kuramitsu et al., 1984; Roberts et al., 2001). 
However, the potential o f Veillonella spp. (which represented 33% o f all the 
antibiotic-resistant bacteria isolated in this study and was the second most prevalent 
group after the streptococci) to transfer antibiotic resistance had not been shown 
previously. Tetracycline resistance was shown to transfer from Veillonella dispar by 
bacterial conjugation to four different oral streptococci in a model system and via 
filter mating (Chapter 8). This finding is important as the oral cavity is a heavily 
colonised environment and oral bacteria have the opportunity to come into close 
contact with and consequently transfer resistance elements to other oral bacteria in 
dental plaque and bacteria which pass through the oral cavity. As previously 
discussed oral bacteria can transfer from person to person and this transfer could 
allow the spread o f a resistant bacterium to a new host and mobile antibiotic
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resistance genes carried by this bacterium may then spread to other antibiotic- 
susceptible bacteria. Veillonella spp. can be found as normal inhabitants o f the gut 
and vaginal microbiota (Bhatti and Frank, 2000) which may present an opportunity 
for the dissemination o f these mobile elements in these environments.
9.6 The future
Antibiotics have been in clinical use for little over 60 years and there are many areas 
in which additional research needs to be focused. In 1998 the British government 
targeted surveillance, prudent antimicrobial use and infection control to combat the 
spread o f resistance. However, before the surveillance began, a major priority 
should have been to standardise our protocols and to encourage the use o f a single 
worldwide scheme for surveillance and antibiotic susceptibility testing.
This study has demonstrated that the oral cavity o f children is a reservoir o f 
antibiotic- and Hg-resistant bacteria, that ethnicity and antibiotic use can alter the 
proportions o f resistant bacteria and that oral bacteria are able to harbour and 
disseminate mobile antibiotic-resistant elements. However, there are still many 
opportunities for further research.
9.6.1 Do antibiotic-resistant bacteria spread within classmates?
To determine i f  the same antibiotic-resistant bacterium had spread from one child to 
another, it would be necessary to determine its presence in unrelated children. This 




9.6.2 Why did some children have such high oral load of antibiotic- 
resistant bacteria and were these high oral loads sporadic or 
continuous?
More work is needed to understand why certain individuals have such high oral 
loads o f antibiotic-resistant bacteria. The use o f a longitudinal study with repeated 
sampling o f the children would allow us to determine i f  this high oral load was short 
term or continued over time and to determine i f  there is a group o f the population 
with consistently high carriage o f antibiotic-resistant bacteria. Antibiotic resistance 
in the oral cavity o f the parents and siblings o f the children would also need to be 
surveyed to see is there is an association with high oral loads within family groups.
9.6.3 How long does it take for the oral microbiota to return to a 
pre-antibiotic level?
A study by Melegaro et al. (2004), demonstrated that the duration o f carriage o f 
Strep, pneumoniae in children under the age o f five years is longer than in older 
family members (51 compared to 19 days). Some o f the children that had used 
antibiotics were sampled close to three months after they had completed their course 
o f antibiotics and these children still had high oral loads o f antibiotic-resistant 
bacteria. This suggests that the three-month period may not be sufficient for the oral 
microbiota to return to pre-antibiotic levels. A longitudinal study sampling the oral 
microbiota from children before, and repeated sampling after, antibiotic use would 




9.6.4 How does repeated antibiotic use affect the oral microbiota?
Previous work has reported that multiple prescriptions o f antibiotics are common in 
childhood (M ille r et al., 2001) and the effects on the carriage o f antibiotic-resistant 
bacteria in the oral cavity after multiple antibiotic use is not known. It would 
therefore be necessary to follow a cohort o f children before and after multiple 
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Dental plaque samples from 40 children were screened for the presence of bacteria resistant to amoxicillin. 
Fifteen children had used amoxicillin and 25 had not used any antibiotic in the 3 months prior to sample 
collection. All (100%) of the children harbored amoxicillin-resistant oral bacteria. The median percentage of 
the total cultivable oral microbiota resistant to amoxicillin was 2.4% (range, 0.1 to 14.3%) in children without 
amoxicillin use and 10.9% (range, 0.8 to 973%) in children with amoxicillin use, with the latter value being 
significantly higher (P  < 0.01). A total of 224 amoxicillin-resistant bacteria were isolated and comprised three 
main genera: Haemophilus spp., Streptococcus spp., and VeiUonella spp. The biodiversity of the amoxicillin- 
resistant microbiota was similar among the isolates from children with and without previous antibiotic use. 
The amoxicillin MIC at which 90% of the isolates were inhibited for isolates from children who had used 
amoxicillin in the previous 3 months was higher (64 mg liter-1) than that obtained for the isolates from 
subjects who had not used antibiotics (16 mg liter-1 ). The majority of the amoxicillin-resistant isolates (65%) 
were also resistant to at least one of the three antibiotics tested (penicillin, erythromycin, and tetracycline), 
with resistance to penicillin (51% of isolates) being the most frequently encountered. However, significantly 
more (P  <  0.05) of the amoxicillin-resistant isolates from subjects with previous amoxicillin use were also 
resistant to erythromycin. This study has demonstrated that a diverse collection of amoxicillin-resistant 
bacteria is present in the oral cavity and that the number, proportions, MICs, and resistance to erythromycin 
can significantly increase with amoxicillin use.
Increases in the levels of antibiotic resistance among patho­
genic bacteria have led to concern in the medical, dental, and 
scientific communities. Antibiotic use in the general popula­
tion is an important factor promoting an increase in antibiotic 
resistance; however, antibiotics are prescribed disproportion­
ately, with higher rates of use in children and elderly individ­
uals. In particular, children younger than age 5 years are the 
most likely age group to receive a prescription for an antibiotic, 
with the broad-spectrum penicillins such as amoxicillin com­
prising 60% of the total antibiotic prescriptions for this age 
group (15). Amoxicillin is not only heavily used in medicine but 
is also frequently prescribed in dentistry and at present is 
recommended for the chemoprophylaxis of infective endocar­
ditis prior to specific dental procedures (4). The oral micro­
biota is an important reservoir of antibiotic-resistant bacteria, 
and several studies have shown that amoxicillin-resistant bac­
teria are carried in the oral cavity (13, 16, 19). Indeed, in a 
previous study (19), all of the children investigated were shown 
to harbor a diverse community of amoxicillin-resistant bacteria 
in their oral cavities. Previous studies have demonstrated that 
the use of amoxicillin, erythromycin, josamycin, and tetracy­
cline can increase the number and/or the proportion of anti­
biotic-resistant oral bacteria (8, 18, 20, 27). However, these 
studies were carried out with adult populations or a model oral 
system and not with young children. The aims of the present 
investigation were to study the effects of amoxicillin use on the
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prevalence, proportions, and identities of amoxicillin-resistant 
bacteria in the oral cavities of children aged 4 to 5 years old.
MATERIALS AND METHODS
Subjects. All children aged 4 to 5 years attending three reception classes in a 
United Kingdom school were included in a dental screening program. Parental 
consent for the collection of dental plaque samples was obtained for 48 children, 
and the children were recruited into the study. Six children were excluded from 
the study due to the use of an antibiotic other than amoxicillin in the 3 months 
prior to sampling, and two children were unavailable for sampling. Samples were 
obtained from 40 children (21 girls, 19 boys). Study group 1 consisted of 25 
children who had not used any class of antibiotic in the 3 months prior to 
sampling, and the second study group consisted of 15 children who had used 
amoxicillin in the 3 months prior to sampling. The local Research and Ethics 
Committee approved the study.
Sample collection and processing. Plaque samples were taken from the entire 
dentition of the supragingival region of each subject by use of a calcium alginate 
swab (Technical Service Consultants Ltd., Heywood, United Kingdom). The 
swab was immediately placed into 4 ml of prereduced Calgon-Ringer solution 
(Oxoid Ltd., Basingstoke, United Kingdom) in a sterile bijou containing five 
sterile 2-mm-diameter glass beads (B DH  Chemicals, Poole, United Kingdom). 
The samples were mixed with a vortex mixer for a minimum of 30 s or until the 
calcium alginate had dissolved. A 10-fold serial dilution of the sample was 
prepared in prereduced tryptone soy broth (Oxoid Ltd.). The total number of 
cultivable bacteria in the specimen was calculated by inoculating samples onto 
Iso-Sensitest agar (Oxoid Ltd.) containing 5% defibrinated horse blood (TCS 
Microbiology, Botolphclaydon, United Kingdom). To determine the number of 
amoxicillin-resistant bacteria, samples were inoculated onto Iso-Sensitest agar 
containing 5% defibrinated horse blood and 8 mg of ampicillin liter-1 (19). The 
plates were incubated in an anaerobic chamber (MACS 1000; Don Whitley 
Scientific Ltd., Shipley, United Kingdom) at 3 T C  for 5 days, and a duplicate set 
was incubated in air supplemented with 5% carbon dioxide at 37°C for 2 days. 
After incubation, the amoxicillin-resistant morphotypes were enumerated sepa­
rately. These were then subcultured and incubated under both aerobic and 
anaerobic conditions to ascertain atmospheric requirements and stored at -70°C  
for further identification.
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Identification. Identification of the amoxicillin-resistant bacterial species was 
carried out by a combination of the Gram stain reaction, enzyme and carbohy­
drate utilization determination (25), and partial 16S rRNAgene sequencing. The 
16S rR N A  gene was amplified by PCR with global primers (primers 27f and 
1492r; Genosys, Sigma, Poole, United Kingdom) and by subsequent partial D N A  
sequencing (10, 26) with an A B I 310 genetic analyzer (PE Biosystems, War­
rington, United Kingdom). The sequences were analyzed by use of the Ribo­
somal Database Project I I  database (12) and the BLAST algorithm at the 
National Center for Biotechnology Information (2).
Statistical analysis and biodiversity. To calculate the percentage of the culti­
vable microbiota resistant to each antibiotic, the total number of resistant iso­
lates was compared with the total number of CFU for each sample. Analysis of 
the total viable counts and the proportions of amoxicillin-resistant microbiota in 
children with and without amoxicillin use in the previous 3 months was carried 
out by the Mann-Whitney U  test. Any differences in the proportions of amoxi­
cillin-resistant bacteria also resistant to additional antibiotics between the two 
groups was assessed by the chi-square test. Data were analyzed with SPSS 
software (22), and the 5%  level of statistical significance was used throughout 
these analyses. The Shannon-Weaver index of diversity (H) was used to deter­
mine the species diversity of antibiotic-resistant bacteria by using the function 
- X  [P, ln(P,)]. P, is equal to n/N, where n is the number of an individual species, 
and N  is the total number of all species (21). H  equals zero when only one species 
is present and increases with species diversity.
Antibiotic susceptibility testing. Susceptibility testing was performed by an 
agar dilution method (3). Concentrations ranging from 0.06 to 512 mg of peni­
cillin, ampicillin, erythromycin, or tetracycline liter-1 were incorporated into 
Iso-Sensitest agar supplemented with 5%  (vol/vol) defibrinated horse blood, and 
incubated at 37°C for 16 to 20 h. The inoculum was standardized and applied to 
the agar surface with a multipoint inoculator (Mast, Merseyside, United King­
dom). The M IC  was defined as the lowest concentration of antibiotic that 
inhibited visible growth.
RESULTS
Identification of amoxicillin-resistant bacteria. In total, 224 
amoxicillin-resistant bacteria (M IC  range, 8 to 128 mg liter-1) 
were isolated from the 40 children (Table 1). In addition to 
those shown in Table 1, three or fewer isolates of Capnocyto- 
phaga granulosa, Capnocytophaga sputigena, Fusobacterium nu- 
cleatum, Gemella haemotysans, Haemophilus haemolyticus, 
Haemophilus segnis, Leptotrichia buccalis, Neisseria perflava, 
Neisseria pharyngis, Neisseria sicca, Neisseria subflava, Staphy­
lococcus epidermidis, Staphylococcus wameri, Rothia mucilagi- 
nosa, Streptococcus cristatus, Streptococcus intermedius, Strep­
tococcus mutans, Streptococcus parasanguis, Streptococcus 
pneumoniae, and Veillonella atypica were recovered. O f these 
224 isolates, 128 amoxicllin-resistant bacteria (9 genera and 25 
species) were isolated from the 25 children who had not taken 
antibiotics and 96 amoxicillin-resistant bacteria (6 genera and 
19 species) were isolated from the 15 children with previous 
amoxicillin use, with 5 genera and 13 species common to both. 
The biodiversity of the amoxicillin-resistant oral microbiota 
was similar in the isolates from children with (H  = 2.6) and 
without (H  = 2.8) previous amoxicillin use. Of the amoxicillin- 
resistant isolates recovered from children with and without 
amoxicillin use, the majority, 83.5 and 81.3%, respectively, 
comprised three main genera: Haemophilus spp., Streptococcus 
spp., and Veillonella spp. F. nucleatum, L. buccalis, N. pharyn­
gis, S. cristatus, S. intermedius, and S. mutans were cultured only 
from children who had taken amoxicillin in the 3 months prior 
to sampling. However, C. granulosa, C. sputigena, G. haemo- 
lysans, H. haemolyticus, H. segnis, N. perflava, N. sicca, N. sub­
flava, S. epidermidis, S. wameri, R. mucilaginosus, and S. pneu­
moniae were isolated only from subjects without recent 
antibiotic use.
Proportion and prevalence of amoxicillin-resistant bacteria.
There was no significant difference in the total counts of the 
oral microbiota between the two study groups (Table 2). All 40 
children harbored amoxicillin-resistant oral bacteria; conse­
quently, there were no differences in the number of children 
harboring antibiotic-resistant bacteria. However, the use of 
amoxicillin in the 3 months prior to sampling significantly in­
creased both the total number of amoxicillin-resistant bacteria 
(P <  0.01) and the proportion of the oral microbiota resistant 
to amoxicillin (P <  0.01). The median percentage of the amoxi­
cillin-resistant oral microbiota increased from 2.4% in subjects 
who had not used antibiotics to 10.9% in subjects who had used 
amoxicillin in the 3 months prior to sampling, with 97% of the 
oral microbiota in one subject resistant to amoxicillin (Table 
2).
Antibiotic resistance patterns. The distribution of the 
amoxicillin MICs for the 128 amoxicillin-resistant bacteria iso­
lated from subjects who had not used antibiotics in the previ­
ous 3 months and the 96 amoxicillin-resistant bacteria isolated 
from subjects who had used amoxicillin in the previous 3 
months are shown in Fig. 1. The amoxicillin MICs ranged from 
8 to 128 mg liter-1 for bacteria isolated from both study 
groups. The M IC  at which 50% of isolates are inhibited 
(M IC 50) was 16 mg liter-1 for bacteria isolated from both 
study groups; however, the M IQ *, for the isolates from chil­
dren who had used amoxicillin in the previous 3 months was 
higher (64 mg liter-1) than that for the isolates from subjects 
who had not used antibiotics (16 mg liter-1 ). The majority of 
the amoxicillin-resistant isolates (64.1 and 65.6% of the iso­
lates from subjects without and with amoxicillin use, respec­
tively) were also resistant to at least one of the three other 
antibiotics tested: penicillin, erythromycin, and tetracycline 
(Table 3). Resistance to penicillin was the most frequently 
encountered, with 49.0 and 52.3% of the isolates from subjects 
with and without amoxicillin use, respectively, being resistant 
to this antibiotic. Only 15.6% of the isolates from both of the 
study groups were resistant to tetracycline. However, signifi­
cantly (P =  0.03) more of the isolates (32.3%) from subjects 
who had used amoxicillin than isolates from subjects who had 
not used antibiotics (19.5%) were resistant to erythromycin. In 
total, 17 amoxicillin-resistant isolates were also resistant to 
penicillin, erythromycin, and tetracycline; and these were iden­
tified as Streptococcus mitis (8 isolates), Streptococcus salivarius 
(3 isolates), and single isolates each of S. mutans, Streptococcus 
oralis, Streptococcus sanguis, S. parasanguis, S. epidermidis, and 
G. haemolysans.
DISCUSSION
Amoxicillin is used in dentistry for the treatment of dental 
alveolar abscesses, endodontic infections, advanced forms of 
periodontal diseases, and prophylaxis for infective endocarditis 
and is used in medicine for the treatment of otitis media, 
sinusitis, bronchitis, and community-acquired pneumonia (4). 
Consequently, factors that promote an increase in amoxicillin 
resistance in the oral microbiota are of concern to both dental 
and medical practitioners.
Antibiotic resistance studies have generally relied on the 
isolation of bacteria on antibiotic-free plates and subsequent 
testing of susceptibility to a range of antibiotics. This method-
TABLE 1. MIC range, MICS0s, and MIC^s of amoxicillin, penicillin, erythromycin, and tetracycline for amoxicillin-resistant isolates
Amoxicillin-resistant bacterium and M IC  (mg liter •) Frequency of resistance
antibiotic Range 50% 90% (no. [%] of isolates)"



















































































































































































































































" M IC  breakpoints were as follows: for Staphylococcus sp., non-S. pneumoniae Streptococcus sp., and G. haemofysans resistance, penicillin, >0.25 mg liter 
erythromycin, >1  mg liter-1 ; tetracycline, a 2  mg liter-1 ; for S. pneumoniae resistance, penicillin, >2  mg liter-1 ; erythromycin, >1 mg liter-1 tetracycline, 2 2  mg 
liter-1 ; for Neisseria sp. resistance; penicillin, > 2  mg liter-1 ; tetracycline, 2 2  mg liter-1 ; for Haemophilus spp. resistance, eiythromycin, 216  mg liter-1 ; tetracycline, 
2 2  mg liter-1 ; for F. nucleatum , Veillonella sp., and P. melaninogenica resistance, penicillin, 2 2  mg liter-1 ; for Capnocytophaga spp., L. buccalis, and R. mucilaginosus, 
guidelines not available (3).
*  — ( no recommendations currently available (3).
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Median (range) total count (C FU / 
ml)
No. (% ) of children harboring 
ampicillin-resistant bacteria
Median (range) count (CFU/ml) of 
amoxicillin-resistant bacteria
Median (range) % microbiota 
resistant to amoxicillin
+
5.5 X  106 (1.0 X  106-7.8 X  107) 
3.2 X  10A (1.2 X  106-3.0 X  107)
100(25)
100(15)
1.3 X  105 (1.0 X  103-7.2 X  10s) 
6.0 X 105" (5.1 X  104-2.8 X  10fi)
2.4 (0.1-14.3) 
10.9“ (0.8-97.3)
“ P < 0.01 (Mann-Whitney test).
ology selects for the detection of resistance in the predominat­
ing microbiota. In this study, the use of ampicillin-containing 
plates allowed the isolation of resistant bacteria. The propor­
tion of resistant bacteria ranged from 0.1 to 97% of the total 
cultivable oral microbiota. Previous studies have shown that 
concentrations of amoxicillin in the oral cavity after adminis­
tration of a single antibiotic dose range from 0.1 to 0.5 mg 
liter-1 in saliva (14, 23) and 1 to 14 mg liter-1 in gingival 
crevicular fluid (1, 24). The concentration of 8 mg of ampicillin 
liter-1 was chosen, as it reflects the concentration found in the 
oral cavity and is comparable to that used in other relevant 
studies (18, 19). Amoxicillin-resistant bacteria were readily iso­
lated, with all of the 40 children harboring amoxicillin-resistant 
bacteria in their oral cavities, which concurs with the results 
obtained in a previous study (19). The use of amoxicillin sig­
nificantly increased both the total number of amoxicillin-resis­
tant bacteria and the proportions of the oral microbiota resis­
tant to amoxicillin. Previous studies have shown that 
amoxicillin use can increase the number of amoxicillin-resis­
tant oral streptococci isolated from the oral cavity (8, 27) and 
that the use of beta-lactam antibiotics can increase the rate of 
carriage of penicillin-resistant S. pneumoniae (7). Interestingly, 
the counts for the total microbiota did not significantly in­
crease with amoxicillin use, which suggests that there was a loss 
of the amoxicillin-susceptible microbiota that was replaced by 
a significant increase in amoxicillin-resistant bacteria. The 
amoxicillin-resistant bacteria comprised 31 different species 
and 11 different genera. Amoxicillin use did not alter the biodi­
versity of the amoxicillin-resistant microbiota, which suggests 
that the increase in the number and proportion of the amoxi­
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increase but, rather, to an overall increase in a diverse collec­
tion of amoxicillin-resistant bacteria.
The MIQxjS of amoxicillin were increased for the isolates 
from children who had used amoxicillin during the 3 months 
prior to sampling. Previous studies have reported increased 
MICs after penicillin-susceptible strains of S. pneumoniae were 
subcultured in amoxicillin- or amoxicillin-clavulanate-contain- 
ing media (5,17), and the presence of amoxicillin in the saliva 
and gingival crevicular fluid during amoxicillin use may have 
provided the selective pressure necessary for this increase in 
the MICqq. The subjects in this study would have received 
amoxicillin as an oral suspension (125 mg/5 ml) rather than in 
the tablet form, which is used in adults. Therefore, in addition 
to the presence of amoxicillin in the saliva and gingival crev­
icular fluid, which would occur in all patients after amoxicillin 
use, it is possible that young children have an additional anti­
biotic challenge, as the antibiotic suspension itself may also be 
able to persist in the oral cavity. Hence, other studies have 
demonstrated that oral suspensions of carbohydrates can re­
main in the oral cavity for over 1 h (11) and that young children 
(age, 3 to 7 years old) have a slower salivary clearance than 
older children and adults (6).
Multiantibiotic-resistant bacteria were frequently seen in the 
samples taken from the children. Indeed, we observed that the 
use of amoxicillin significantly increased the number of amoxi­
cillin-resistant isolates which were additionally resistant to 
erythromycin. We have previously shown in vitro that the use 
of tetracycline selected for bacteria that were resistant to sev­
eral antibiotics, leading to an increase in the overall level of
TABLE 3. Multiresistance profiles as numbers and proportions of 
amoxicillin-resistant bacteria from subjects with and without 
amoxicillin use in the previous 3 months resistant to three 
additional antibiotics
AtaoUcM n MC 4ag*n«
FIG. 1. M IC  o f amoxicillin for isolates from children with and 
without amoxicillin use in the previous 3 months. White bars, no 
amoxicillin use; black bars, amoxicillin use.
Antimicrobial agent
No. (% ) of resistant 
isolates




AM X 46 (35.9) 33 (34.4)
AMX-penicillin 52 (40.6) 28 (29.2)
AMX-erythromycin 4(3.1) 9 (9.4)*
AMX-tetracyciine 5 (3.9) 3(3.1)
AMX-penicillin-erythromycin 6(4.7) 11 (11.5)
AMX-penicillin-tetracycline 0(0) 1 (1.0)
AMX-erythromycin-tetracycline 6(4.7) 3 (3.1)
AMX-penicillin-erythromycin-tetracycline 9 (7.0) 8 (8.3)
Total 128 (100) 96 (100)
“ A M X , amoxicillin. 
b P < 0.05 (chi-square test).
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resistance in the population (18). Multiple prescriptions of 
antibiotics are common throughout childhood (13), and thus, 
their use could result in the repeated selection of an antibiotic- 
resistant oral microbiota. This is of concern, as patients who 
become infected with antibiotic-resistant bacteria in the com­
munity have been shown to have a higher incidence of hospi­
talization, longer durations of stay in hospital, and increased 
mortality compared to patients infected with antibiotic-sensi­
tive strains (9).
This study has demonstrated that amoxicillin-resistant bac­
teria comprising a wide variety of species are present in the 
oral cavity and that the number, proportions, MICs, and resis­
tance to erythromycin can significantly increase with amoxicil­
lin use.
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The aim of this study was to investigate the effects of tetracycline administration on the 
viability and antibiotic resistance profiles of microcosm dental plaques. A constant depth film 
fermenter was used to generate multi-species biofilms, which were grown for 216 h before 
tetracycline was added. The composition of the microcosm plaques was determined by viable 
counting on selective and non-selective media. The prevalence of antibiotic-resistant organ­
isms was determined on antibiotic-containing media. Before administration of tetracycline, the 
biofilms had a total viable anaerobic count of 7 x 107 cfu per biofilm. They contained 7% lacto- 
bacilli, 19% streptococci and 2% Actinomyces spp. Immediately after pulsing with tetracycline, 
the composition of the biofilms changed and they consisted of 30% lactobacilli, 1.5% strepto­
cocci and 3% Actinomyces spp., with a total anaerobic count of 1 x 107 cfu per biofilm. The pre­
valence and composition of the antibiotic-resistant microflora changed dramatically after the 
addition of tetracycline, with the proportion of the microflora displaying resistance to tetra­
cycline increasing from 6% to 45%. Corresponding changes in the proportions of the microfiora 
displaying resistance to other antibiotics were as follows: 5-28% for erythromycin, 1-5% for 
vancomycin and 0.4-3% for ampicillin. The results of this study have shown that the addition of 
tetracycline to microcosm dental plaques alters their composition and enriches for bacteria 
resistant to tetracycline and other unrelated agents.
Introduction
The tetracyclines came into clinical practice over 50 years 
ago1 and are considered a relatively safe group o f bacterio­
static antibiotics.2 With a broad spectrum of activity, few side 
effects and low cost, they are a popular group of antibiotics 
for clinical use. In 1994 in the UK over 20% of the orally 
administered antibiotics sold were tetracyclines.3 This group 
of antibiotics is used for the treatment of a range o f bacterial 
infections, including those o f the skin, oral cavity and respir­
atory tract, and is widely used in dentistry. Although there 
has been some variability in the success of clinical treat­
ment,4 6 topically and systemically administered tetracy­
clines have been, and still are, used for the treatment of 
periodontal and endodontal infections.
There is growing concern over the emergence of anti­
biotic-resistant bacteria. Lacroix &  Walker7 showed that 
from 68 patients with adult periodontitis, the numbers of 
tetracycline-resistant bacteria from subgingival plaque 
samples represented c. 12% of the total viable count. In a 
separate study, the median percentage of the oral microflora 
resistant to doxycycline, a tetracycline derivative, was shown 
to be 4.3%, ranging from 0% to 26% in the saliva of 20 
human subjects.8 The extensive use of antimicrobials both in 
the community and hospitals has accelerated the emergence 
of antibiotic-resistant organisms.9 11 This has caused increas­
ing concern in the medical and scientific community as to the 
level of antibiotic use in the general population and the 
degree of inappropriate antibiotic prescription. The biofilm 
mode of growth can also affect antibiotic sensitivity.
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Bacteria living in biofilms in general are considered less 
susceptible to antibiotics than free-living bacteria.12 When 
Pseudomonas aeruginosa cells that were susceptible to 
tobramycin were grown as a biofilm, there was a c. 1000-fold 
reduction in susceptibility to this antibiotic.13 The attachment 
of Klebsiella pneumoniae to the surface of a glass slide 
resulted in a 150-fold decrease in susceptibility to hypochlor- 
ous acid.14 When treating biofilm-associated Porphyro- 
monas gingivalis with metronidazole the MICs were 160 
times higher than those obtained for planktonic cells.15 
Another study has reported that in order to eliminate bacteria 
grown in biofilms, MICs greater than 500 times the M IC  
determined for planktonic culture may be required.16
The purpose o f this study was to determine the bacterial 
composition and the antibiotic susceptibility o f microcosm 
dental plaques. Resistance to penicillin, ampicillin, erythro­
mycin, chloramphenicol, tetracycline and vancomycin was 
investigated before and after the addition of tetracycline in 
concentrations that could be found in the oral cavity 




Human saliva was used as an inoculum to provide a multi­
species biofilm consisting o f organisms found in the oral 
cavity. The saliva was collected from 10 healthy individuals 
who had not taken antibiotics in the previous 3 months, and 
an equal volume from each of the subjects was pooled. A li­
quots o f 1 mL were stored at -80°C  for subsequent use.
Production o f biofilms
Biofilms were grown in a constant depth film fermenter 
(CDFF; University of Wales, Cardiff, UK) as described by 
Wilson.17 The CDFF is a sophisticated means of generating 
large numbers of identical biofilms and has been used to 
investigate factors that may influence the growth o f bacterial 
communities in the oral ecosystem.18 Previous studies involv­
ing the growth o f microcosm plaques in the CDFF from saliva 
samples have shown good reproducibility between runs.1920 
Briefly, the CDFF is comprised of a stainless steel turntable, 
which rotates under polytetrafluoroethylene (PTFE) scraper 
blades. The turntable holds 15 PTFE pans flush around its 
rim, each having five vertical holes containing 5 mm diam­
eter PTFE plugs. The biofilms were grown on bovine enamel 
discs, 5 mm in diameter and 1 mm in depth, which sit on the 
plugs and were recessed 300 pm below the height of the pan. 
Media and nutrients enter through a stainless steel plate at the 
top o f the fermenter, which also has an air inlet and sample 
port, whereas the base plate has an effluent outlet. The
nutrient source for the experiments was a mucin-containing 
artificial saliva, the composition of which has been described 
previously.21
Inoculation o f the C D F F
Seven hundred and fifty microlitres of the pooled saliva were 
added to 500 mL of artificial saliva. This was mixed and 
pumped into the CDFF for 8 h. After this time, the inocu­
lation vessel was disconnected and the medium reservoir 
containing sterile artificial saliva was connected to the 
CDFF. The artificial saliva was delivered via a peristaltic 
pump (Watson-Marlow, Falmouth, UK) at a rate of 0.5 mL/ 
min, corresponding to the resting salivary flow rate in 
man.22-24
Antibiotic delivery
Experiments were carried out with and without the addition 
of tetracycline. For the administration o f tetracycline, 100 
mL of sterile artificial saliva containing 2 mg/L tetracycline 
(Sigma, Poole, UK) were pumped into the CDFF for 2 h via a 
second peristaltic pump. After this period, the concentration 
of tetracycline was increased to 12 mg/L for 1 h, which was 
subsequently followed by a 2 h addition of 2 mg/L tetra­
cycline. These concentrations o f antibiotic were selected as 
they mimic the peak concentration of tetracycline found in 
the oral cavity after a single systemic dose.25
Culture methods
Pans were removed from the CDFF before and after the addi­
tion o f tetracycline, the bovine enamel discs were aseptically 
removed and placed into 1 mL of phosphate-buffered saline 
(Sigma), and then vortexed for 1 min to disrupt the biofilm. 
Three discs from each pan were used for determining the 
bacterial composition of the biofilms; spread-plating of each 
biofilm was carried out in duplicate. The total anaerobic 
count was carried out on Fastidious anaerobic agar (FAA) 
(LabM, Bury, U K) containing 5% defibrinated horse blood 
(E and O Laboratories, Bonnybridge, UK). Lactobacilli were 
isolated from FAA plates on the basis o f colonial 
morphology, Actinomyces spp. were isolated on Cadmium 
fluoride/acriflavin/tellurite agar plates26 and streptococci 
were isolated on Mitis Salivarius agar (Difco Laboratories, 
Detroit, M I, USA). A ll o f the plates were incubated 
anaerobically for 3 days at 37°C. Antibiotic-resistant organ­
isms were isolated on Isosensitest agar (Oxoid, Basingstoke, 
UK) containing 5% defibrinated horse blood supplemented 
with antibiotics (Sigma) at the following concentrations: 
penicillin 4 mg/L, ampicillin 8 mg/L, erythromycin 1 mg/L, 
tetracycline 10 mg/L, chloramphenicol 5 mg/L and vanco­
mycin 8 mg/L.27 Plates were incubated either anaerobically 
or aerobically at 37°C for 3 days. Organisms were identified
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Figure 1. Total viable counts before and after the addition o f tetracycline, designated by filled symbols: total anaerobic count, filled diamonds; 
lactobacilli, filled squares; streptococci, filled triangles; actinomycetes, filled circles. Dotted lines and open symbols represent the control 
experiments in which tetracycline was not added: total anaerobic count, open diamonds; lactobacilli, open squares; streptococci, open triangles; 
actinomycetes, open circles. Error bars represent s.D.
by Gram-reaction, biochemical analysis and PCR amplifica­
tion with subsequent partial DNA sequencing of their 16S 
rRNA gene as described previously28 using universal 
primers.29 Identifications were obtained by the use of the 
ribosomal database.30 DNA sequencing was carried out using 
an A B B  10 Genetic Analyser (PE Biosystems, Warrington, 
UK). Further differentiation o f the various streptococcal 
species was achieved by carbohydrate fermentation and 
enzyme substrate utilization tests.31
Results
Composition o f biofilms
Before the addition of tetracycline at 221 h, the microcosm 
plaques had a mean total viable anaerobic count of 7 x 107 
±  3.6 x 107 cfu per biofilm (Figure 1). This value changed 
after the pulse of tetracycline to the fermenter, there was an 
immediate reduction in the total viable anaerobic count to
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Table 1. Percentage microbial composition of microcosm plaques, compared with the total anaerobic 
count, before (216 h) and after (221 h) the addition of tetracycline (5 h addition of tetracycline between 
216 and 221 h)
Species
Time (h)
72 216 221 240 336 408
Lactobacilli 0.07 6.74 30.62 24.58 30.13 31.63
Streptococci 1.7 18.71 1.46 11.98 13.38 3.27
Actinomyces spp. 1.2 2.14 3.07 0.95 4.25 4.31
1.3 x 107 cfu per biofilm. This was further reduced with a 
94% kill to 6 x 106 cfu per biofilm 24 h (240 h) after the addi­
tion of tetracycline. The total anaerobic viable count never 
fully recovered to the pre-tetracycline level (Figure 1). There 
was no obvious effect on the numbers of lactobacilli immedi­
ately after pulsing with tetracycline; however, 24 h after 
pulsing, the numbers of viable lactobacilli reduced to 1.5 x 
106 cfu per biofilm, which was followed by an increase in the 
viable lactobacilli count up to 8 days post-delivery. The 
greatest reductions in the viable counts were seen for the 
streptococci, with a reduction o f 98.5%, decreasing from
1.3 x 107 to 1.9 x 105 cfu per biofilm (Figure 1) immediately 
after tetracycline delivery. The number o f Actinomyces spp. 
also decreased after the addition of tetracycline with a reduc­
tion of 96% 24 h post-antibiotic delivery.
The relative proportions of bacteria in the biofilm changed 
dramatically after the addition of tetracycline to the fermenter 
(Table 1). The composition changed from a community in 
which streptococci predominated to one in which Lacto­
bacillus was the predominant genus. These compositional 
changes were not observed in the control biofilms grown in 
the absence o f tetracycline (Figure 1).
Antibiotic resistance profile
There were 11 vancomycin-resistant isolates, all identified as 
Lactobacillus fermentum, which are intrinsically resistant to 
this antibiotic. The 21 tetracycline-resistant isolates were iden­
tified as L. fermentum, Streptococcus gordonii, Streptococcus 
mitis, Streptococcus oralis, Streptococcus parasanguinis, 
Streptococcus salivarius and Streptococcus sanguinis. 
Multi-antibiotic-resistant bacteria were readily isolated; o f 
the tetracycline-resistant isolates, 67% were also resistant 
to erythromycin and 11% were intrinsically vancomycin 
resistant.
Immediately before and after tetracycline delivery all anti­
biotic-resistant viable counts were of a similar level. 
However, the antibiotic resistance profile of the community 
dramatically changed from 24 h post-tetracycline delivery 
(240 h). The numbers of viable erythromycin-resistant
isolates had decreased by 92.6%, and remained depressed 
throughout the study. The tetracycline-resistant microflora 
mirrored the response of the erythromycin-resistant isolates; 
at 8 days post-tetracycline addition the numbers o f viable 
tetracycline-resistant isolates had reduced by 92%.
In contrast, the number of vancomycin-resistant isolates 
remained constant up to 24 h post-antibiotic delivery, being 
6.5 x 105 cfu per biofilm. The viable counts for the vanco­
mycin-resistant bacteria then increased over time reaching 
2.7 x 106 cfu per biofilm. The microcosm altered in composi­
tion from one where a tetracycline- and erythromycin- 
resistant microflora predominated, to one at 8 days post-puls­
ing where the vancomycin-resistant bacteria were the greatest 
component. There was a slight increase in the number of 
ampicillin-resistant bacteria immediately after tetracycline 
delivery. Penicillin-resistant and chloramphenicol-resistant 
isolates were undetectable.
The percentage of the total microflora that was resistant to 
the four different antibiotics changed substantially after the 
addition o f tetracycline (Figure 2). Tetracycline-resistant 
isolates showed an immediate increase after the 5 h tetracy­
cline pulse from 6% to 45% of the total microflora; however, 
this subsequently reduced until 8 days after the pulse the 
percentage had reduced to a level just below that obtained 
before the pulse (4.5%). The percentage of erythromycin- 
resistant isolates also increased after the tetracycline pulse, 
increasing from 5% to 28%, which also subsequently 
reduced over time. Initially, there was a slight increase in the 
percentage of vancomycin-resistant isolates from 1% to 5% 
immediately after the addition of tetracycline. This increase 
continued with the vancomycin-resistant isolates reaching a 
maximum of 30% of the total viable microflora. Duplicate 
test runs were carried out, each over a 408 h period. For each 
run, the addition o f tetracycline altered the composition and 
increased the proportions of antibiotic-resistant bacteria. In 
the control biofilms grown in the absence of tetracycline, the 
proportions of antibiotic-resistant bacteria did not vary over 
408 h. The mean percentage of the oral microflora resistant to 
each of the antibiotics in the control biofilms was: ampicillin
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Figure 2. Percentage o f the viable bacteria resistant to one o f four different antibiotics before and after the addition o f tetracycline (221 h). 
Ampicillin, squares; erythromycin, triangles; tetracycline, crosses; vancomycin, circles.
0.01% (range 0-0.02% ), erythromycin 0.7% (0.3-2.0% ), 
tetracycline 2.6% (1.4-5.8% ) and vancomycin 2.3% (1 .4 - 
3.8%).
Discussion
The purpose of this study was to determine the effect of a 
single tetracycline pulse on the viability, composition and 
antibiotic resistance profile of microcosm dental plaques. 
The addition of tetracycline to the model system to concentra­
tions that can be obtained in the oral cavity was found to have 
a profound effect on the composition of the biofilms. The 
total anaerobic count was unable to recover to that observed 
before pulsing and remained depressed throughout the study. 
The reduction in sensitive populations was in part respons­
ible for the observed increase in the proportions o f anti­
biotic-resistant bacteria. Preus et a 1.32 demonstrated a similar 
reduction in total numbers of cultivable bacteria after topical 
application of minocycline in a clinical study. Tetracycline- 
sensitive oral bacterial species are defined as having MICs of 
<4 mg/L.27 The administration of tetracycline 12 mg/L, only 
three-fold higher than this, reduced the total anaerobic count 
by 94%, indicating that the majority of the bacteria existing 
in the biofilm were sensitive to clinically obtainable levels of 
tetracycline.25 Other studies have reported that to eliminate 
bacteria grown in biofilms, MICs greater than 500 times or 
even 1000 times the M IC  found in batch culture may be 
required.1316 In the present study, a single pulse o f tetra­
cycline was sufficient to alter the microbial composition of 
the microcosm plaques with a notable change from a micro­
flora predominating in streptococci to one where lactobacilli 
predominated. The lactobacilli were identified as strains of
L. fermentum, an organism that has been shown to have cario- 
genic potential.33 34
The presence of tetracycline also resulted in a change in 
the antibiotic resistance profile of the biofilms. The emerg­
ence o f antibiotic-resistant bacteria has frequently been 
reported to be a direct result of antibiotic usage9-35 and in the 
present study the addition of tetracycline resulted in an 
increase in the proportions of ampicillin-, erythromycin-, 
tetracycline- and vancomycin-resistant isolates; these anti­
biotics are members of four different classes of antibiotics. 
The ampicillin-resistant microflora before the addition of 
tetracycline comprised <0.5% of the total anaerobic count, 
consistent with results obtained from other studies which 
demonstrated that ampicillin-resistant bacteria only consti­
tute a low percentage of the oral microflora.8'36 In the present 
study, it was not until the addition o f tetracycline to the 
system that the percentage of ampicillin-resistant isolates 
increased, reaching a maximum of 4% o f the total anaerobic 
microflora.
Our data show that a pulse of tetracycline is selecting for 
organisms that are resistant to multiple antibiotics. This is not 
surprising, as multiply resistant bacteria are frequently 
isolated so that selection for one resistance will increase the 
overall level o f resistance in a population. Furthermore, in 
additional work we have demonstrated the presence of 
Tn9/6-like elements in the tetracycline-resistant strepto­
cocci isolated.37 These conjugative transposons have been 
shown to transfer within the model oral biofilms37 and this 
may also account for the observed increase in the proportions 
of antibiotic-resistant bacteria. These elements commonly 
contain resistances to antibiotics other than tetracycline 
(especially erythromycin), and tetracycline can stimulate the
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transfer o f these elements. Therefore, pulsing the oral cavity 
with tetracycline could lead to the spread of these genetic 
elements through the oral microflora. It has been shown that 
i f  people are fed low doses of tetracycline, their faecal enteric 
microflora can acquire tetracycline resistance, and may also 
become multi-resistant.38
The antibiotic profile data demonstrate that there was also 
a dramatic increase in the percentage of vancomycin- 
resistant bacteria after the addition of tetracycline. This 
change reflects the increase in proportions of lactobacilli. 
The vancomycin-resistant isolates in the study were members 
of the intrinsically resistant Lactobacillus genus, in partic­
ular L. fermentum .
Tetracyclines may be administered for the treatment of a 
range o f bacterial infections and for their non-antibacterial 
properties. This investigation has demonstrated that the addi­
tion o f tetracycline at clinically obtainable levels to a model 
oral biofilm not only substantially alters the bacterial compo­
sition, but also the antibiotic resistance profile of the micro­
bial community.
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